a3560095.s4	One CD 0	patient NN B-noun.person	was VBD 0	prematurely RB B-adv.all	discontinued VBN B-verb.stative	from IN 0	the DT 0	study NN B-noun.artifact	for IN 0	severe JJ B-adj.all	headache NN B-noun.state	and CC 0	abdominal_pain NN B-noun.person	. . 0	. . 0
a8073369.s9	No DT 0	histopathological JJ B-adj.all	alterations NNS B-noun.act	or CC 0	differences NNS B-noun.communication	in IN 0	bone NN 0	formation NN B-noun.act	were VBD 0	seen VBN B-verb.perception	in IN 0	the DT 0	limbs NNS B-noun.animal	or CC 0	toes NNS 0	of IN 0	any DT 0	chicks NNS B-noun.possession	from IN 0	any DT 0	group NN B-noun.possession	, , 0	however RB 0	, , 0	extensive JJ B-adj.all	cranial_hemorrhage NN B-noun.artifact	occurred VBD B-verb.stative	in IN 0	all DT 0	nicotine JJ B-adj.all	sulfate NN B-noun.person	- : 0	treated VBN B-verb.social	chicks NNS B-noun.possession	. . 0	. . 0
a20698227.s9	CONCLUSION NN B-noun.group	, , 0	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	study NN B-noun.artifact	in IN 0	the DT 0	literature NN B-noun.act	investigating VBG B-verb.stative	a DT 0	link NN B-noun.artifact	between IN 0	angiogenesis NN B-noun.location	soluble JJ B-adj.all	markers NNS B-noun.person	and CC 0	ribavirin NN 0	induced VBN B-verb.creation	anemia NN B-noun.state	in IN 0	patients NNS B-noun.person	with IN 0	hepatitis NNP B-noun.person	C NNP I-noun.person	and CC 0	we PRP 0	could MD 0	not RB B-adv.all	find VB B-verb.change	any DT 0	relation NN B-noun.possession	. . 0	. . 0
a10704919.s7	This DT 0	was VBD 0	further RBR B-adv.all	evidenced VBN B-verb.communication	by IN 0	absence NN B-noun.act	of IN 0	oxygen NN B-noun.animal	consumption NN I-noun.animal	and CC 0	hemoglobin NN B-noun.person	oxidation NN B-noun.person	both DT 0	determined VBD B-verb.communication	in IN 0	parallel NN 0	with IN 0	TAM NNP B-noun.group	- : 0	induced VBN B-verb.communication	hemolysis NN I-verb.communication	. . 0	. . 0
a7269015.s3	The DT 0	similarity NN B-noun.attribute	between IN 0	the DT 0	histologic JJ B-adj.pert	appearances NNS B-noun.attribute	of IN 0	busulfan JJ B-adj.all	cystitis NN B-noun.state	and CC 0	both DT 0	radiation NN B-noun.act	and CC 0	cyclophosphamide NN B-noun.person	- : 0	induced VBN B-verb.creation	cystitis NN 0	is VBZ 0	discussed VBN B-verb.communication	and CC 0	the DT 0	world NN B-noun.cognition	literature NN I-noun.cognition	reviewed VBN B-verb.change	. . 0	. . 0
a10739826.s7	These DT 0	analyses NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	the DT 0	higher JJR B-adj.all	risk NN B-noun.person	observed VBN B-verb.perception	for IN 0	the DT 0	newer JJR B-adj.all	OC NNP 0	in IN 0	other JJ 0	studies NNS B-noun.group	may MD 0	be VB B-verb.stative	the DT 0	result NN B-noun.act	of IN 0	inadequate JJ B-adj.all	comparisons NNS B-noun.person	of IN 0	pill NN B-noun.location	users NNS B-noun.person	with IN 0	different JJ B-adj.all	patterns NNS B-noun.artifact	of IN 0	pill NN B-noun.artifact	use NN I-noun.artifact	. . 0	. . 0
a12695819.s1	Our PRP$ 0	objective NN B-noun.cognition	was VBD B-verb.stative	to TO 0	investigate VB B-verb.emotion	brain NN B-noun.group	MR NNP 0	imaging VBG B-verb.cognition	findings NNS B-noun.act	and CC 0	the DT 0	utility NN B-noun.attribute	of IN 0	diffusion NN B-noun.attribute	- : 0	weighted JJ B-verb.social	( ( 0	DW NNP 0	) ) 0	imaging NN B-verb.creation	in IN 0	organ NN B-noun.animal	transplant NN I-noun.animal	patients NNS B-noun.person	who WP 0	developed VBD B-verb.creation	neurologic JJ B-adj.all	symptoms NNS B-noun.body	during IN 0	tacrolimus NN 0	therapy NN 0	. . 0	. . 0
a12202650.s1	The DT 0	pathophysiology NN B-noun.attribute	of IN 0	painful JJ B-adj.all	temporomandibular_disorders NNS B-noun.other	is VBZ B-verb.stative	not RB B-adv.all	fully RB B-adv.all	understood VBN B-verb.cognition	, , 0	but CC 0	evidence NN B-noun.person	suggests VBZ B-verb.communication	that IN 0	muscle_pain JJ B-adj.all	modulates NNS B-noun.substance	motor NN 0	function NN B-noun.act	in IN 0	characteristic JJ B-adj.all	ways NNS B-noun.act	. . 0	. . 0
a6888657.s9	The DT 0	data NNS B-noun.cognition	extend VBP B-verb.stative	the DT 0	findings NNS B-noun.act	of IN 0	other JJ 0	investigators NNS B-noun.person	, , 0	further RB B-adv.all	establishing VBG B-verb.cognition	the DT 0	DES NNP B-noun.group	- : 0	induced VBN B-verb.creation	tumor NN B-noun.feeling	as IN 0	a DT 0	model NN B-noun.person	for IN 0	study NN B-noun.act	of IN 0	PRL NNP 0	cellular JJ B-adj.all	control NN B-noun.act	mechanisms NNS B-noun.person	. . 0	. . 0
a2348231.s7	Dipyridamole NNP B-noun.person	significantly RB B-adv.all	increased VBN B-verb.change	coronary JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	before RB 0	and CC 0	after RB 0	7.5 CD 0	or CC 0	15 CD B-adj.all	mm FW 0	/ FW 0	kg FW 0	i.v FW 0	. . 0	. . 0
a10342929.s1	The DT 0	estimated VBN B-adj.all	incidence NN B-noun.event	of IN 0	angioedema NN 0	during IN 0	angiotensin NN B-noun.person	- : 0	converting_enzyme_(ACE)_inhibitor NN B-noun.relation	treatment NN I-noun.relation	is VBZ B-verb.stative	between IN 0	1 CD B-adj.all	and CC 0	7 CD B-adj.all	per IN 0	thousand CD 0	patients NNS B-noun.person	. . 0	. . 0
a3187073.s6	In IN 0	the DT 0	pre NN B-noun.person	- : 0	treatment NN B-verb.social	evaluation NN B-noun.act	, , 0	signs NNS B-noun.communication	of IN 0	cardiovascular_disease NNP 0	were VBD 0	found VBN B-verb.possession	in IN 0	33 CD 0	patients NNS B-noun.person	( ( 0	43 CD 0	% NN 0	) ) 0	. . 0	. . 0
a10704919.s4	The DT 0	extension NN B-noun.act	of IN 0	hemolysis NN B-noun.animal	is VBZ B-verb.stative	variable JJ B-adj.all	with IN 0	erythrocyte NN B-noun.cognition	samples NNS B-noun.cognition	, , 0	but CC 0	12.5 CD 0	microM IN 0	TAM NNP B-noun.person	induces VBZ B-verb.communication	total JJ B-adj.all	hemolysis NN B-noun.state	of IN 0	all DT 0	tested VBN B-verb.social	suspensions NNS B-noun.person	. . 0	. . 0
a17854040.s4	HBsAg NNP B-noun.person	, , 0	anti NNS B-noun.person	- : 0	HBs NNP B-noun.person	, , 0	anti NNS B-noun.person	- : 0	HBc NNP B-noun.person	, , 0	and CC 0	anti NNS B-noun.person	- : 0	HIV NNP B-noun.group	1/2 CD 0	were VBD 0	determined VBN B-verb.communication	as IN 0	part NN 0	of IN 0	routine JJ B-adj.all	diagnosis NN B-noun.person	using VBG B-verb.consumption	Axsym NNP B-noun.person	assays NNS I-noun.person	( ( 0	Abbott NNP B-noun.group	Laboratories NNP I-noun.group	, , 0	North NNP B-noun.person	Chicago NNP I-noun.person	, , 0	IL NNP 0	) ) 0	. . 0	. . 0
a17491223.s3	METHODS NNS B-noun.attribute	, , 0	The DT 0	study NN B-noun.artifact	group NN I-noun.artifact	comprised VBD B-verb.stative	40 CD B-adj.all	patients NNS B-noun.person	undergoing VBG B-verb.communication	Sestamibi NNP B-noun.person	- : 0	SPECT VB 0	/ DT 0	dobutamine NN B-noun.quantity	stress NN 0	test NN 0	. . 0	. . 0
a9249847.s0	Iatrogenically RB B-adv.all	induced VBN B-verb.creation	intractable JJ B-adj.all	atrioventricular_reentrant_tachycardia NNS B-noun.location	after IN 0	verapamil NN B-noun.artifact	and CC 0	catheter NN B-noun.person	ablation NN B-noun.person	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	Wolff NNP B-noun.person	- : 0	Parkinson NNP B-noun.person	- : 0	White_syndrome JJ 0	and CC 0	idiopathic_dilated_cardiomyopathy JJ B-noun.person	. . 0	. . 0
a84204.s7	They PRP 0	should MD 0	be VB B-verb.stative	closely RB B-adj.all	observed JJ B-verb.perception	and CC 0	should MD 0	be VB 0	given VBN B-verb.possession	reduced JJ B-adj.all	doses NNS B-noun.quantity	of IN 0	cimetidine NN B-noun.act	. . 0	. . 0
a1728522.s2	This DT 0	type NN B-noun.cognition	of IN 0	lesion NN B-noun.act	broadens VBZ B-verb.change	the DT 0	spectrum NN B-noun.artifact	of IN 0	liver_injury NN B-noun.possession	due JJ 0	to TO 0	this DT 0	drug NN 0	combination NN 0	, , 0	mainly RB B-adv.all	represented VBN B-verb.social	by IN 0	a DT 0	benign JJ B-adj.all	cholestatic_syndrome NN B-noun.group	. . 0	. . 0
a15120741.s2	Population NN B-noun.possession	responses NNS I-noun.possession	in IN 0	granule NN B-noun.body	cells NNS I-noun.body	of IN 0	the DT 0	dentate JJ B-adj.all	gyrus NNS B-noun.person	were VBD 0	examined VBN B-verb.communication	in IN 0	transverse NN B-noun.act	slices NNS B-noun.act	of IN 0	the DT 0	ventral JJ B-noun.body	hippocampus NN I-noun.body	from IN 0	pilocarpine NN B-noun.person	- : 0	treated VBN B-verb.communication	and CC 0	untreated JJ B-adj.all	mice NNS B-noun.person	. . 0	. . 0
a2440413.s2	1981 CD 0	) ) 0	. . 0	. . 0
a16680561.s11	These DT 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	during IN 0	concomitant JJ B-adj.all	treatment NN B-noun.communication	with IN 0	cinacalcet NN B-noun.food	, , 0	dose JJ B-adj.all	adjustment NN B-noun.communication	may MD 0	be VB B-verb.stative	necessary JJ B-adj.all	for IN 0	drugs NNS B-noun.artifact	that WDT 0	demonstrate VBP B-verb.stative	a DT 0	narrow JJ B-adj.all	therapeutic JJ B-adj.all	index NN B-noun.communication	and CC 0	are VBP 0	metabolized VBN B-verb.cognition	by IN 0	CYP2D6 NNP B-noun.person	. . 0	. . 0
a20470218.s2	Outcome JJ B-adj.all	improvement NN B-noun.state	with IN 0	more RBR B-adv.all	intensive JJ B-adj.all	chemotherapy NN B-noun.group	has VBZ 0	significantly RB B-adv.all	increased VBD B-verb.change	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	adverse JJ B-adj.all	events NNS B-noun.person	. . 0	. . 0
a230316.s11	The DT 0	full JJ B-adj.all	syndrome NN 0	of IN 0	subacute JJ B-adj.all	myelo NN B-noun.person	- : 0	optic_neuropathy JJ B-noun.person	was VBD B-verb.stative	more RBR B-adv.all	frequent JJ B-adj.all	in IN 0	women NNS B-noun.person	, , 0	but CC 0	they PRP 0	tended VBD B-verb.social	to TO 0	have VB 0	taken VBN B-verb.possession	greater JJR B-adj.all	quantities NNS B-noun.person	of IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a3192036.s4	On IN 0	the DT 0	first JJ B-adj.all	day NN B-noun.person	of IN 0	the DT 0	schedule NN B-noun.person	, , 0	moderate JJ B-adj.all	high JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	Methotrexate NNP B-noun.person	, , 0	Etoposide NNP B-noun.person	and CC 0	Cyclophosphamide NNP B-noun.person	were VBD 0	administered VBN B-verb.perception	. . 0	. . 0
a3341566.s3	During IN 0	HEM NNP 0	- : 0	induced VBN B-verb.creation	hypotension NN 0	the DT 0	cardiac JJ B-adj.all	output NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	and CC 0	systemic JJ B-adj.all	vascular JJ B-adj.all	resistance NN B-noun.phenomenon	higher RBR B-adv.all	compared VBN B-verb.change	with IN 0	that DT 0	in IN 0	the DT 0	SNP NNP 0	group NN 0	. . 0	. . 0
a12483326.s2	With IN 0	current JJ B-adj.all	treatment NN B-noun.communication	regimens VBZ 0	including VBG 0	combined VBN B-verb.change	surgery NN I-verb.change	, , 0	radiation NN B-noun.act	and CC 0	chemotherapy NN B-noun.body	, , 0	the DT 0	average JJ B-adj.all	life NN B-noun.person	expectancy NN B-noun.person	of IN 0	the DT 0	patients NNS B-noun.person	is VBZ 0	limited VBN B-verb.change	to TO 0	approximately RB B-verb.consumption	1 CD B-adj.all	year NN B-noun.time	. . 0	. . 0
a7423039.s7	In IN 0	the DT 0	adriamycin NN B-noun.person	- : 0	treated VBN B-verb.communication	cells NNS B-noun.body	, , 0	the DT 0	addition NN B-noun.act	of IN 0	adenosine NN B-noun.person	increased VBD B-verb.change	the DT 0	adenylate JJ B-adj.all	charge NN B-noun.act	and CC 0	, , 0	concomitant NN B-noun.person	with IN 0	this DT 0	inrcease NN B-noun.event	, , 0	the DT 0	cells NNS B-noun.body	' POS 0	functional JJ B-adj.all	integrity NN B-noun.attribute	, , 0	in IN B-adj.all	terms NNS I-adj.all	of IN I-adj.all	percentage NN B-noun.possession	of IN 0	beating VBG B-verb.contact	cells NNS B-noun.body	and CC 0	rate NN B-noun.time	of IN 0	contractions NNS B-noun.food	, , 0	was VBD 0	maintained VBN B-verb.stative	. . 0	. . 0
a4071154.s4	Since IN 0	nonsteroidal JJ B-adj.all	anti NNS B-noun.person	- : 0	inflammatory JJ B-adj.all	agents NNS B-noun.person	interfere VBP B-verb.stative	with IN 0	this DT 0	compensatory JJ B-adj.all	mechanism NN B-noun.artifact	and CC 0	may MD 0	cause VB B-verb.emotion	acute_renal_failure NN I-verb.emotion	, , 0	they PRP 0	should MD 0	be VB 0	used VBN B-verb.consumption	with IN 0	caution NN B-noun.cognition	in IN 0	such JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a12695819.s4	Apparent JJ B-adj.all	diffusion NN B-noun.relation	coefficient NN I-noun.relation	( ( 0	ADC NNP B-noun.group	) ) 0	values NNS B-noun.attribute	on IN 0	the DT 0	initial JJ B-adj.all	MR NNP 0	study NN B-noun.artifact	were VBD 0	correlated VBN B-verb.stative	with IN 0	reversibility NN B-noun.act	of IN 0	the DT 0	lesions NNS B-noun.artifact	. . 0	. . 0
a6287825.s2	There EX 0	is VBZ B-verb.stative	a DT 0	male JJ B-adj.all	preponderance NN B-noun.person	and CC 0	the DT 0	peak JJ B-adj.all	incidence NN B-noun.relation	is VBZ B-verb.stative	in IN 0	the DT 0	fourth JJ B-adj.all	decade NN B-noun.act	. . 0	. . 0
a1468485.s3	We PRP 0	then RB B-adv.all	used VBN B-verb.consumption	hyperbaric JJ B-adj.all	oxygen NN B-noun.person	at IN 0	an DT 0	absolute JJ B-adj.all	pressure NN B-noun.act	of IN 0	2 CD B-adj.all	atm NN B-noun.quantity	, , 0	5 CD B-adj.all	days NNS B-noun.person	a DT 0	week NN B-noun.time	for IN 0	8 CD B-adj.all	consecutive JJ B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a10704919.s2	This DT 0	work NN B-noun.cognition	evaluates VBZ B-verb.change	the DT 0	effects NNS B-noun.phenomenon	of IN 0	TAM NNP B-noun.other	on IN 0	isolated VBN B-verb.change	human JJ B-adj.all	erythrocytes NNS B-noun.person	, , 0	attempting VBG B-verb.stative	to TO 0	identify VB B-verb.cognition	the DT 0	underlying VBG B-adj.all	mechanisms NNS B-noun.person	on IN 0	TAM NNP B-noun.group	- : 0	induced VBN B-verb.creation	hemolytic_anemia NNP B-noun.location	and CC 0	the DT 0	involvement NN B-noun.person	of IN 0	biomembranes NNS B-noun.food	in IN 0	its PRP$ 0	cytostatic JJ B-adj.all	action NN B-noun.person	mechanisms NNS B-noun.person	. . 0	. . 0
a2348231.s9	Neither DT 0	dose NN B-noun.quantity	of IN 0	pentoxifylline NN B-noun.person	significantly RB B-adv.all	decreased VBD B-verb.change	the DT 0	dipyridamole NN B-noun.person	- : 0	induced VBN B-verb.creation	hyperemia NN 0	, , 0	while IN 0	peak JJ B-noun.person	coronary JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	after IN 0	theophylline PRP 0	( ( 0	p IN 0	less JJR B-noun.quantity	than IN 0	0.01 CD 0	) ) 0	. . 0	. . 0
a8690168.s8	Number NNP B-noun.person	and CC 0	total JJ B-adj.all	anionic JJ 0	site NN 0	surface NN B-noun.location	in IN 0	the DT 0	remaining VBG B-verb.change	part NN B-noun.possession	of IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	( ( 0	lamina FW 0	densa FW 0	and CC 0	lamina NN B-noun.artifact	rara JJ B-adj.all	interna NN B-noun.location	) ) 0	were VBD B-verb.stative	not RB B-adv.all	significantly RB B-adv.all	changed VBN B-verb.change	. . 0	. . 0
a12820454.s14	CONCLUSION NN B-noun.group	, , 0	Our PRP$ 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	rHuEPO SYM 0	- : 0	beta JJ B-adj.all	correctable JJ B-adj.all	CAB NNP B-noun.group	- : 0	induced VBN B-verb.creation	anemia NN B-noun.state	occurs VBZ B-verb.stative	in IN 0	14.3 CD 0	% NN 0	of IN 0	prostate_cancer NN B-noun.person	patients NNS B-noun.person	after IN 0	6 CD B-adj.all	months NNS B-noun.person	of IN 0	therapy NN B-noun.act	. . 0	. . 0
a17854040.s9	The DT 0	HBV NNP 0	viral JJ B-noun.body	loads NNS I-noun.body	for IN 0	mono NN B-noun.substance	- : 0	infected JJ B-adj.all	and CC 0	co SYM 0	- : 0	infected JJ B-adj.all	patients NNS B-noun.person	ranged VBD B-verb.contact	from IN 0	3.32 CD 0	x DT 0	10(2 NNP B-noun.location	) ) 0	to TO 0	3.82 CD 0	x DT 0	10(7 NNP B-noun.location	) ) 0	and CC 0	< $ 0	200 CD 0	to TO 0	4.40 CD 0	x DT 0	10(3 NNP B-noun.location	) ) 0	copies NNS B-noun.quantity	/ : 0	ml PRP 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a18182964.s5	RESULTS NNS B-noun.artifact	, , 0	There EX 0	were VBD B-verb.stative	more JJR B-adj.all	incidents NNS B-noun.event	of IN 0	bradycardia NNS B-noun.food	in IN 0	subjects NNS B-noun.person	treated VBN B-verb.social	with IN 0	clonidine NN 0	compared VBN B-verb.possession	with IN 0	those DT 0	not RB B-adv.all	treated VBN B-verb.change	with IN 0	clonidine NN B-noun.cognition	( ( 0	17.5 CD 0	% NN 0	versus CC 0	3.4 CD 0	% NN 0	, , 0	p UH 0	= : 0	.02 LS 0	) ) 0	, , 0	but CC 0	no DT 0	other JJ 0	significant JJ B-adj.all	group NN B-noun.group	differences NNS B-noun.group	regarding VBG B-verb.stative	electrocardiogram NN B-noun.person	and CC 0	other JJ 0	cardiovascular JJ B-adj.all	outcomes NNS B-noun.artifact	. . 0	. . 0
a20470218.s1	Central_nervous_system_(CNS)_complications NNS B-noun.artifact	during IN 0	treatment NN B-noun.communication	of IN 0	childhood NN B-noun.location	acute_lymphoblastic_leukemia NN I-noun.location	( ( 0	ALL NNP 0	) ) 0	remain VBP B-verb.stative	a DT 0	challenging JJ B-adj.all	clinical JJ B-adj.all	problem NN B-noun.communication	. . 0	. . 0
a2670794.s5	Renal_damage NN B-noun.artifact	as IN 0	reflected VBN B-verb.perception	by IN 0	an DT 0	increase NN B-noun.act	in IN 0	serum NN B-adj.all	urea NN B-noun.artifact	and CC 0	in IN 0	kidney NN B-noun.act	weight NN B-noun.artifact	was VBD 0	prevented VBN B-verb.creation	by IN 0	Captopril NNP B-noun.person	. . 0	. . 0
a12443032.s0	Cocaine NN B-noun.person	related VBD B-verb.communication	chest_pain NN B-noun.communication	, , 0	are VBP B-verb.stative	we PRP 0	seeing VBG B-verb.perception	the DT 0	tip NN 0	of IN 0	an DT 0	iceberg NN B-noun.person	? . 0	. . 0
a6666578.s8	The DT 0	endothelial JJ B-adj.all	ultrastructure NN B-noun.person	was VBD B-verb.stative	unaffected JJ B-adj.all	by IN 0	D NNP 0	- : 0	pen NN B-noun.person	, , 0	and CC 0	no DT 0	differences NNS B-noun.person	in IN 0	aortic JJ B-adj.all	131I NNP B-noun.person	- : 0	HSA NNP B-noun.group	radioactivity NN B-noun.attribute	or CC 0	aorta NN B-noun.communication	/ : 0	serum NN B-noun.person	- : 0	ratio NN B-noun.person	were VBD 0	recorded VBN B-verb.communication	between IN 0	experimental JJ B-adj.all	and CC 0	control NN B-noun.act	groups NNS B-noun.group	10 CD B-adj.all	minutes NNS B-noun.time	after IN 0	tracer NN B-noun.person	injection NN B-noun.person	, , 0	indicating VBG B-verb.communication	that IN 0	the DT 0	permeability NN B-noun.person	of IN 0	the DT 0	endothelial JJ B-adj.all	barrier NN B-noun.artifact	to TO 0	albumin VB 0	remained VBD B-verb.stative	unaffected JJ B-adj.all	by IN 0	D NNP 0	- : 0	pen NN B-noun.person	treatment NN B-noun.person	. . 0	. . 0
a17175308.s18	Mean JJ B-adj.all	serum NN 0	creatinine NN 0	level NN B-noun.artifact	before IN 0	conversion NN B-noun.cognition	was VBD B-verb.stative	2.21 CD 0	mg PRP B-noun.quantity	/ : 0	dL : 0	and CC 0	thereafter RB 0	, , 0	4.93 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	( ( 0	P UH 0	= : 0	.02 LS 0	) ) 0	. . 0	. . 0
a11198499.s0	Hypotension NN 0	following VBG 0	the DT 0	initiation NN B-noun.act	of IN 0	tizanidine NN B-noun.location	in IN 0	a DT 0	patient NN B-noun.person	treated VBN B-verb.body	with IN 0	an DT 0	angiotensin NN B-noun.person	converting VBG B-verb.possession	enzyme JJ B-adj.all	inhibitor NN B-noun.person	for IN 0	chronic JJ B-adj.all	hypertension NN B-noun.act	. . 0	. . 0
a6666578.s0	D SYM 0	- : 0	penicillamine NN B-noun.person	- : 0	induced VBN B-verb.creation	angiopathy NN 0	in IN 0	rats NNS B-noun.animal	. . 0	The DT 0	effect NN B-noun.cognition	of IN 0	high JJ B-adj.all	dose NN B-noun.quantity	D SYM 0	- : 0	penicillamine NN B-noun.person	treatment NN B-noun.person	on IN 0	aortic JJ B-adj.all	permeability NN B-noun.person	to TO 0	albumin VB B-verb.possession	and CC 0	on IN 0	the DT 0	ultrastructure NN B-noun.act	of IN 0	the DT 0	vessel NN B-noun.artifact	. . 0	. . 0
a2273650.s2	Similarly RB B-adv.all	, , 0	pre VBP B-verb.stative	- : 0	test NN B-adj.all	scopolamine NN B-noun.person	partially RB B-adv.all	reversed VBD B-verb.change	the DT 0	scopolamine NN B-noun.person	- : 0	induced VBN B-verb.creation	amnesia NN B-noun.artifact	, , 0	but CC 0	not RB B-adv.all	significantly RB B-adv.all	, , 0	and CC 0	pre VBP B-verb.stative	- : 0	test NN B-adj.all	cycloheximide NN B-noun.person	failed VBD B-verb.social	to TO 0	reverse VB B-verb.communication	the DT 0	cycloheximide NN B-noun.group	- : 0	induced VBN B-verb.creation	amnesia NN B-noun.artifact	. . 0	. . 0
a2024540.s6	All DT 0	patients NNS B-noun.person	recovered VBD B-verb.communication	. . 0	. . 0
a12820454.s6	The DT 0	duration NN 0	of IN 0	the DT 0	study NN B-noun.artifact	was VBD B-verb.stative	six CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a6287825.s10	Heredofamilial NNP B-noun.person	and CC 0	connective_tissue_disorders NNS B-noun.person	were VBD B-verb.stative	rare JJ B-adj.all	. . 0	. . 0
a6503301.s1	A DT 0	case NN B-noun.state	of IN 0	veno NN B-noun.person	- : 0	occlusive_disease_of_the_liver RB 0	with IN 0	fatal JJ B-adj.all	outcome NN 0	after IN 0	dacarbazine NN B-noun.person	( ( 0	DTIC NNP 0	) ) 0	therapy NN 0	for IN 0	melanoma NN B-noun.person	is VBZ 0	reported VBN B-verb.communication	. . 0	. . 0
a12615818.s0	The DT 0	risk NN 0	of IN 0	venous_thromboembolism NN B-noun.artifact	in IN 0	women NNS B-noun.person	prescribed VBD B-verb.communication	cyproterone_acetate NNP B-noun.person	in IN 0	combination NN 0	with IN 0	ethinyl_estradiol NN 0	, , 0	a DT 0	nested JJ B-adj.all	cohort NN B-noun.person	analysis NN B-noun.person	and CC 0	case NN B-noun.person	- : 0	control NN B-noun.act	study NN B-noun.artifact	. . 0	. . 0
a10704919.s8	Furthermore RB B-adv.all	, , 0	it PRP 0	was VBD 0	observed VBN B-verb.perception	that IN 0	TAM NNP 0	inhibits VBZ B-verb.stative	the DT 0	peroxidation NN B-noun.person	of IN 0	human JJ B-adj.all	erythrocytes NNS B-noun.person	induced VBN B-verb.creation	by IN 0	AAPH NNP B-noun.person	, , 0	thus RB 0	ruling VBG B-verb.stative	out RP 0	TAM NNP B-noun.person	- : 0	induced VBN B-verb.creation	cell NN B-noun.body	oxidative JJ B-adj.all	stress NN B-noun.state	. . 0	. . 0
a891050.s1	A DT 0	case NN B-noun.state	is VBZ 0	reported VBN B-verb.communication	of IN 0	the DT 0	hemolytic_uremic_syndrome NNP B-noun.location	( ( 0	HUS NNP 0	) ) 0	in IN 0	a DT 0	woman NN B-noun.person	taking VBG B-verb.social	oral_contraceptives NNS I-verb.social	. . 0	. . 0
a19300402.s9	Therefore RB 0	, , 0	concomitant JJ B-adj.all	administration NN B-noun.time	of IN 0	small JJ B-adj.all	doses NNS B-noun.quantity	of IN 0	bradykinin NN B-noun.person	receptor NN B-noun.person	antagonists NNS B-noun.person	and CC 0	NO DT 0	synthase NN 0	inhibitors NNS B-noun.person	can MD 0	be VB B-verb.stative	effective JJ B-adj.all	in IN 0	alleviation NN B-noun.act	of IN 0	neuropathic_pain JJ B-noun.person	, , 0	even RB B-adv.all	in IN 0	hospital NN B-noun.artifact	care NN I-noun.artifact	. . 0	. . 0
a17491223.s2	OBJECTIVES NNS B-noun.artifact	, , 0	To TO 0	assess VB B-verb.cognition	the DT 0	added VBN B-verb.change	diagnostic JJ B-adj.all	value NN B-noun.attribute	of IN 0	a DT 0	new JJ B-adj.all	cardiac JJ B-adj.all	performance NN B-noun.person	index NN B-noun.person	( ( 0	dP UH 0	/ : 0	dtejc NN B-noun.attribute	) ) 0	measurement NN B-noun.attribute	, , 0	based VBN B-verb.cognition	on IN 0	brachial JJ B-adj.all	artery NN B-noun.attribute	flow NN B-noun.event	changes NNS I-noun.event	, , 0	as IN 0	compared VBN 0	to TO 0	standard JJ B-adj.all	12-lead JJ B-noun.group	ECG NNP I-noun.group	, , 0	for IN 0	detecting VBG B-verb.communication	dobutamine NN B-noun.person	- : 0	induced VBN B-verb.creation	myocardial_ischemia NNP I-verb.creation	, , 0	using VBG B-verb.consumption	Tc99m JJ I-verb.consumption	- : 0	Sestamibi NNP B-noun.person	single JJ I-noun.person	- : 0	photon NN B-noun.time	emission NN 0	computed VBN B-verb.stative	tomography NN 0	as IN 0	the DT 0	gold JJ B-adj.all	standard NN B-noun.person	of IN 0	comparison NN B-noun.person	to TO 0	assess VB B-verb.cognition	the DT 0	presence NN B-noun.person	or CC 0	absence NN B-noun.act	of IN 0	ischemia NN B-noun.food	. . 0	. . 0
a1420741.s11	The DT 0	results NNS B-noun.communication	of IN 0	this DT 0	pilot NN B-adj.all	study NN B-noun.artifact	suggest VBP B-verb.communication	that IN 0	fusidic_acid JJ 0	may MD 0	be VB B-verb.stative	of IN 0	benefit NN B-noun.food	in IN 0	selected VBN B-verb.cognition	chronic NN 0	active JJ B-adj.all	Crohn's_disease NN B-noun.location	patients NNS B-noun.person	in IN 0	whom WP 0	conventional JJ B-adj.all	treatment NN B-noun.communication	is VBZ B-verb.stative	ineffective JJ B-adj.all	. . 0	. . 0
a15278670.s5	However RB 0	, , 0	the DT 0	threshold NN B-noun.artifact	( ( 0	61.6 CD 0	+ : 0	/- $ 0	8.7 CD 0	mg NN B-noun.quantity	. . 0	. . 0
a7423039.s2	Adriamycin VB B-verb.change	inhibited JJ B-adj.all	cell NN B-noun.body	growth NN 0	and CC 0	the DT 0	rhythmic JJ B-adj.all	contractions NNS B-noun.phenomenon	characteristic JJ B-adj.all	of IN 0	myocardial JJ B-noun.body	cells NNS I-noun.body	in IN 0	culture NN B-noun.cognition	. . 0	. . 0
a2951327.s1	In IN 0	six CD 0	conscious JJ B-adj.all	, , 0	trained JJ B-adj.all	dogs NNS B-noun.person	, , 0	maintained VBN B-verb.stative	on IN 0	a DT 0	normal JJ B-adj.all	sodium NN 0	intake NN 0	of IN 0	2 CD 0	to TO 0	4 CD B-adj.all	mEq CD 0	/ ) 0	kg RB 0	/ JJ 0	day NN 0	, , 0	sympathetic JJ B-adj.all	activity NN B-noun.state	was VBD 0	assessed VBN B-verb.cognition	as IN 0	the DT 0	release NN B-adj.pert	rate NN B-noun.time	of IN 0	norepinephrine NN B-noun.person	and CC 0	epinephrine NN B-noun.location	during IN 0	15-minute JJ 0	i.v NNP 0	. . 0	. . 0
a6666578.s2	Pair NNP B-noun.person	fed VBD B-verb.consumption	rats NNS B-noun.person	served VBD B-verb.social	as IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a7449470.s0	Late RB B-adv.all	, , 0	late JJ B-adj.all	doxorubicin NN B-noun.artifact	cardiotoxicity NN I-noun.artifact	. . 0	. . 0
a3341566.s2	Mean VB B-verb.stative	arterial JJ B-adj.all	pressure NN B-noun.person	was VBD 0	decreased VBN B-verb.change	to TO 0	50 CD B-adj.all	mm NN B-noun.quantity	Hg NNP 0	for IN 0	30 CD B-adj.all	minutes NNS B-noun.time	either CC 0	by IN 0	hemorrhage NN 0	( ( 0	HEM NNP 0	, , 0	n PRP 0	= $ 0	7 CD B-adj.all	) ) 0	or CC 0	by IN 0	continuous JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	sodium_nitroprusside JJ 0	( ( 0	SNP NNP 0	, , 0	n PRP 0	= $ 0	7 CD B-adj.all	) ) 0	. . 0	. . 0
a17042910.s12	Vascular JJ B-adj.all	eNOS NNS B-noun.artifact	mRNA WDT 0	was VBD 0	assessed VBN B-verb.cognition	by IN 0	semi NNS B-noun.person	- : 0	quantitative JJ B-adj.all	reverse NN B-noun.process	transcription NN B-noun.act	- : 0	polymerase NN B-noun.phenomenon	chain NN B-noun.phenomenon	reaction NN B-noun.process	. . 0	. . 0
a18261172.s6	Proteinuria NNP B-noun.person	increased VBD B-verb.change	significantly RB B-adv.all	from IN 0	a DT 0	median NN B-noun.communication	of IN 0	0.13 CD 0	g NN B-noun.quantity	/ : 0	day NN B-noun.person	( ( 0	range NN B-noun.communication	0 CD B-noun.quantity	- : 0	5.7 CD 0	) ) 0	preswitch VB 0	to TO 0	0.23 CD 0	g RB 0	/ JJ 0	day NN 0	( ( 0	0 CD B-noun.quantity	- : 0	9.88 CD 0	) ) 0	at IN 0	24 CD B-adj.all	months NNS B-noun.person	postswitch VB B-verb.stative	( ( 0	p IN 0	= SYM 0	0.0024 CD 0	) ) 0	. . 0	. . 0
a15120741.s5	Focal JJ B-adj.all	glutamate NN B-noun.phenomenon	photostimulation NN I-noun.phenomenon	of IN 0	the DT 0	granule NN B-noun.location	cell NN B-noun.person	layer NN I-noun.person	at IN 0	sites NNS B-noun.location	distant VBP B-verb.stative	from IN 0	the DT 0	recording NN B-noun.act	pipette NN B-noun.person	resulted VBD B-verb.social	in IN 0	population NN B-adj.all	responses NNS B-noun.act	of IN 0	1 CD B-adj.all	- : 0	30 CD B-adj.all	s DT 0	duration NN B-noun.act	in IN 0	slices NNS B-noun.act	from IN 0	SE NNP 0	survivors NNS 0	but CC 0	not RB B-adv.all	other JJ B-adj.all	groups NNS B-noun.group	. . 0	. . 0
a11897407.s4	99mTc SYM 0	- : 0	glucarate NN B-noun.person	was VBD B-verb.stative	easy JJ B-adj.all	to TO 0	prepare VB B-verb.social	, , 0	stable JJ B-adj.all	for IN 0	96 CD 0	h NN 0	and CC 0	was VBD 0	used VBN B-verb.consumption	to TO 0	study VB B-verb.cognition	its PRP$ 0	biodistribution NN B-noun.act	in IN 0	rats NNS B-noun.animal	with IN 0	isoproterenol NN B-noun.feeling	- : 0	induced VBN B-verb.creation	acute JJ B-adj.all	myocardial_infarction NN B-noun.person	. . 0	. . 0
a1420741.s7	Five CD 0	of IN 0	8 CD B-adj.all	patients NNS B-noun.person	( ( 0	63 CD 0	% NN 0	) ) 0	improved VBN B-verb.change	during IN 0	fusidic_acid JJ 0	treatment NN B-noun.communication	, , 0	3 CD B-adj.all	at IN 0	two CD B-noun.time	weeks NNS I-noun.time	and CC 0	2 CD B-adj.all	after IN 0	four CD B-noun.time	weeks NNS B-noun.time	. . 0	. . 0
a18261172.s4	In IN 0	this DT 0	study NN B-noun.artifact	, , 0	long RB 0	- : 0	term NN B-noun.time	cardiac NN 0	transplant NN 0	patients NNS B-noun.person	were VBD 0	switched VBN B-verb.motion	from IN 0	cyclosporine NN B-noun.person	to TO 0	Srl NNP B-noun.person	- : 0	based VBN B-verb.cognition	IS NNP 0	. . 0	. . 0
a12090760.s0	Antagonism NNP B-noun.attribute	between IN 0	interleukin JJ B-noun.communication	3 CD B-adj.all	and CC 0	erythropoietin NN B-noun.person	in IN 0	mice NNS B-noun.animal	with IN 0	azidothymidine JJ B-noun.person	- : 0	induced VBN B-verb.creation	anemia NN B-noun.state	and CC 0	in IN 0	bone NN 0	marrow VB B-verb.communication	endothelial JJ B-adj.all	cells NNS B-noun.body	. . 0	. . 0
a18503483.s7	Improvement NN B-noun.state	and CC 0	eventually RB B-adv.all	full JJ B-adj.all	recovery NN B-noun.person	only RB B-adv.all	occurred VBD B-verb.cognition	after IN 0	TAC NNP B-noun.other	was VBD B-verb.stative	completely RB B-adv.all	discontinued VBN B-verb.stative	and CC 0	successfully RB B-adv.all	replaced VBN B-verb.social	by IN 0	everolimus NN 0	. . 0	. . 0
a20882060.s3	The DT 0	present JJ B-adj.all	study NN B-noun.communication	aimed VBN B-verb.communication	to TO 0	investigate VB B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	pallidal JJ B-adj.all	neurotensin NN B-noun.person	on IN 0	haloperidol NN B-noun.person	- : 0	induced VBN B-verb.creation	parkinsonian_symptoms NNS B-noun.artifact	. . 0	. . 0
a9625142.s3	These DT 0	responded VBD B-verb.stative	to TO 0	systemic JJ B-adj.all	steroids NNS B-noun.artifact	and CC 0	immunoglobulins NNS B-noun.person	. . 0	. . 0
a9625142.s1	An DT 0	80-yr JJ B-noun.group	- : 0	old JJ B-adj.all	man NN B-noun.group	developed VBD B-verb.creation	acute JJ B-adj.all	hepatitis NN 0	shortly RB B-adv.all	after IN 0	ingesting VBG B-verb.social	oral JJ B-adj.all	ceftriaxone NN 0	. . 0	. . 0
a7248170.s1	The DT 0	yield NN B-noun.cognition	of IN 0	severe JJ B-adj.all	cirrhosis_of_the_liver NN B-noun.act	( ( 0	defined VBN B-verb.stative	as IN 0	a DT 0	shrunken JJ 0	finely RB B-adv.all	nodular JJ B-adj.all	liver NN B-noun.food	with IN 0	micronodular JJ B-adj.all	histology NN B-noun.attribute	, , 0	ascites VBZ B-verb.communication	greater JJR B-adj.all	than IN 0	30 CD B-adj.all	ml NN B-noun.quantity	, , 0	plasma NN 0	albumin RB 0	less JJR 0	than IN 0	2.2 CD 0	g FW 0	/ FW 0	dl FW 0	, , 0	splenomegaly RB B-adv.all	2 CD B-adj.all	- : 0	3 CD B-adj.all	times NNS B-noun.event	normal JJ B-adj.all	, , 0	and CC 0	testicular JJ B-adj.all	atrophy NN B-noun.person	approximately RB B-adv.all	half JJ B-adj.all	normal JJ B-adj.all	weight NN B-noun.attribute	) ) 0	after IN 0	12 CD B-adj.all	doses NNS B-noun.quantity	of IN 0	carbon_tetrachloride JJ 0	given VBN B-verb.possession	intragastrically RB B-adv.all	in IN 0	the DT 0	phenobarbitone NN B-noun.person	- : 0	primed JJ B-adj.all	rat NN B-noun.person	was VBD 0	increased VBN B-verb.change	from IN 0	25 CD B-adj.all	% NN 0	to TO 0	56 CD 0	% NN 0	by IN 0	giving VBG B-verb.possession	the DT 0	initial JJ B-adj.all	" NN 0	calibrating VBG B-verb.communication	" ( 0	dose NN B-noun.quantity	of IN 0	carbon_tetrachloride NN 0	at IN 0	the DT 0	peak NN B-noun.time	of IN 0	the DT 0	phenobarbitone NN B-noun.person	- : 0	induced VBN B-verb.creation	enlargement_of_the_liver RB 0	. . 0	. . 0
a16298782.s5	The DT 0	otoprotectant_L JJ 0	- : 0	NAME NN B-noun.group	was VBD 0	administered VBN B-verb.possession	topically RB B-adv.all	to TO 0	12/27 CD 0	animals NNS B-noun.animal	. . 0	. . 0
a9334596.s20	8 CD B-adj.all	of IN 0	12 CD 0	compared VBN B-verb.communication	to TO 0	only RB B-adv.all	9 CD B-noun.quantity	of IN 0	22 CD B-adj.all	cases NNS B-noun.quantity	with IN 0	prolactin NN B-noun.substance	between IN 0	20 CD B-adj.all	and CC 0	35 CD 0	ng./ml NNP B-noun.person	. . 0	) ) 0	. . 0	. . 0
a10520387.s1	The DT 0	marked JJ B-adj.all	vasodilator NN B-noun.person	and CC 0	negative JJ B-adj.all	inotropic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	propofol NN B-noun.person	are VBP B-verb.stative	disadvantages NNS B-noun.person	in IN 0	frail NN B-noun.body	elderly JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a18208574.s7	The DT 0	Receiver NNP B-noun.other	Operative NNP I-noun.other	Characteristic NNP I-noun.other	Curve NNP I-noun.other	showed VBD B-verb.communication	that IN 0	OD NNP 0	> $ 0	1.27 CD 0	in IN 0	the DT 0	isolated VBN B-verb.change	- : 0	HIT VBN 0	group NN 0	had VBD 0	a DT 0	significantly RB B-adv.all	higher JJR B-adj.all	chance NN B-noun.act	of IN 0	developing VBG B-verb.communication	thrombosis NN B-noun.communication	by IN 0	day NN 0	30 CD 0	. . 0	. . 0
a10739826.s4	Totals NNS B-noun.person	of IN 0	128 CD 0	cases NNS B-noun.quantity	and CC 0	650 CD 0	controls NNS B-noun.artifact	were VBD 0	analysed VBN B-verb.cognition	for IN 0	repeat NN B-noun.artifact	use NN I-noun.artifact	and CC 0	135 CD 0	cases NNS B-noun.quantity	and CC 0	622 CD 0	controls NNS B-noun.act	for IN 0	switching VBG B-verb.change	patterns NNS B-noun.artifact	. . 0	. . 0
a8302922.s6	EBFF NNP B-noun.group	did VBD 0	not RB B-adv.all	change VB B-verb.change	during IN 0	PGE1 JJ B-adj.all	infusion NN B-noun.cognition	whereas IN 0	in IN 0	the DT 0	TMP NNP 0	group NN 0	, , 0	EBF NNP 0	decreased VBD B-verb.change	significantly RB B-adv.all	at IN 0	30 CD B-adj.all	and CC 0	60 CD B-adj.all	min NN B-noun.quantity	after IN 0	the DT 0	start NN B-noun.attribute	of IN 0	TMP NNP 0	( ( 0	preinfusion NN B-noun.person	, , 0	45.9 CD 0	+ : 0	/- $ 0	13.9 CD 0	ml/100g CD B-noun.quantity	/ DT 0	min NN B-noun.quantity	. . 0	. . 0
a3173179.s3	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	in IN 0	which WDT 0	myocardial_infarction NN B-noun.person	coincided VBD B-verb.change	with IN 0	the DT 0	introduction NN B-noun.act	of IN 0	captopril NN B-noun.artifact	and CC 0	the DT 0	withdrawal NN B-noun.act	of IN 0	verapamil NN B-noun.food	in IN 0	a DT 0	previously RB B-adv.all	asymptomatic JJ B-adj.all	woman NN B-noun.person	with IN 0	severe JJ 0	hypertension NN 0	. . 0	. . 0
a19581773.s6	The DT 0	ocular_myasthenia NN 0	associated VBN B-verb.cognition	with IN 0	combination NN B-noun.person	therapy NN 0	of IN 0	pegylated_IFN_alpha-2b NNP B-noun.person	and CC 0	ribavirin NN B-noun.person	for IN 0	CHC NNP B-noun.group	is VBZ B-verb.stative	very RB B-adv.all	rarely RB B-adv.all	reported VBN B-verb.communication	, , 0	therefore RB B-adv.all	, , 0	we PRP 0	present VBP B-verb.communication	this DT 0	case NN B-noun.state	with IN 0	a DT 0	review NN B-noun.act	of IN 0	the DT 0	various JJ B-adj.all	eye NN B-noun.location	complications NNS B-noun.person	of IN 0	IFN NNP 0	therapy NN 0	. . 0	. . 0
a17042910.s18	4 LS 0	. . 0	. . 0
a18503483.s0	Recovery NN B-noun.process	of IN 0	tacrolimus NN B-noun.person	- : 0	associated VBN B-verb.cognition	brachial_neuritis NN B-noun.location	after IN 0	conversion NN B-noun.person	to TO 0	everolimus NN 0	in IN 0	a DT 0	pediatric JJ B-adj.all	renal JJ B-adj.all	transplant NN B-noun.communication	recipient NN B-noun.communication	-- : 0	case NN B-noun.state	report NN I-noun.state	and CC 0	review NN B-noun.act	of IN 0	the DT 0	literature NN B-noun.act	. . 0	. . 0
a18208574.s6	However RB 0	, , 0	OD NNP 0	was VBD B-verb.stative	significantly RB B-adv.all	higher JJR B-adj.all	in IN 0	all DT 0	patients NNS B-noun.person	with IN 0	thrombosis NN B-noun.cognition	( ( 0	n UH 0	= $ 0	48 CD 0	, , 0	1.34 CD 0	+ : 0	/- $ 0	0.89 CD 0	) ) 0	, , 0	including VBG 0	isolated VBN B-verb.change	- : 0	HIT NN B-noun.group	patients NNS B-noun.person	who WP 0	later RB B-adv.all	developed VBD B-verb.creation	thrombosis NN 0	within IN 0	30 CD B-adj.all	d NN B-noun.quantity	( ( 0	n UH 0	= $ 0	8 CD B-adj.all	, , 0	1.84 CD 0	+ : 0	/- $ 0	0.64 CD 0	) ) 0	as IN 0	compared VBN 0	to TO 0	isolated VBN B-verb.change	- : 0	HIT NN B-noun.group	patients NNS B-noun.person	who WP 0	did VBD 0	not RB B-adv.all	develop VB B-verb.change	thrombosis NN I-verb.change	( ( 0	0.96 CD 0	+ : 0	/- $ 0	0.75 CD 0	, , 0	P NNP 0	= SYM 0	0.011 CD 0	and CC 0	P NNP 0	= SYM 0	0.008 CD 0	) ) 0	. . 0	. . 0
a8690168.s5	A DT 0	minority NN B-noun.attribute	of IN 0	anionic JJ B-adj.all	sites NNS B-noun.location	were VBD 0	scattered VBN B-verb.contact	throughout IN 0	the DT 0	lamina NN B-noun.artifact	densa NN I-noun.artifact	and CC 0	lamina NN B-noun.artifact	rara JJ B-adj.all	interna NN B-noun.person	, , 0	and CC 0	were VBD B-verb.stative	significantly RB B-adv.all	smaller JJR B-adj.all	than IN 0	those DT 0	in IN 0	the DT 0	lamina NN B-noun.artifact	rara JJ B-adj.all	externa NN B-noun.group	of IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	( ( 0	p<0.001 JJ 0	and CC 0	p<0.01 NNP B-noun.person	for IN 0	diabetic NN B-noun.person	and CC 0	control NN B-noun.act	rats NNS B-noun.location	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a4071154.s2	Prompt JJ B-adj.all	restoration NN B-noun.act	of IN 0	renal JJ B-adj.all	function NN B-noun.act	followed VBN B-verb.stative	drug NN 0	withdrawal NN 0	, , 0	while IN 0	re SYM 0	- : 0	exposure NN B-noun.person	to TO 0	a DT 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	indomethacin NN B-noun.person	caused VBD B-verb.communication	recurrence NN B-noun.person	of IN 0	acute JJ B-adj.all	reversible JJ B-adj.all	oliguria NNS B-noun.person	. . 0	. . 0
a8073369.s10	There EX 0	was VBD B-verb.stative	a DT 0	statistically RB B-adv.all	significant JJ B-adj.all	( ( 0	P NNP 0	< , 0	or CC 0	= $ 0	0.01 CD 0	) ) 0	decrease NN B-noun.state	in IN 0	movement NN B-noun.communication	in IN 0	coniine NN 0	and CC 0	nicotine JJ B-adj.all	sulfate NN B-noun.person	treated VBN B-verb.social	chicks NNS B-noun.animal	as IN 0	determined VBN B-verb.communication	by IN 0	ultrasound NN B-noun.person	. . 0	. . 0
a3192036.s6	Formation NN B-noun.act	of IN 0	these DT 0	plugs NNS B-noun.person	was VBD B-verb.stative	probably RB B-adv.all	due JJ 0	to TO 0	extensive JJ B-adj.all	tumor NN B-noun.artifact	necrosis NN B-noun.person	at IN 0	the DT 0	level NN B-noun.state	of IN 0	the DT 0	walls NNS B-noun.artifact	of IN 0	the DT 0	major JJ B-adj.all	uterine NN B-noun.act	veins NNS B-noun.artifact	, , 0	which WDT 0	resulted VBD B-verb.stative	in IN 0	an DT 0	open JJ B-adj.all	exchange NN B-noun.act	of IN 0	tumor NN B-noun.feeling	plugs NNS 0	to TO 0	the DT 0	vascular JJ B-adj.all	spaces NNS B-noun.artifact	, , 0	decrease VB B-verb.communication	in IN 0	tumor NN 0	tissue NN 0	coherence NN 0	secondary JJ B-adj.all	to TO 0	chemotherapy VB B-verb.cognition	may MD 0	have VB 0	further RBR B-adv.all	contributed VBD B-verb.communication	to TO 0	the DT 0	formation NN B-noun.act	of IN 0	tumor NN B-noun.feeling	emboli NN B-noun.person	. . 0	. . 0
a3997294.s4	Review NNP B-noun.person	of IN 0	this DT 0	and CC 0	previously RB B-adv.all	reported VBN B-verb.communication	cases NNS B-noun.person	indicates VBZ B-verb.communication	the DT 0	need NN B-noun.object	for IN 0	early JJ B-adj.all	diagnosis NN B-noun.relation	of IN 0	amiodarone JJ B-adj.all	pneumonitis NN B-noun.artifact	, , 0	immediate JJ B-adj.all	withdrawal NN B-noun.person	of IN 0	amiodarone NN 0	, , 0	and CC 0	prompt JJ B-adj.all	but CC 0	continued VBD B-verb.stative	steroid JJ B-adj.all	therapy NN 0	to TO 0	ensure VB B-verb.stative	full JJ B-adj.all	recovery NN B-noun.process	. . 0	. . 0
a11679859.s9	One CD 0	study NN B-verb.cognition	participant NN B-noun.person	was VBD 0	excluded VBN B-verb.social	after IN 0	protocol NN B-noun.time	violation NN B-noun.act	. . 0	. . 0
a869641.s5	FLA-63 NN B-noun.artifact	, , 0	a DT 0	dopamine NN B-noun.person	- : 0	beta NN B-noun.person	- : 0	oxidase NN 0	inhibitor NN 0	, , 0	did VBD 0	not RB B-adv.all	have VB B-verb.change	any DT 0	effect NN B-noun.cognition	on IN 0	the DT 0	hypotension NN B-noun.person	, , 0	bradycardia NNS B-noun.person	or CC 0	reflex JJ B-noun.substance	- : 0	enhancing VBG B-verb.stative	effect NN 0	of IN 0	L NNP 0	- : 0	dopa NN B-noun.person	. . 0	. . 0
a18221780.s3	To TO 0	this DT 0	end NN B-noun.event	, , 0	persistent JJ B-adj.all	hyperalgesia NN B-noun.person	was VBD 0	induced VBN B-verb.creation	by IN 0	administration NN B-noun.time	of IN 0	capsaicin NN B-noun.food	in IN 0	the DT 0	tail NN B-noun.time	of IN 0	gonadally RB B-adv.all	intact JJ B-adj.all	F344 JJ B-noun.artifact	rats NNS I-noun.artifact	, , 0	following VBG 0	which WDT 0	the DT 0	tail NN B-noun.body	was VBD 0	immersed VBN B-verb.cognition	in IN 0	a DT 0	mildly RB B-adv.all	noxious JJ B-adj.all	thermal JJ B-adj.pert	stimulus NN B-noun.state	, , 0	and CC 0	tail NN B-noun.body	- : 0	withdrawal NN B-noun.animal	latencies NNS I-noun.animal	measured VBN B-verb.cognition	. . 0	. . 0
a11256525.s8	In IN 0	this DT 0	patient NN B-noun.person	, , 0	renal_artery_stenosis NN B-noun.body	combined VBN B-verb.change	with IN 0	heart_failure NN B-noun.food	and CC 0	diuretic JJ B-adj.all	therapy NN B-noun.person	certainly RB B-adv.all	resulted VBD B-verb.stative	in IN 0	a DT 0	strong JJ B-adj.all	activation NN B-noun.act	of IN 0	the DT 0	renin NN B-noun.person	- : 0	angiotensin NN 0	system NN B-noun.cognition	( ( 0	RAS NNP 0	) ) 0	. . 0	. . 0
a3341566.s4	The DT 0	systemic JJ B-adj.all	, , 0	central JJ B-noun.body	venous JJ I-noun.body	, , 0	pulmonary JJ B-adj.all	capillary JJ B-noun.person	wedge NN I-noun.person	pressures NNS B-noun.person	, , 0	and CC 0	heart NN B-noun.body	rates NNS B-noun.time	, , 0	were VBD B-verb.stative	similar JJ B-adj.all	in IN 0	the DT 0	two CD 0	groups NNS B-noun.group	. . 0	. . 0
a11391224.s9	CONCLUSIONS NNS B-noun.artifact	, , 0	We PRP 0	conclude VBP B-verb.cognition	that IN 0	in IN 0	transplants NNS B-noun.artifact	, , 0	there EX 0	is VBZ B-verb.stative	a DT 0	strong JJ B-adj.all	association NN B-noun.cognition	between IN 0	well UH 0	- : 0	developed VBD B-verb.creation	PTCR NNP B-noun.group	and CC 0	TG NNP 0	, , 0	while IN 0	the DT 0	significance NN B-noun.communication	of IN 0	mild JJ B-noun.person	PTCR NNP I-noun.person	and CC 0	its PRP$ 0	predictive JJ B-adj.all	value NN B-noun.attribute	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	TG NNP 0	is VBZ B-verb.stative	unclear JJ B-adj.all	. . 0	. . 0
a1732369.s0	Dobutamine NN 0	stress NN 0	echocardiography NN 0	, , 0	a DT 0	sensitive JJ B-adj.all	indicator NN B-noun.person	of IN 0	diminished JJ B-adj.all	myocardial JJ B-adj.all	function NN B-noun.act	in IN 0	asymptomatic JJ B-adj.all	doxorubicin NN B-noun.person	- : 0	treated VBD B-verb.communication	long RB 0	- : 0	term NN B-noun.time	survivors NNS 0	of IN 0	childhood NN 0	cancer NN B-noun.state	. . 0	. . 0
a15036754.s3	The DT 0	protective JJ B-adj.all	action NN B-noun.process	of IN 0	subcutaneously RB B-adv.all	( ( 0	SC NNP 0	) ) 0	administered VBN B-verb.possession	antidotes NNS B-noun.possession	or CC 0	their PRP$ 0	combinations NNS B-noun.communication	in IN 0	DFP NNP 0	( ( 0	2.0 CD 0	mg PRP 0	/ ( 0	kg IN 0	BW NNP 0	) ) 0	intoxication NN B-noun.possession	was VBD 0	studied VBN B-verb.cognition	in IN 0	9 CD B-adj.all	- : 0	10-weeks NNS B-noun.time	- : 0	old JJ B-adj.all	Han NNP B-noun.person	- : 0	Wistar NNP B-noun.person	male NN B-noun.artifact	rats NNS I-noun.artifact	. . 0	. . 0
a7862923.s0	Effect NN 0	of IN 0	switching VBG B-verb.motion	carbamazepine NN 0	to TO 0	oxcarbazepine VB B-verb.social	on IN 0	the DT 0	plasma NN B-noun.plant	levels NNS B-noun.state	of IN 0	neuroleptics NNS B-noun.person	. . 0	A DT 0	case NN B-noun.state	report NN B-noun.communication	. . 0	. . 0
a11419773.s1	We PRP 0	describe VBP B-verb.communication	a DT 0	25-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	with IN 0	pre SYM 0	- : 0	existing VBG B-verb.stative	mitral_valve_prolapse NN 0	who WP 0	developed VBD B-verb.body	intractable JJ B-adj.all	ventricular_fibrillation NN B-noun.communication	after IN 0	consuming VBG B-verb.social	a DT 0	" JJ 0	natural JJ B-adj.all	energy NN B-noun.attribute	" : 0	guarana NN B-noun.artifact	health NN I-noun.artifact	drink NN B-noun.artifact	containing VBG B-verb.stative	a DT 0	high JJ B-adj.all	concentration NN B-noun.attribute	of IN 0	caffeine NN B-noun.person	. . 0	. . 0
a3173179.s4	Possible JJ B-adj.all	mechanisms NNS B-noun.person	that WDT 0	involve VBP B-verb.stative	a DT 0	verapamil NN B-noun.person	- : 0	related JJ B-adj.all	increase NN B-noun.act	in IN 0	platelet NN B-noun.location	and/or CC 0	vascular JJ B-adj.all	alpha NN B-noun.artifact	2-adrenoreceptor JJ 0	affinity NN B-noun.attribute	for IN 0	catecholamines NNS B-noun.animal	are VBP 0	discussed VBN B-verb.communication	. . 0	. . 0
a2673163.s1	We PRP 0	describe VBP B-verb.cognition	eight CD 0	patients NNS B-noun.person	in IN 0	whom WP 0	cocaine NN 0	use NN 0	was VBD 0	related VBN B-verb.communication	to TO 0	stroke VB B-verb.communication	and CC 0	review VB B-verb.consumption	39 CD 0	cases NNS B-noun.quantity	from IN 0	the DT 0	literature NN B-noun.act	. . 0	. . 0
a12202650.s5	The DT 0	normalized JJ B-adj.all	reflex NN B-noun.person	amplitude IN 0	increased VBN B-verb.change	with IN 0	an DT 0	increase NN B-noun.act	in IN 0	velocity NN B-noun.time	at IN 0	a DT 0	given VBN B-verb.possession	displacement NN B-noun.person	, , 0	but CC 0	remained VBD B-verb.change	constant JJ B-adj.all	with IN 0	different JJ B-adj.all	displacements NNS B-noun.person	at IN 0	a DT 0	given VBN B-verb.possession	velocity NN B-noun.phenomenon	. . 0	. . 0
a19631624.s8	A DT 0	conjunction NN 0	analysis NN 0	of IN 0	the DT 0	encode NN B-noun.artifact	and CC 0	recall VB B-verb.cognition	phases NNS B-noun.person	of IN 0	the DT 0	task NN B-noun.group	revealed VBD B-verb.perception	ecstasy JJ B-adj.pert	- : 0	specific JJ B-adj.all	hyperactivity NN B-noun.attribute	in IN 0	bilateral JJ B-adj.all	frontal JJ B-noun.body	regions NNS I-noun.body	, , 0	left VBD B-verb.stative	temporal JJ B-adj.all	, , 0	right JJ B-adj.all	parietal NN B-noun.artifact	, , 0	bilateral JJ B-adj.all	temporal JJ B-adj.all	, , 0	and CC 0	bilateral JJ B-adj.all	occipital JJ B-adj.all	brain NN B-noun.act	regions NNS I-noun.act	. . 0	. . 0
a2070391.s2	To TO 0	determine VB B-verb.communication	if IN 0	the DT 0	addition NN B-noun.act	of IN 0	a DT 0	buffering NN B-noun.person	solution NN B-noun.person	to TO 0	adjust VB B-verb.change	the DT 0	pH CD 0	of IN 0	lidocaine NN B-noun.body	into IN 0	the DT 0	physiologic JJ B-adj.pert	range NN B-noun.person	would MD 0	reduce VB B-verb.change	pain NN I-verb.change	during IN 0	injection NN B-noun.act	, , 0	we PRP 0	performed VBD B-verb.social	a DT 0	blinded JJ B-adj.all	randomized JJ B-adj.all	study NN B-noun.artifact	in IN 0	patients NNS B-noun.person	undergoing VBG B-verb.communication	cardiac JJ B-noun.phenomenon	catheterization NN I-noun.phenomenon	. . 0	. . 0
a18261172.s9	Patients NNS B-noun.person	without IN 0	proteinuria NN B-noun.person	had VBD 0	increased VBN B-verb.change	renal JJ B-adj.all	function NN B-noun.act	( ( 0	median JJ B-adj.all	42.5 CD B-noun.other	vs. FW I-noun.other	64.1 CD I-noun.other	, , 0	p PRP 0	= $ 0	0.25 CD 0	) ) 0	, , 0	whereas IN 0	patients NNS B-noun.person	who WP 0	developed VBD B-verb.creation	high JJ B-adj.all	- : 0	grade NN B-noun.attribute	proteinuria NN B-noun.person	showed VBD B-verb.communication	decreased VBN B-verb.change	renal JJ B-adj.all	function NN B-noun.act	at IN 0	the DT 0	end NN B-noun.time	of IN 0	follow NN B-noun.shape	- : 0	up RB B-adv.all	( ( 0	median JJ B-adj.all	39.6 CD B-noun.other	vs. FW I-noun.other	29.2 CD I-noun.other	, , 0	p PRP 0	= $ 0	0.125 CD 0	) ) 0	. . 0	. . 0
a17466854.s6	A DT 0	chi NNS B-noun.person	- : 0	square JJ B-adj.all	test NN B-noun.person	was VBD 0	used VBN B-verb.consumption	to TO 0	assess VB B-verb.cognition	the DT 0	statistical JJ B-adj.all	significance NN B-noun.act	of IN 0	results NNS B-noun.phenomenon	. . 0	. . 0
a1639466.s2	Six CD 0	weeks NNS B-noun.time	after IN 0	clipping VBG B-verb.motion	of IN 0	one CD 0	renal JJ B-noun.body	artery NN I-noun.body	, , 0	hypertensive JJ B-adj.all	rats NNS B-noun.animal	( ( 0	178 CD 0	+ . 0	/- $ 0	4 CD B-adj.all	mm IN 0	Hg NNP 0	) ) 0	were VBD B-verb.stative	randomly RB B-adv.all	assigned VBN B-verb.social	to TO 0	three CD 0	groups NNS 0	, , 0	untreated JJ B-adj.all	hypertensive JJ B-adj.all	controls NNS B-noun.cognition	( ( 0	n FW 0	= FW 0	8) FW 0	, , 0	enalapril VBP B-verb.stative	- : 0	treated VBN B-verb.communication	( ( 0	n FW 0	= FW 0	8) FW 0	, , 0	or CC 0	nitrendipine NN B-noun.person	- : 0	treated VBN B-verb.communication	( ( 0	n UH 0	= $ 0	10 CD B-adj.all	) ) 0	. . 0	. . 0
a2024540.s1	Since IN 0	the DT 0	introduction NN B-noun.act	of IN 0	angiotensin_converting_enzyme_(ACE)_inhibitors NNS 0	into IN 0	the DT 0	adjunctive JJ B-adj.all	treatment NN B-noun.communication	of IN 0	patients NNS B-noun.person	with IN 0	congestive_heart_failure NN B-noun.food	, , 0	cases NNS B-noun.person	of IN 0	severe JJ 0	hypotension NN 0	, , 0	especially RB B-adv.all	on IN 0	the DT 0	first JJ B-adj.all	day NN B-noun.person	of IN 0	treatment NN B-noun.communication	, , 0	have VBP 0	occasionally RB B-adv.all	been VBN 0	reported VBN B-verb.communication	. . 0	. . 0
a16298782.s0	Nitro SYM 0	- : 0	L SYM 0	- : 0	arginine_methyl_ester NN B-noun.person	, , 0	a DT 0	potential JJ B-adj.all	protector NN B-noun.person	against IN 0	gentamicin NN 0	ototoxicity NN 0	. . 0	. . 0
a8231633.s0	Effects NNS B-noun.phenomenon	of IN 0	calcium NN 0	channel NN 0	blockers NNS B-noun.person	on IN 0	bupivacaine NN B-noun.act	- : 0	induced VBN B-verb.creation	toxicity NN B-noun.attribute	. . 0	. . 0
a6888657.s1	Pituitary_tumors NNS B-noun.person	were VBD 0	induced VBN B-verb.creation	in IN 0	F344 JJ B-adj.all	female NN I-adj.all	rats NNS B-noun.phenomenon	by IN 0	chronic JJ B-adj.all	treatment NN B-noun.plant	with IN 0	diethylstilbestrol NN B-noun.substance	( ( 0	DES NNP B-noun.group	, , 0	8 CD B-adj.all	- : 0	10 CD B-adj.all	mg NN B-noun.quantity	) ) 0	implanted VBN B-verb.change	subcutaneously RB B-adv.all	in IN 0	silastic JJ B-adj.all	capsules NNS B-noun.artifact	. . 0	. . 0
a10704919.s10	However RB 0	, , 0	TAM NNP B-noun.person	induces VBZ B-verb.communication	release NN B-noun.state	of IN 0	peripheral JJ B-adj.pert	proteins NNS B-noun.possession	of IN 0	membrane NN B-noun.person	- : 0	cytoskeleton NN B-noun.person	and CC 0	cytosol JJ B-adj.all	proteins NNS B-noun.person	essentially RB B-adv.all	bound VBN B-verb.change	to TO 0	band VB B-verb.cognition	3 CD 0	. . 0	. . 0
a20698227.s10	Future JJ B-adj.all	research NN B-noun.act	with IN 0	larger JJR B-adj.all	number NN B-noun.attribute	of IN 0	patients NNS B-noun.person	is VBZ 0	needed VBN 0	to TO 0	find VB B-verb.change	out RP 0	modifiable JJ B-adj.all	factors NNS B-noun.person	that WDT 0	will MD 0	improve VB B-verb.change	the DT 0	safety NN B-noun.person	of IN 0	ribavirin NN 0	therapy NN 0	. . 0	. . 0
a3676049.s8	These DT 0	changes NNS B-noun.artifact	might MD 0	offer VB B-verb.possession	protection NN B-noun.possession	to TO 0	brain NN B-verb.consumption	tissue NN 0	during IN 0	periods NNS B-noun.person	of IN 0	induced JJ B-verb.creation	hypotension NN 0	. . 0	. . 0
a16160878.s0	Behavioral JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	urotensin NN B-noun.person	- : 0	II NNP 0	centrally RB B-adv.all	administered VBN B-verb.possession	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a230316.s10	Older JJR B-adj.all	subjects NNS B-noun.person	tended VBD B-verb.social	to TO 0	display VB B-verb.perception	more JJR B-noun.quantity	side JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a12820454.s7	RESULTS NNS B-noun.artifact	, , 0	The DT 0	mean JJ B-adj.all	hemoglobin NN B-noun.person	( ( 0	Hb NNP 0	) ) 0	levels NNS B-noun.state	were VBD B-verb.stative	significantly RB B-adv.all	declined VBD B-verb.communication	in IN 0	all DT 0	patients NNS B-noun.person	from IN 0	baseline NN B-noun.person	of IN 0	14.2 CD 0	g PRP 0	/ : 0	dl PRP 0	to TO 0	14.0 CD 0	g FW 0	/ FW 0	dl FW 0	, , 0	13.5 CD 0	g FW 0	/ FW 0	dl FW 0	, , 0	13.2 CD 0	g FW 0	/ FW 0	dl FW 0	and CC 0	12.7 CD 0	g PRP 0	/ : 0	dl PRP 0	at IN 0	1 CD B-adj.all	, , 0	2 CD B-adj.all	, , 0	3 CD B-adj.all	and CC 0	6 CD B-adj.all	months NNS B-noun.person	post RB B-adv.all	- : 0	CAB NN B-noun.group	, , 0	respectively RB B-adv.all	. . 0	. . 0
a2348231.s2	Many JJ 0	of IN 0	these DT 0	patients NNS B-noun.person	are VBP 0	taking VBG B-verb.social	pentoxifylline NN I-verb.social	( ( 0	Trental NNP B-noun.location	) ) 0	, , 0	a DT 0	methylxanthine NN B-noun.person	derivative NN 0	which WDT 0	may MD 0	improve VB B-verb.cognition	intermittent_claudication NN I-verb.cognition	. . 0	. . 0
a19631624.s12	These DT 0	ecstasy JJ B-adj.pert	- : 0	specific JJ B-adj.all	effects NNS B-noun.phenomenon	may MD 0	be VB 0	related VBN B-verb.cognition	to TO 0	the DT 0	vulnerability NN B-noun.state	of IN 0	isocortical JJ B-adj.all	and CC 0	allocortical JJ B-adj.all	regions NNS B-noun.motive	to TO 0	the DT 0	neurotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	ecstasy NN B-noun.person	. . 0	. . 0
a11679859.s11	In IN 0	the DT 0	bolus JJ 0	group NN 0	, , 0	26.0 CD B-noun.quantity	% NN 0	( ( 0	13/50 CD 0	) ) 0	had VBD 0	akathisia NNS 0	compared VBN B-verb.possession	with IN 0	32.7 CD 0	% NN 0	( ( 0	16/49 CD 0	) ) 0	in IN 0	the DT 0	infusion NN B-noun.cognition	group NN 0	( ( 0	Delta=-6.7 JJ 0	% NN 0	, , 0	95 CD 0	% NN 0	confidence NN B-noun.act	interval NN I-noun.act	[ '' 0	CI NNP 0	] $ 0	-24.6 CD 0	% NN 0	to TO 0	11.2 CD 0	% NN 0	) ) 0	. . 0	. . 0
a9334596.s14	Prolactin NNP B-noun.person	exceeded VBD B-verb.stative	20 CD B-adj.all	ng./ml NNP B-noun.person	. . 0	. . 0
a9334596.s11	Two CD 0	pituitary_tumors NNS 0	were VBD 0	discovered VBN B-verb.creation	after IN 0	testosterone NN B-verb.social	determination NN B-noun.process	. . 0	. . 0
a19300402.s2	METHODS NNS B-noun.attribute	, , 0	The DT 0	changes NNS B-noun.relation	in IN 0	pain NN B-noun.artifact	thresholds NNS B-noun.artifact	were VBD 0	determined VBN B-verb.cognition	using VBG B-verb.consumption	mechanical JJ B-adj.all	stimuli NNS B-noun.artifact	-- : 0	the DT 0	modification NN B-noun.time	of IN 0	the DT 0	classic JJ B-adj.all	paw NN 0	withdrawal NN 0	test NN 0	described VBN B-verb.communication	by IN 0	Randall NNP B-noun.person	- : 0	Selitto NN B-noun.person	. . 0	. . 0
a10807237.s10	Hunt NNP B-noun.person	and CC 0	Hess NNP B-noun.person	grade NN I-noun.person	( ( 0	P NNP 0	< $ 0	0.005 CD 0	) ) 0	and CC 0	age NN B-noun.person	( ( 0	P NNP 0	< $ 0	0.007 CD 0	) ) 0	were VBD B-verb.stative	significant JJ B-adj.all	predictors NNS B-noun.person	of IN 0	outcome NN 0	for IN 0	the DT 0	patients NNS B-noun.person	with IN 0	cocaine NN B-noun.person	- : 0	related VBN B-verb.cognition	aneurysms NNS 0	. . 0	. . 0
a11391224.s3	METHODS NNS B-noun.attribute	, , 0	We PRP 0	examined VBD B-verb.consumption	278 CD 0	consecutive JJ B-adj.all	renal JJ B-noun.body	specimens NNS I-noun.body	( ( 0	from IN 0	135 CD 0	transplants NNS B-noun.act	and CC 0	143 CD 0	native JJ B-adj.all	kidneys NNS B-noun.artifact	) ) 0	for IN 0	ultrastructural JJ B-adj.all	evidence NN B-noun.attribute	of IN 0	PTCR NNP B-noun.group	. . 0	. . 0
a3693336.s0	Triazolam SYM 0	- : 0	induced JJ B-verb.creation	brief JJ B-adj.all	episodes NNS B-noun.communication	of IN 0	secondary JJ B-adj.all	mania NN B-noun.person	in IN 0	a DT 0	depressed JJ B-adj.all	patient NN B-noun.person	. . 0	. . 0
a9334596.s8	RESULTS NNS B-noun.artifact	, , 0	Testosterone NNP B-noun.person	was VBD B-verb.stative	less JJR B-noun.quantity	than IN 0	3 CD B-adj.all	ng./ml NNP B-noun.person	. . 0	. . 0
a2440413.s3	In IN 0	this DT 0	study NN B-noun.artifact	, , 0	the DT 0	severity NN B-noun.attribute	of IN 0	response NN B-noun.communication	to TO 0	other JJ 0	seizure NN B-noun.act	- : 0	inducing VBG B-verb.communication	agents NNS B-noun.person	was VBD 0	tested VBN B-verb.social	in IN 0	mice NNS B-noun.animal	1 CD B-adj.all	and CC 0	24 CD B-adj.all	h NN 0	after IN 0	intraperitoneal JJ B-adj.all	administration NN B-noun.time	of IN 0	80 CD 0	mg FW 0	/ FW 0	kg FW 0	gamma NN B-noun.act	- : 0	HCH NN 0	. . 0	. . 0
a17466854.s8	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	administration NN B-noun.time	of IN 0	methylprednisolone NN B-noun.attribute	and CC 0	gentamicin NN B-noun.person	in IN 0	the DT 0	posterior JJ B-adj.all	sub NN B-noun.person	- : 0	Tenon NNP B-noun.person	's POS 0	space NN B-noun.location	was VBD 0	related VBN B-verb.communication	to TO 0	a DT 0	high JJ B-adj.all	incidence NN B-noun.attribute	of IN 0	side JJ 0	effects NNS 0	including VBG B-verb.stative	nausea,_vomiting JJ I-verb.stative	, , 0	and CC 0	headache NN B-noun.state	. . 0	. . 0
a3187073.s2	Obviously RB B-adv.all	, , 0	there EX 0	is VBZ B-verb.stative	a DT 0	need NN B-noun.motive	for IN 0	effective JJ B-adj.all	chemotherapy NN B-noun.communication	. . 0	. . 0
a12090760.s5	There EX 0	was VBD B-verb.stative	a DT 0	significant JJ B-adj.all	reduction NN B-noun.cognition	of IN 0	thymidine JJ B-adj.all	incorporation NN B-noun.event	into IN 0	both DT 0	erythroid JJ B-adj.all	and CC 0	endothelial JJ B-adj.all	cells NNS B-noun.body	in IN 0	cultures NNS B-noun.act	pre VBP B-verb.stative	- : 0	treated VBN B-verb.communication	with IN 0	IGF NNP B-noun.group	- : 0	IL-3 NN B-noun.other	and CC 0	EPO NNP 0	. . 0	. . 0
a15278670.s3	l(-1 LS 0	) ) 0	with IN 0	lidocaine JJ B-adj.all	infusion NN B-noun.cognition	( ( 0	6 CD B-adj.all	mg.kg(-1).min(-1 NN B-noun.quantity	) ) 0	) ) 0	, , 0	increasing VBG B-verb.change	significantly RB B-adv.all	to TO 0	66.6 CD 0	+ : 0	/- $ 0	10.9 CD 0	mg NN B-noun.quantity	. . 0	. . 0
a9334596.s5	Prolactin NNP B-noun.person	results NNS I-noun.person	were VBD 0	compared VBN B-verb.change	with IN 0	those DT 0	of IN 0	a DT 0	previous JJ B-adj.all	personal JJ B-adj.all	cohort NN B-noun.person	of IN 0	1,340 CD 0	patients NNS B-noun.person	with IN 0	erectile_dysfunction NNP B-noun.person	and CC 0	systematic JJ B-adj.all	prolactin NN B-noun.substance	determination NN B-noun.cognition	. . 0	. . 0
a1639466.s4	After IN 0	6 CD B-adj.all	weeks NNS B-noun.time	of IN 0	treatment NN B-noun.communication	, , 0	renal JJ B-adj.all	hemodynamics NNS B-noun.person	( ( 0	glomerular JJ B-adj.all	filtration NN B-noun.process	rate NN B-noun.time	and CC 0	renal JJ B-adj.all	plasma NN B-noun.attribute	flow NN B-noun.process	) ) 0	were VBD 0	measured VBN B-verb.change	in IN 0	the DT 0	anesthetized JJ B-adj.all	rats NNS B-noun.person	. . 0	. . 0
a16181582.s6	The DT 0	problems NNS B-noun.communication	in IN 0	diagnosing NN B-verb.communication	this DT 0	condition NN B-noun.communication	are VBP 0	subsequently RB B-adv.all	discussed VBN B-verb.communication	. . 0	. . 0
a15458908.s0	Safety NN B-noun.person	and CC 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	associated VBN B-verb.cognition	with IN 0	raloxifene NN B-noun.person	, , 0	multiple JJ B-adj.all	outcomes NNS B-noun.event	of IN 0	raloxifene NN B-noun.phenomenon	evaluation NN B-noun.process	. . 0	. . 0
a7423039.s6	The DT 0	addition NN 0	of IN 0	1 CD B-adj.all	mM CD B-noun.quantity	adenosine NN B-noun.quantity	to TO 0	the DT 0	myocardial JJ B-adj.all	cell NN B-noun.body	cultures NNS I-noun.body	markedly RB B-adv.all	increases VBZ B-verb.change	the DT 0	ATP NNP 0	concentration NN 0	through IN 0	a DT 0	pathway NN B-noun.location	reportedly RB B-adv.all	leading VBG B-verb.cognition	to TO 0	a DT 0	compartmentalized JJ B-adj.all	ATP NNP 0	pool NN 0	. . 0	. . 0
a869641.s12	Furthermore RB B-adv.all	, , 0	the DT 0	effects NNS B-noun.phenomenon	are VBP 0	mediated VBN B-verb.cognition	through IN 0	dopamine NN 0	rather RB 0	than IN 0	norepinephrine NN B-noun.person	and CC 0	do VBP 0	not RB B-adv.all	require VB B-verb.communication	the DT 0	carotid NN B-noun.group	sinus IN 0	baroreceptors NNS B-noun.person	. . 0	. . 0
a2071257.s6	The DT 0	findings NNS B-noun.act	of IN 0	this DT 0	study NN B-noun.communication	indicate VBP B-verb.communication	that IN 0	the DT 0	drug NN B-noun.person	is VBZ B-verb.stative	able JJ B-adj.all	to TO 0	antagonize VB B-verb.cognition	impairment_of_attention_and_memory JJ 0	induced VBN B-verb.creation	by IN 0	scopolamine NN B-noun.person	. . 0	. . 0
a16298782.s3	Their_ototoxicity NN 0	is VBZ B-verb.stative	a DT 0	serious JJ B-adj.all	health NN B-noun.attribute	problem NN B-noun.communication	and CC 0	, , 0	as IN 0	their_ototoxic JJ 0	mechanism NN B-noun.artifact	involves VBZ B-verb.stative	the DT 0	production NN B-noun.artifact	of IN 0	NO NNP B-noun.communication	, , 0	we PRP 0	need VBP 0	to TO 0	assess VB B-verb.cognition	the DT 0	use NN 0	of IN 0	NO NNP 0	inhibitors NNS 0	for IN 0	the DT 0	prevention NN B-noun.artifact	of_aminoglycoside RB 0	- : 0	induced_sensorineural_hearing_loss NN 0	. . 0	. . 0
a12596116.s3	The DT 0	authors NNS B-noun.person	discuss VBP B-verb.cognition	the DT 0	mechanism NN B-noun.attribute	of IN 0	the DT 0	occurrence NN B-noun.state	of IN 0	this DT 0	complication NN B-noun.communication	and CC 0	recommend VB B-verb.communication	caution NN B-noun.cognition	of IN 0	its PRP$ 0	use NN B-noun.process	in IN 0	high JJ B-adj.all	- : 0	risk NN 0	premature JJ B-adj.all	neonates NNS B-noun.artifact	. . 0	. . 0
a7468724.s1	Severe JJ B-adj.all	cardiovascular_complications NNS B-noun.group	occurred VBD B-verb.competition	in IN 0	eight CD 0	of IN 0	160 CD 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	terbutaline NN B-noun.person	for IN 0	preterm_labor NNP B-noun.person	. . 0	. . 0
a230316.s3	Of IN 0	the DT 0	remainder NN B-noun.person	, , 0	a DT 0	relationship NN B-noun.state	to TO 0	clioquinol NN B-noun.person	was VBD 0	considered VBN B-verb.cognition	probable JJ B-adj.all	in IN 0	42 CD 0	and CC 0	possible JJ B-adj.all	in IN 0	69 CD B-adj.all	cases NNS B-noun.quantity	. . 0	. . 0
a6229975.s3	The DT 0	timolol NN B-noun.group	- : 0	treated VBN B-verb.communication	patients NNS B-noun.person	showed VBD B-verb.communication	a DT 0	small JJ B-noun.person	but CC 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	heart NN 0	size NN B-noun.attribute	from IN 0	baseline NN B-noun.person	in IN 0	contrast NN 0	to TO 0	a DT 0	decrease NN B-noun.event	in IN 0	the DT 0	placebo NN B-noun.location	group NN 0	. . 0	. . 0
a11256525.s9	Under IN 0	such JJ B-adj.all	conditions NNS B-noun.possession	, , 0	angiotensin_II JJ B-adj.all	receptor NN B-noun.artifact	blockade NN B-noun.act	by IN 0	losartan NN B-noun.communication	probably RB B-adv.all	induced VBD B-verb.creation	a DT 0	critical JJ B-adj.all	fall NN B-noun.act	in IN 0	glomerular JJ B-adj.all	filtration NN B-noun.phenomenon	pressure NN I-noun.phenomenon	. . 0	. . 0
a11569530.s6	Four CD 0	compounds NNS B-noun.person	known VBN B-verb.cognition	to TO 0	increase VB B-verb.change	QT NNP 0	interval NN 0	and CC 0	cause VB B-verb.creation	TDP NNP 0	were VBD 0	investigated VBN B-verb.communication	, , 0	terfenadine NN B-noun.person	, , 0	terodiline NN B-noun.person	, , 0	cisapride NN B-noun.person	and CC 0	E4031 NNP B-noun.person	. . 0	. . 0
a11198499.s2	In IN 0	addition NN 0	to TO 0	their PRP$ 0	effects NNS B-noun.phenomenon	on IN 0	spasticity NN B-noun.location	, , 0	certain JJ B-adj.all	adverse JJ B-adj.all	cardiorespiratory NN B-noun.substance	effects NNS B-noun.phenomenon	have VBP 0	been VBN 0	reported VBN B-verb.communication	. . 0	. . 0
a10739826.s1	The DT 0	epidemiological JJ B-adj.all	studies NNS B-noun.group	that WDT 0	assessed VBD B-verb.social	the DT I-verb.social	risk NN I-verb.social	of IN 0	venous_thromboembolism NN B-noun.artifact	( ( 0	VTE NNP 0	) ) 0	associated VBN B-verb.cognition	with IN 0	newer JJR B-adj.all	oral_contraceptives NNS B-noun.time	( ( 0	OC NNP 0	) ) 0	did VBD 0	not RB B-adv.all	distinguish VB B-verb.cognition	between IN 0	patterns NNS B-noun.person	of IN 0	OC NNP 0	use NN 0	, , 0	namely RB B-adj.all	first JJ B-noun.quantity	- : 0	time NN B-noun.group	users NNS B-noun.person	, , 0	repeaters NNS B-noun.person	and CC 0	switchers NNS B-noun.person	. . 0	. . 0
a10807237.s5	Age NN B-noun.person	at IN 0	presentation NN B-noun.communication	, , 0	time NN B-noun.time	of IN 0	ictus NN B-noun.food	after IN 0	intoxication NN B-noun.time	, , 0	Hunt NNP B-noun.person	and CC 0	Hess NNP B-noun.person	grade NN I-noun.person	of IN 0	subarachnoid_hemorrhage NN B-noun.food	, , 0	size NN B-noun.attribute	of IN 0	the DT 0	aneurysm NN B-noun.artifact	, , 0	location NN 0	of IN 0	the DT 0	aneurysm NN B-noun.artifact	, , 0	and CC 0	the DT 0	Glasgow NNP B-noun.other	Outcome NNP I-noun.other	Scale NNP I-noun.other	score NN B-noun.group	were VBD 0	assessed VBN B-verb.communication	and CC 0	compared VBN B-verb.change	. . 0	. . 0
a12820454.s13	Severe NNP B-noun.person	and CC 0	clinically RB B-adv.all	evident JJ B-adj.all	anemia NN B-noun.person	was VBD 0	easily RB B-adv.all	corrected VBN B-verb.change	by IN 0	subcutaneous JJ B-adj.all	injections NNS B-noun.communication	( ( 0	3 CD B-adj.all	times NNS B-noun.event	/ : 0	week NN B-noun.time	for IN 0	1 CD B-adj.all	month NN B-noun.quantity	) ) 0	of IN 0	recombinant JJ B-adj.all	erythropoietin NN B-noun.cognition	( ( 0	rHuEPO UH 0	- : 0	beta NN 0	) ) 0	. . 0	. . 0
a869641.s3	in IN 0	anesthetize DT 0	MAO NNP B-noun.group	- : 0	inhibited JJ B-adj.all	dogs NNS B-noun.artifact	. . 0	. . 0
a1639466.s0	Adverse JJ B-adj.all	effect NN B-noun.cognition	of IN 0	the DT 0	calcium NN B-noun.artifact	channel NN 0	blocker NN B-adj.all	nitrendipine NN B-noun.person	on IN 0	nephrosclerosis NN B-noun.food	in IN 0	rats NNS B-noun.animal	with IN 0	renovascular_hypertension NN B-noun.act	. . 0	. . 0
a12483326.s4	Generally RB B-adv.all	, , 0	carboplatin NN 0	is VBZ 0	said VBN B-verb.communication	to TO 0	have VB B-verb.change	milder JJR B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	than IN 0	cisplatin NN B-noun.person	, , 0	whose WP$ 0	ocular_and_orbital_toxicity NN B-noun.state	are VBP B-verb.stative	well RB B-adj.all	known VBN I-adj.all	. . 0	. . 0
a869641.s7	Removal NN B-noun.person	of IN 0	the DT 0	carotid NN B-noun.group	sinuses NNS B-noun.person	caused VBD B-verb.communication	an DT 0	elevation NN B-noun.act	blood NN B-noun.act	pressure NN B-noun.act	and CC 0	heart NN B-noun.body	rate NN B-noun.time	and CC 0	abolished VBD B-verb.contact	the DT 0	negative JJ B-adj.all	chronotropic NN B-noun.phenomenon	effect NN B-noun.phenomenon	of IN 0	norepinephrine NN B-noun.person	. . 0	. . 0
a7516729.s8	Independent JJ B-adj.all	but CC 0	not RB B-adv.all	additive JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	Na NNP B-noun.person	and CC 0	Ca NNP 0	are VBP 0	shown VBN B-verb.creation	by IN 0	decreases NNS B-noun.person	in IN 0	the DT 0	values NNS B-noun.attribute	of IN 0	[ : 0	verapamil]o RB B-adv.all	needed VBN B-verb.consumption	to TO 0	reduce VB B-verb.change	BF NNP 0	by IN 0	30 CD B-adj.all	% NN 0	( ( 0	IC30 NN 0	) ) 0	with IN 0	the DT 0	following VBG 0	order NN 0	of IN 0	inhibitory JJ B-adj.all	potency NN B-noun.person	, , 0	LNa NNP B-noun.group	> NNP I-noun.group	LCa NNP I-noun.group	> NNP I-noun.group	HCa NNP I-noun.group	> NNP I-noun.group	N NNP I-noun.group	, , 0	resulting VBG B-verb.stative	LNa+HCa CD 0	similar JJ B-adj.all	to TO 0	LNa NNP B-noun.person	. . 0	. . 0
a15120741.s0	Recurrent NN B-noun.person	excitation NN B-noun.act	in IN 0	the DT 0	dentate JJ B-adj.all	gyrus NN B-noun.person	of IN 0	a DT 0	murine NN B-noun.act	model NN B-noun.artifact	of IN 0	temporal_lobe_epilepsy JJ B-noun.artifact	. . 0	. . 0
a15278670.s9	However RB 0	, , 0	there EX 0	was VBD B-verb.stative	no DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	in IN 0	the DT 0	lidocaine NN B-noun.location	concentrations NNS B-noun.person	measured VBN B-verb.cognition	when WRB 0	the DT 0	systolic JJ B-adj.all	blood NN B-noun.act	pressure NN B-noun.act	became VBD B-verb.stative	70 CD B-adj.all	mmHg NNP B-noun.person	. . 0	. . 0
a3070035.s2	His PRP$ 0	renal JJ B-adj.all	function NN B-noun.act	remained VBD B-verb.stative	impaired JJ B-adj.all	but CC 0	stable JJ 0	during IN 0	2 CD B-adj.all	years NNS B-noun.quantity	' POS 0	treatment NN B-noun.communication	with IN 0	captopril NN B-noun.artifact	but CC 0	returned VBD B-verb.change	to TO 0	pre VB B-verb.social	- : 0	treatment NN B-noun.plant	levels NNS B-noun.state	soon RB 0	after IN 0	cessation NN B-noun.time	of IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a7199841.s5	None NN 0	of IN 0	the DT 0	animals NNS B-noun.artifact	that WDT 0	received VBD B-verb.possession	bupivacaine NN B-noun.person	, , 0	normal JJ B-adj.all	saline NN B-noun.act	, , 0	or CC 0	normal JJ B-adj.all	saline NN 0	titrated VBN 0	to TO 0	a DT 0	pH $ 0	3.0 CD 0	developed VBD B-verb.creation	hind PRP 0	- : 0	limb NN B-noun.person	paralysis NN B-noun.person	. . 0	. . 0
a2096243.s5	It PRP 0	may MD 0	be VB 0	attributed VBN B-verb.social	to TO 0	the DT 0	structural_damage_to_the_frontal_lobe NN B-noun.artifact	. . 0	. . 0
a2024540.s2	To TO 0	assess VB B-verb.cognition	the DT 0	safety NN B-noun.person	of IN 0	the DT 0	ACE_inhibitor NN B-noun.other	enalapril VBP B-verb.change	a DT 0	multicenter NN B-noun.person	, , 0	randomized VBD B-verb.cognition	, , 0	prazosin NN B-noun.person	- : 0	controlled VBN B-verb.social	trial NN B-noun.act	was VBD 0	designed VBN B-verb.cognition	that IN 0	compared VBN B-verb.change	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	symptomatic JJ B-adj.all	hypotension NN B-noun.act	on IN 0	the DT 0	first JJ B-adj.all	day NN B-noun.person	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a3187073.s4	The DT 0	aim NN 0	of IN 0	the DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	clarify VB B-verb.cognition	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	adverse JJ B-adj.all	cardiac JJ B-adj.pert	effects NNS B-noun.phenomenon	to TO 0	this DT 0	treatment NN B-noun.communication	. . 0	. . 0
a11027905.s2	Animal NNP B-noun.person	and CC 0	clinical JJ B-adj.all	studies NNS B-noun.group	have VBP 0	suggested VBN B-verb.communication	that IN 0	N SYM 0	- : 0	methyl NN B-noun.attribute	- : 0	D SYM 0	- : 0	aspartate NN B-noun.person	( ( 0	NMDA NNP 0	) ) 0	antagonists NNS B-noun.location	, , 0	such JJ 0	as IN 0	ketamine NN B-noun.person	, , 0	may MD 0	be VB B-verb.stative	effective JJ B-adj.all	in IN 0	improving VBG B-verb.change	opioid JJ B-adj.all	analgesia NN B-noun.object	in IN 0	difficult JJ B-adj.all	pain NN B-noun.cognition	syndromes NNS I-noun.cognition	, , 0	such JJ 0	as IN 0	neuropathic_pain JJ B-noun.person	. . 0	. . 0
a1639466.s3	Sham NNP B-noun.person	- : 0	operated VBD B-verb.contact	rats NNS B-noun.person	served VBD B-verb.social	as IN 0	normotensive JJ B-adj.all	controls NNS B-noun.cognition	( ( 0	128 CD 0	+ . 0	/- $ 0	3 CD B-adj.all	mm NN B-noun.quantity	Hg NNP 0	, , 0	n FW 0	= FW 0	8) FW 0	. . 0	. . 0
a17242861.s7	B6 JJ B-adj.all	mice NNS B-noun.person	were VBD B-verb.stative	resistant JJ B-adj.all	to TO 0	seizures NNS B-noun.act	and CC 0	slower JJR B-adj.all	to TO 0	reach VB B-verb.communication	stages NNS B-noun.communication	compared VBN B-verb.communication	to TO 0	A DT 0	/ JJ 0	J NNP 0	mice NNS B-noun.animal	. . 0	. . 0
a10807237.s3	METHODS NNS B-noun.attribute	, , 0	A DT 0	review NN B-noun.act	of IN 0	admissions NNS B-noun.artifact	during IN 0	a DT 0	6-year JJ B-adj.all	period NN B-noun.person	revealed VBD B-verb.perception	14 CD B-adj.all	patients NNS B-noun.person	with IN 0	cocaine NN B-noun.person	- : 0	related VBN B-verb.cognition	aneurysms NNS 0	. . 0	. . 0
a1436384.s8	Depletion NN B-noun.act	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.artifact	was VBD B-verb.stative	also RB B-adv.all	antagonized VBN B-verb.cognition	when WRB 0	LY274614 NN B-noun.person	was VBD 0	given VBN B-verb.possession	after IN 0	the DT 0	injection NN B-noun.act	of IN 0	amphetamine NN B-noun.person	, , 0	LY274614 NN 0	protected VBN B-verb.cognition	when WRB 0	given VBN B-verb.possession	up RP 0	to TO 0	4 CD B-adj.all	hr RB B-noun.time	after IN 0	but CC 0	not RB B-adv.all	when WRB 0	given VBN B-verb.possession	8 CD B-adj.all	or CC 0	24 CD B-adj.all	hr NN B-noun.time	after IN 0	amphetamine NN B-noun.person	. . 0	. . 0
a2670794.s7	It PRP 0	is VBZ 0	suggested VBN B-verb.communication	that IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	Captopril NNP B-noun.person	on IN 0	the DT 0	lungs NNS B-noun.artifact	may MD 0	be VB B-verb.stative	attributable JJ B-adj.all	to TO 0	a DT 0	vasodilatory JJ B-adj.all	effect NN 0	due JJ 0	to TO 0	a DT 0	reduction NN B-noun.act	in IN 0	the DT 0	circulating JJ B-adj.all	level NN B-noun.attribute	of IN 0	Angiotension_II NNP B-noun.person	and CC 0	an DT 0	increase NN B-noun.act	in IN 0	prostacyclin NN B-noun.substance	( ( 0	secondary JJ B-adj.all	to TO 0	an DT 0	increase NN B-noun.act	in IN 0	bradykinin NN 0	) ) 0	. . 0	. . 0
a10807237.s11	CONCLUSION NN B-noun.group	, , 0	Cocaine NNP 0	use NN 0	predisposed VBD B-verb.stative	aneurysmal_rupture NN 0	at IN 0	a DT 0	significantly RB B-adv.all	earlier JJR B-adj.all	age NN B-noun.person	and CC 0	in IN 0	much RB 0	smaller JJR B-adj.all	aneurysms NNS B-noun.person	. . 0	. . 0
a18208574.s9	Multivariate JJ B-adj.all	analysis NN B-noun.person	showed VBD B-verb.communication	a DT 0	2.8-fold JJ B-noun.artifact	increased VBN B-verb.change	risk NN 0	of IN 0	thrombosis NN B-noun.food	in IN 0	females NNS B-noun.person	. . 0	. . 0
a9334596.s4	Determination NN B-noun.person	was VBD 0	repeated VBN B-verb.communication	in IN 0	case NN B-noun.state	of IN 0	abnormal JJ B-adj.all	first JJ B-adj.all	results NNS B-noun.communication	. . 0	. . 0
a11391224.s0	Peritubular JJ B-adj.all	capillary JJ B-adj.all	basement NN B-noun.person	membrane NN B-noun.person	reduplication NN B-noun.person	in IN 0	allografts NNS B-noun.animal	and CC 0	native JJ B-noun.person	kidney_disease NNP I-noun.person	, , 0	a DT 0	clinicopathologic JJ B-adj.all	study NN B-noun.artifact	of IN 0	278 CD 0	consecutive JJ B-adj.all	renal JJ B-noun.body	specimens NNS I-noun.body	. . 0	. . 0
a18182964.s9	CONCLUSIONS NNS B-noun.artifact	, , 0	Clonidine NNP B-noun.person	, , 0	used VBN B-verb.consumption	alone RB B-adv.all	or CC 0	with IN 0	methylphenidate NN B-noun.food	, , 0	appears VBZ B-verb.cognition	safe JJ B-noun.person	and CC 0	well RB 0	tolerated VBN 0	in IN 0	childhood NN 0	ADHD NNP B-noun.group	. . 0	. . 0
a1732369.s5	Echocardiographic NNP B-noun.person	Doppler NNP I-noun.person	studies NNS I-noun.person	were VBD 0	performed VBN B-verb.social	before IN 0	infusion NN B-noun.cognition	and CC 0	after IN 0	15 CD B-adj.all	min NN B-noun.quantity	of IN 0	infusion NN B-noun.cognition	at IN 0	each DT 0	rate NN B-noun.time	. . 0	. . 0
a11256525.s2	He PRP 0	was VBD 0	hospitalized VBN B-verb.social	for IN 0	a DT 0	myocardial_infarction NN B-noun.person	with IN 0	pulmonary_edema NN B-noun.artifact	, , 0	treated VBN B-verb.change	with IN 0	high JJ B-noun.group	- : 0	dose NN B-noun.person	diuretics NNS B-noun.person	. . 0	. . 0
a20698227.s5	RESULTS NNS B-noun.artifact	, , 0	We PRP 0	observed VBD B-verb.perception	a DT 0	significant JJ B-adj.all	decrease NN B-noun.state	in IN 0	haptoglobin NN 0	levels NNS B-noun.state	at IN 0	the DT 0	end NN B-noun.time	of IN 0	the DT 0	treatment NN B-noun.plant	period NN B-noun.person	. . 0	. . 0
a18261172.s10	Thus RB 0	, , 0	proteinuria NN B-noun.person	may MD 0	develop VB B-verb.stative	in IN 0	cardiac JJ B-adj.all	transplant NN B-noun.person	patients NNS B-noun.person	after IN 0	switch VB B-verb.social	to TO 0	Srl NNP B-noun.person	, , 0	which WDT 0	may MD 0	have VB B-verb.possession	an DT 0	adverse JJ B-adj.all	effect NN B-noun.cognition	on IN 0	renal JJ B-adj.all	function NN B-noun.act	in IN 0	these DT 0	patients NNS B-noun.person	. . 0	. . 0
a15278670.s1	The DT 0	influence NN B-noun.cognition	of IN 0	sevoflurane NN 0	on IN 0	lidocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	convulsions NNS B-noun.possession	was VBD 0	studied VBN B-verb.cognition	in IN 0	cats NNS B-noun.location	. . 0	. . 0
a2951327.s2	infusions NNS B-noun.cognition	of IN 0	human JJ B-adj.all	alpha NN B-noun.person	- : 0	atrial JJ B-adj.all	natriuretic JJ B-adj.all	factor NN B-noun.person	. . 0	. . 0
a8690168.s4	The DT 0	majority NN B-noun.quantity	of IN 0	anionic JJ B-adj.all	sites NNS B-noun.location	( ( 0	74 CD 0	% NN 0	in IN 0	diabetic NN B-noun.person	and CC 0	81 CD 0	% NN 0	in IN 0	control NN B-noun.act	rats NNS B-noun.location	) ) 0	were VBD 0	found VBN B-verb.possession	within IN 0	the DT 0	lamina NN B-noun.artifact	rara JJ B-adj.all	externa NN B-noun.group	of IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	. . 0	. . 0
a435349.s1	Suxamethonium_chloride RB 0	( ( 0	Sch NNP 0	) ) 0	was VBD 0	administered VBN B-verb.possession	i.v NNP I-verb.possession	. . 0	. . 0
a19631624.s9	Ecstasy NNP B-noun.person	- : 0	specific JJ B-adj.all	hypoactivity NN B-noun.attribute	was VBD B-verb.stative	evident JJ B-adj.all	in IN 0	the DT 0	right JJ B-adj.all	dorsal NN 0	anterior RB 0	cingulated JJ B-adj.all	cortex NN B-noun.person	( ( 0	ACC NNP 0	) ) 0	and CC 0	left VBD B-verb.motion	posterior RB B-adj.all	cingulated JJ B-adj.all	cortex NN B-noun.person	. . 0	. . 0
a19300402.s4	Pretreatment NN B-noun.person	with IN 0	L SYM 0	- : 0	NOArg NN B-noun.person	and CC 0	L NNP 0	- : 0	NIL NNP B-noun.person	but CC 0	not RB B-adv.all	7-NI JJ 0	, , 0	significantly RB B-adv.all	increases VBZ B-verb.change	antihyperalgesic JJ B-adj.all	activity NN B-noun.state	both DT 0	HOE_140 NNP B-noun.person	and CC 0	des_Arg10_HOE_140 NN B-noun.person	. . 0	. . 0
a18996674.s3	The DT 0	management NN B-noun.group	options NNS B-noun.person	in IN 0	the DT 0	ED NNP 0	, , 0	as IN 0	exemplified VBN B-verb.communication	by IN 0	four CD 0	individual JJ B-adj.all	case NN B-noun.state	reports NNS B-noun.communication	, , 0	in IN 0	particular JJ B-adj.all	the DT 0	use NN 0	of IN 0	a DT 0	minimally RB B-adv.all	invasive JJ B-adj.all	method NN B-noun.attribute	of IN 0	intracorporal JJ B-noun.phenomenon	epinephrine NN I-noun.phenomenon	instillation NN B-noun.artifact	, , 0	are VBP 0	discussed VBN B-verb.communication	. . 0	. . 0
a6503301.s4	Small- JJ B-noun.artifact	and CC 0	medium NN B-noun.person	- : 0	sized VBD B-verb.creation	hepatic JJ B-adj.all	veins NNS B-noun.person	were VBD 0	blocked VBN B-verb.contact	by IN 0	thrombosis NN B-noun.communication	. . 0	. . 0
a17491223.s7	dP SYM 0	/ PRP$ 0	dtejc JJ B-adj.all	outcome NN B-noun.person	was VBD 0	combined VBN B-verb.change	with IN 0	the DT 0	ECG NNP B-noun.group	results NNS B-noun.artifact	, , 0	giving VBG B-verb.possession	an DT 0	ECG NNP B-noun.group	- : 0	enhanced JJ B-adj.all	value NN B-noun.possession	, , 0	and CC 0	compared VBN B-verb.cognition	to TO 0	ECG NNP 0	alone RB 0	. . 0	. . 0
a1436384.s9	The DT 0	prolonged JJ B-adj.all	depletion NN B-noun.process	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.artifact	in IN 0	mice NNS B-noun.animal	, , 0	given VBN B-verb.possession	multiple JJ B-adj.all	injections NNS B-noun.act	of IN 0	methamphetamine NN B-noun.attribute	, , 0	was VBD B-verb.stative	also RB B-adv.all	antagonized JJ B-adj.all	dose NN B-noun.person	- : 0	dependently RB B-adv.all	and CC 0	completely RB B-adv.all	by IN 0	LY274614 NN B-noun.person	. . 0	. . 0
a1987816.s1	OBJECTIVE NNP B-noun.group	, , 0	This DT 0	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	determine VB B-verb.communication	whether IN 0	patients NNS B-noun.person	maintained VBD B-verb.stative	on IN 0	a DT 0	regimen NNS B-noun.person	of IN 0	lithium NN B-noun.animal	on IN 0	a DT 0	once RB B-adv.all	- : 0	per SYM 0	- : 0	day NN B-noun.person	schedule NN B-noun.person	have VBP B-verb.change	lower JJR B-adj.all	urine NN B-noun.location	volumes NNS B-noun.artifact	than IN 0	do VBP 0	patients NNS B-noun.person	receiving VBG B-verb.change	multiple JJ B-adj.all	doses NNS B-noun.artifact	per IN 0	day NN B-noun.animal	. . 0	. . 0
a17854040.s6	HBV NNP 0	viral JJ B-adj.all	load NN B-noun.phenomenon	was VBD 0	performed VBN B-verb.social	with IN 0	Amplicor NNP B-noun.group	HBV NNP I-noun.group	Monitor NNP I-noun.group	test NN B-noun.communication	v2.0 NNP I-noun.communication	( ( 0	Roche NNP B-noun.person	Diagnostics NNP I-noun.person	, , 0	Penzberg NNP B-noun.person	, , 0	Germany NNP B-noun.location	) ) 0	. . 0	. . 0
a3412544.s2	The DT 0	risk NN 0	of IN 0	renal_papillary_necrosis NN B-noun.food	was VBD 0	increased VBN B-verb.change	nearly RB B-adj.all	20-fold JJ 0	by IN 0	consumption NN B-noun.act	of IN 0	phenacetin NN B-noun.food	, , 0	which WDT 0	also RB B-adv.all	increased VBD B-verb.change	the DT 0	risk NN B-verb.social	for IN 0	cancer_of_the_renal_pelvis_and_bladder NN B-noun.person	but CC 0	not RB B-adv.all	for IN 0	ureteric_cancer NN B-noun.person	. . 0	. . 0
a15458908.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	examine VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	raloxifene NN B-noun.person	on IN 0	major JJ B-adj.all	adverse JJ B-adj.pert	events NNS B-noun.event	that WDT 0	occur VBP B-verb.stative	with IN 0	postmenopausal JJ B-adj.all	estrogen NN B-noun.act	therapy NN B-noun.act	or CC 0	tamoxifen VBN B-verb.communication	. . 0	. . 0
a6692345.s1	The DT 0	co SYM 0	- : 0	administration NN B-noun.time	of IN 0	aspirin NN B-noun.person	with IN 0	N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide JJ 0	( ( 0	FANFT NNP B-noun.group	) ) 0	to TO 0	rats NNS B-noun.person	resulted VBD B-verb.social	in IN 0	a DT 0	reduced JJ B-adj.all	incidence NN B-noun.quantity	of IN 0	FANFT NNP B-noun.group	- : 0	induced VBN B-verb.creation	bladder_carcinomas NNS B-noun.object	but CC 0	a DT 0	concomitant JJ B-adj.all	induction NN B-noun.cognition	of IN 0	forestomach_tumors NNS B-noun.object	. . 0	. . 0
a7444978.s1	Streptomycin NNP B-noun.person	sulfate NN I-noun.person	( ( 0	300 CD 0	mg NN B-noun.quantity	/ ( 0	kg IN 0	s.c NNP 0	. . 0	) ) 0	. . 0
a19300402.s3	RESULTS NNS B-noun.artifact	, , 0	The DT 0	results NNS B-noun.communication	of IN 0	this DT 0	paper NN B-noun.communication	confirm NN B-noun.communication	that IN 0	inhibition NN B-noun.attribute	of IN 0	bradykinin NN B-noun.plant	receptors NNS B-noun.person	and CC 0	inducible JJ B-adj.all	NO DT 0	synthase NN 0	but CC 0	not RB B-adv.all	neuronal JJ B-adj.all	NO NNP 0	synthase NN 0	activity NN B-noun.process	reduces VBZ B-verb.change	diabetic_hyperalgesia NN I-verb.change	. . 0	. . 0
a84204.s5	The DT 0	cerebrospinal JJ B-adj.all	fluid NN B-noun.state	, , 0	serum NN 0	ratio NN 0	of IN 0	cimetidine JJ B-adj.all	concentrations NNS B-noun.artifact	was VBD B-verb.stative	0.24,1 NNP B-noun.person	and CC 0	indicates VBZ B-verb.communication	that IN 0	cimetidine NN B-noun.person	passes VBZ B-verb.possession	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.person	barrier NN I-noun.person	, , 0	it PRP 0	also RB B-adv.all	raises VBZ B-verb.communication	the DT 0	possibility NN B-noun.state	that IN 0	M.S. NNP B-noun.person	changes NNS I-noun.person	are VBP B-verb.stative	due JJ 0	to TO 0	blockade VB B-verb.change	of IN 0	histamine NN B-noun.communication	H2-receptors NNS B-noun.person	in IN 0	the DT 0	central JJ B-noun.body	nervous JJ I-noun.body	system NN B-noun.cognition	. . 0	. . 0
a12820454.s3	All DT 0	patients NNS B-noun.person	received VBD B-verb.possession	CAB NNP B-noun.group	[ POS 0	leuprolide_acetate JJ B-noun.other	( ( 0	LHRH NNP B-noun.group	- : 0	A NN 0	) ) 0	3.75 CD 0	mg NN B-noun.quantity	, , 0	intramuscularly RB B-adv.all	, , 0	every DT 0	28 CD B-adj.all	days NNS B-noun.person	plus CC 0	250 CD 0	mg NN B-noun.quantity	flutamide NN 0	, , 0	tid NN 0	, , 0	per IN 0	Os NNP B-noun.person	] NNP I-noun.person	and CC 0	were VBD 0	evaluated VBN B-verb.communication	for IN 0	anemia NN B-noun.state	by IN 0	physical JJ B-adj.all	examination NN B-noun.act	and CC 0	laboratory NN B-noun.artifact	tests NNS B-noun.person	at IN 0	baseline NN B-noun.act	and CC 0	4 CD B-adj.all	subsequent JJ B-noun.cognition	intervals NNS I-noun.cognition	( ( 0	1 CD 0	, , 0	2 CD B-adj.all	, , 0	3 CD B-adj.all	and CC 0	6 CD B-adj.all	months NNS B-noun.person	post RB B-adv.all	- : 0	CAB NN B-noun.group	) ) 0	. . 0	. . 0
a6229975.s1	The DT 0	effect NN B-noun.cognition	of IN 0	long JJ B-noun.body	- : 0	term NN B-noun.time	timolol NN 0	treatment NN B-noun.communication	on IN 0	heart NN 0	size NN B-noun.attribute	after IN 0	myocardial_infarction NN B-noun.person	was VBD 0	evaluated VBN B-verb.change	by IN 0	X NNP 0	- : 0	ray NN B-noun.person	in IN 0	a DT 0	double JJ B-adj.all	- : 0	blind JJ B-adj.all	study NN B-noun.artifact	including VBG B-verb.stative	241 CD 0	patients NNS B-noun.person	( ( 0	placebo NN 0	126 CD 0	, , 0	timolol NN 0	115 CD 0	) ) 0	. . 0	. . 0
a16680561.s0	Pharmacokinetics NNS B-noun.person	of IN 0	desipramine_HCl NN B-noun.time	when WRB 0	administered VBN B-verb.possession	with IN 0	cinacalcet_HCl NNP B-noun.group	. . 0	. . 0
a9653867.s0	Thyroxine JJ 0	abuse NN 0	, , 0	an DT 0	unusual JJ B-adj.all	case NN B-noun.state	of IN 0	thyrotoxicosis NN B-noun.food	in IN 0	pregnancy NN B-noun.person	. . 0	. . 0
a435349.s8	Fasciculations NNS B-noun.person	in IN 0	the DT 0	six CD 0	areas NNS B-noun.location	and CC 0	the DT 0	total JJ B-adj.all	fasciculation NN B-noun.act	score NN B-noun.group	were VBD 0	related VBN B-verb.communication	directly RB B-adv.all	to TO 0	the DT 0	rate NN B-noun.time	of IN 0	infusion NN B-noun.cognition	. . 0	. . 0
a1130930.s3	High JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	this DT 0	antibiotic JJ B-adj.all	combination NN B-noun.group	should MD 0	be VB 0	avoided VBN B-verb.social	especially RB B-adv.all	in IN 0	elderly JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a3714122.s5	In IN 0	contrast NN 0	, , 0	dosages NNS B-noun.person	of IN 0	Mipafox NNP B-noun.person	( ( 0	less JJR B-noun.quantity	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	5 CD B-adj.all	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	which WDT 0	inhibited VBD B-verb.change	mean JJ B-adj.all	NTE NNP 0	activity NN B-noun.process	in IN 0	spinal JJ B-adj.all	cord NN B-noun.state	less JJR 0	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	61 CD 0	% NN 0	and CC 0	brain NN B-noun.person	less JJR 0	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	60 CD B-adj.all	% NN 0	produced VBN B-verb.creation	this DT 0	degree NN B-noun.communication	of IN 0	cord_damage NN B-noun.food	in IN 0	only RB B-adv.all	9 CD B-adj.all	% NN 0	of IN 0	the DT 0	animals NNS B-noun.artifact	. . 0	. . 0
a9523805.s3	Prilocaine NN B-noun.person	is VBZ B-verb.stative	an DT 0	amide JJ B-adj.all	local JJ B-adj.all	anesthetic JJ 0	with IN 0	a DT 0	duration NN 0	of IN 0	action NN B-noun.process	similar JJ B-adj.all	to TO 0	that DT 0	of IN 0	lidocaine NN B-noun.phenomenon	. . 0	. . 0
a7053303.s0	Age NN B-noun.person	and CC 0	renal JJ B-adj.all	clearance NN B-noun.act	of IN 0	cimetidine NN B-noun.act	. . 0	. . 0
a6133211.s2	In IN 0	the DT 0	singleton JJ B-adj.all	pregnancy NN B-noun.person	, , 0	the DT 0	mother NN B-noun.person	had VBD B-verb.change	ulcerative_colitis NNP B-noun.location	, , 0	and CC 0	the DT 0	infant NN B-noun.person	, , 0	a DT 0	male NN B-noun.person	, , 0	had VBD 0	coarctation_of_the_aorta NNP B-noun.other	and CC 0	a DT 0	ventricular_septal_defect NN B-noun.artifact	. . 0	. . 0
a6503301.s2	There EX 0	was VBD B-verb.stative	a DT 0	fulminant JJ B-adj.all	clinical JJ B-adj.all	course NN B-noun.object	from IN 0	start NN B-noun.act	of IN 0	symptoms NNS B-noun.location	until IN 0	death NN B-noun.time	. . 0	. . 0
a2894766.s0	Sulfasalazine SYM 0	- : 0	induced VBN B-verb.creation	lupus_erythematosus NN 0	. . 0	. . 0
a17042910.s19	Treatment NN B-noun.person	with IN 0	Ato NNP B-noun.person	improved VBD B-verb.change	endothelial JJ B-adj.all	function NN B-noun.act	, , 0	reduced VBD B-verb.change	superoxide JJ 0	production NN B-noun.artifact	and CC 0	reduced VBD B-verb.change	SBP NNP 0	in IN 0	Dex NNP B-noun.person	- : 0	treated VBD B-verb.communication	SD NNP 0	rats NNS B-noun.animal	. . 0	. . 0
a6103707.s3	Plasma NNP B-noun.person	concentrations NNS I-noun.person	of IN 0	the DT 0	drug NN B-noun.person	were VBD 0	estimated VBN B-verb.cognition	by IN 0	gas NN B-noun.person	- : 0	liquid JJ B-adj.all	chromatography NN B-noun.state	, , 0	in IN 0	a DT 0	smaller JJR B-adj.all	number NN B-noun.quantity	of IN 0	the DT 0	subjects NNS B-noun.person	. . 0	. . 0
a3341566.s6	The DT 0	SPV NNP 0	during IN 0	hypotension NN B-noun.person	was VBD B-verb.stative	15.7 CD 0	+ : 0	/- $ 0	6.7 CD 0	mm NN B-noun.quantity	Hg NNP 0	in IN 0	the DT 0	HEM NNP 0	group NN 0	, , 0	compared VBN B-verb.cognition	with IN 0	9.1 CD 0	+ : 0	/- $ 0	2.0 CD B-noun.quantity	mm NN B-noun.quantity	Hg NNP 0	in IN 0	the DT 0	SNP NNP 0	group NN 0	( ( 0	P NNP 0	less JJR 0	than IN 0	0.02 CD 0	) ) 0	. . 0	. . 0
a3782049.s2	The DT 0	clinical JJ B-adj.all	signs NNS B-noun.communication	and CC 0	symptoms NNS B-noun.body	, , 0	typical JJ B-adj.all	laboratory NN B-noun.artifact	features NNS I-noun.artifact	, , 0	and CC 0	complications NNS B-noun.person	of IN 0	rhabdomyolysis NN B-noun.animal	are VBP 0	presented VBN B-verb.perception	. . 0	. . 0
a15957009.s6	Both DT 0	, , 0	Ro4368554 NNP B-noun.person	( ( 0	3 CD 0	and CC 0	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	intraperitoneally RB B-adv.all	( ( 0	i.p FW 0	. . 0	) ) 0	) ) 0	. . 0
a1992636.s0	Hemolytic_anemia NN 0	associated VBN B-verb.cognition	with IN 0	the DT 0	use NN 0	of IN 0	omeprazole NN B-noun.shape	. . 0	. . 0
a10704919.s3	TAM NNP 0	induces VBZ B-verb.communication	hemolysis NN B-noun.state	of IN 0	erythrocytes NNS B-noun.location	as IN 0	a DT 0	function NN B-noun.act	of IN 0	concentration NN B-noun.cognition	. . 0	. . 0
a2440413.s8	The DT 0	pharmacological JJ B-adj.all	challenge NN B-noun.possession	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	tolerance NN B-noun.act	may MD 0	occur VB B-verb.cognition	to TO 0	seizure NN B-noun.phenomenon	activity NN B-noun.process	induced VBN B-verb.creation	by IN 0	PTZ NNP B-noun.person	and CC 0	PTX NNP B-noun.group	24 CD B-adj.all	h NN 0	after IN 0	gamma NN B-noun.act	- : 0	HCH NN 0	, , 0	since IN 0	the DT 0	response NN B-noun.communication	to TO 0	only RB 0	these DT 0	two CD 0	seizure NN B-noun.act	- : 0	inducing VBG B-verb.communication	agents NNS B-noun.person	is VBZ 0	decreased VBN B-verb.change	. . 0	. . 0
a11027905.s13	This DT 0	observation NN B-noun.communication	should MD 0	be VB 0	tested VBN B-verb.social	in IN 0	studies NNS B-noun.act	of IN 0	prolonged VBN B-verb.creation	ketamine NN B-noun.process	administration NN B-noun.time	. . 0	. . 0
a18182964.s3	Doses NNS B-noun.person	were VBD B-verb.stative	flexibly RB B-adv.all	titrated VBN B-verb.change	up RP 0	to TO 0	0.6 CD 0	mg RB B-noun.quantity	/ JJ 0	day NN 0	for IN 0	clonidine NN B-noun.act	and CC 0	60 CD B-adj.all	mg RB B-noun.quantity	/ JJ 0	day NN 0	for IN 0	methylphenidate NN B-noun.attribute	( ( 0	both DT 0	with IN 0	divided VBN B-verb.social	dosing NN 0	) ) 0	. . 0	. . 0
a3629586.s0	The DT 0	hematologic JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	cefonicid NN B-noun.body	and CC 0	cefazedone NN 0	in IN 0	the DT 0	dog NN B-noun.animal	, , 0	a DT 0	potential JJ B-adj.all	model NN B-noun.person	of IN 0	cephalosporin NN B-noun.substance	hematotoxicity NN B-noun.state	in IN 0	man NN 0	. . 0	. . 0
a8073369.s4	The DT 0	purpose NN B-noun.attribute	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	evaluate VB B-verb.communication	and CC 0	compare VB B-verb.stative	the DT 0	effects NNS B-noun.phenomenon	of IN 0	coniine NN B-noun.act	and CC 0	nicotine NN B-noun.person	in IN 0	the DT 0	developing VBG B-noun.artifact	chick NN I-noun.artifact	. . 0	. . 0
a11391224.s1	BACKGROUND NN 0	, , 0	An DT 0	association NN B-noun.cognition	has VBZ 0	been VBN 0	found VBN B-verb.possession	between IN 0	transplant_glomerulopathy JJ 0	( ( 0	TG NNP 0	) ) 0	and CC 0	reduplication NN B-noun.act	of IN 0	peritubular JJ B-adj.all	capillary JJ B-adj.all	basement NN B-noun.person	membranes NNS B-noun.person	( ( 0	PTCR NNP B-noun.group	) ) 0	. . 0	. . 0
a17175308.s8	Before IN 0	conversion NN B-noun.communication	8 CD B-adj.all	( ( 0	32 CD 0	% NN 0	) ) 0	patients NNS B-noun.person	had VBD 0	no DT 0	proteinuria NN B-noun.person	, , 0	whereas WRB 0	afterwards RB 0	all DT 0	patients NNS B-noun.person	had VBD 0	proteinuria NNS B-noun.person	. . 0	. . 0
a9334596.s23	However RB 0	, , 0	cost NN B-noun.person	- : 0	effective JJ B-adj.all	screening NN B-noun.communication	strategies NNS B-noun.communication	recommended VBN B-verb.communication	so RB B-adv.all	far RB B-adv.all	missed VBN B-verb.stative	40 CD B-adj.all	to TO 0	50 CD B-adj.all	% NN 0	of IN 0	cases NNS B-noun.person	improved VBN B-verb.change	with IN 0	endocrine JJ B-adj.all	therapy NN B-noun.artifact	and CC 0	the_pituitary_tumors NNS B-noun.person	. . 0	. . 0
a2070391.s4	The DT 0	mean JJ B-adj.all	pain NN B-noun.cognition	score NN B-noun.food	for IN 0	buffered VBN B-verb.social	lidocaine NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	than IN 0	the DT 0	mean JJ B-adj.all	score NN B-noun.group	for IN 0	standard JJ B-adj.all	lidocaine NN B-noun.phenomenon	( ( 0	2.7 CD 0	+ : 0	/- $ 0	1.9 CD 0	vs. FW 0	3.8 CD 0	+ : 0	/- # 0	2.2 CD 0	, , 0	P NNP 0	= SYM 0	0.03 CD 0	) ) 0	. . 0	. . 0
a7053303.s3	The DT 0	extrapolated JJ B-adj.all	6-hr JJ B-adj.all	serum NN B-noun.body	concentration NN B-noun.event	of IN 0	cimetidine NN B-noun.phenomenon	per IN 0	unit NN B-noun.artifact	dose NN I-noun.artifact	, , 0	after IN 0	intravenous JJ B-adj.all	cimetidine NN B-noun.location	, , 0	increased VBN B-verb.change	with IN 0	age NN B-noun.time	of IN 0	the DT 0	patients NNS B-noun.person	. . 0	. . 0
a8421099.s4	In IN 0	8 CD B-adj.all	patients NNS B-noun.person	followed VBD B-verb.stative	for IN 0	24 CD B-adj.all	weeks NNS B-noun.time	, , 0	gallbladder NN B-noun.person	contractility NN B-noun.person	remained VBD B-verb.communication	depressed JJ B-verb.emotion	throughout IN 0	therapy NN B-noun.act	. . 0	. . 0
a11198499.s3	Adults NNS B-noun.animal	chronically RB B-adv.all	treated VBN B-verb.change	with IN 0	angiotensin NN 0	converting VBG B-verb.stative	enzyme JJ B-adj.all	inhibitors NNS B-noun.person	may MD 0	have VB B-verb.stative	a DT 0	limited VBN B-adj.all	ability NN B-noun.feeling	to TO 0	respond VB B-verb.communication	to TO 0	hypotension NN 0	when WRB 0	the DT 0	sympathetic JJ B-adj.all	response NN B-noun.communication	is VBZ B-verb.stative	simultaneously RB B-adv.all	blocked VBN B-verb.contact	. . 0	. . 0
a12907309.s8	Neuroprotection NN B-noun.person	rendered VBN B-verb.creation	by IN 0	MPEP NNP B-noun.group	may MD 0	be VB 0	associated VBN B-verb.cognition	with IN 0	the DT 0	reduction NN B-noun.act	of IN 0	the DT 0	methamphetamine NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dopamine NN 0	efflux NN 0	in IN 0	the DT 0	striatum NN 0	due JJ 0	to TO 0	the DT 0	blockade NN B-noun.attribute	of IN 0	extrastriatal JJ B-adj.all	mGluR5 NNP B-noun.person	, , 0	and CC 0	with IN 0	a DT 0	decrease NN B-noun.event	in IN 0	hyperthermia NN 0	. . 0	. . 0
a17242861.s5	Three CD B-adj.all	hundred CD 0	fifty JJ B-adj.all	- : 0	five CD 0	adult NN 0	male NN 0	CSS NNP 0	mice NNS B-noun.animal	, , 0	58 CD 0	B6 NN B-noun.quantity	, , 0	and CC 0	39 CD 0	A DT 0	/ JJ 0	J NNP 0	were VBD 0	tested VBN B-verb.social	for IN 0	susceptibility NN 0	to TO 0	pilocarpine VB B-verb.social	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.feeling	. . 0	. . 0
a10704919.s6	The DT 0	hemolytic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	TAM NNP B-noun.group	is VBZ 0	prevented VBN B-verb.creation	by IN 0	low JJ B-adj.all	concentrations NNS B-noun.person	of IN 0	alpha NN B-noun.act	- : 0	tocopherol NN B-noun.act	( ( 0	alpha UH 0	- : 0	T NN 0	) ) 0	and CC 0	alpha NN B-noun.person	- : 0	tocopherol_acetate JJ B-noun.time	( ( 0	alpha UH 0	- : 0	TAc NNP B-noun.other	) ) 0	( ( 0	inactivated JJ B-adj.all	functional JJ B-adj.all	hydroxyl NN 0	) ) 0	indicating VBG B-verb.communication	that IN 0	TAM NNP B-noun.group	- : 0	induced VBN B-verb.creation	hemolysis NN I-noun.animal	is VBZ B-verb.stative	not RB B-adv.all	related VBN B-verb.communication	to TO 0	oxidative JJ B-adj.all	membrane NN B-noun.person	damage NN B-noun.person	. . 0	. . 0
a3187073.s12	It PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	patients NNS B-noun.person	on IN 0	5-FU NN 0	treatment NN B-noun.communication	should MD 0	be VB B-verb.stative	under IN 0	close JJ B-adj.all	supervision NN B-noun.artifact	and CC 0	that IN 0	the DT 0	treatment NN B-noun.plant	should MD 0	be VB 0	discontinued VBN B-verb.communication	if IN 0	chest_pain JJ B-adj.all	or CC 0	tachyarrhythmia NN B-noun.animal	is VBZ 0	observed VBN B-verb.perception	. . 0	. . 0
a2670794.s1	Induction NN 0	of IN 0	intravascular_coagulation NN B-noun.act	and CC 0	inhibition NN B-noun.attribute	of IN 0	fibrinolysis NN B-noun.food	by IN 0	injection NN B-noun.act	of IN 0	thrombin NN B-noun.communication	and CC 0	tranexamic_acid NNP B-noun.person	( ( 0	AMCA NNP B-noun.group	) ) 0	in IN 0	the DT 0	rat NN 0	gives VBZ B-verb.creation	rise NN B-noun.attribute	to TO 0	pulmonary_and_renal_insufficiency NN B-noun.person	resembling VBG B-verb.cognition	that IN 0	occurring VBG B-verb.competition	after IN 0	trauma NN B-noun.communication	or CC 0	sepsis NN B-noun.body	in IN 0	man NN 0	. . 0	. . 0
a18208574.s0	Higher JJR B-adj.all	optical JJ B-adj.all	density NN B-noun.process	of IN 0	an DT 0	antigen NN B-adj.all	assay NN B-noun.state	predicts VBZ B-verb.creation	thrombosis NN B-noun.state	in IN 0	patients NNS B-noun.person	with IN 0	heparin NN B-noun.person	- : 0	induced VBN B-verb.creation	thrombocytopenia NN B-noun.artifact	. . 0	. . 0
a6308277.s2	Because IN 0	salicylates NNS B-noun.artifact	have VBP 0	been VBN 0	reported VBN B-verb.communication	to TO 0	augment VB B-verb.communication	the DT 0	stimulatory JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	caffeine NN B-noun.person	on IN 0	the DT 0	CNS NNP B-noun.group	, , 0	attention NN 0	was VBD 0	focused VBN B-verb.social	on IN 0	the DT 0	possibility NN B-noun.state	that IN 0	the DT 0	presence NN B-noun.person	of IN 0	acetaminophen NN B-noun.quantity	( ( 0	52 CD 0	micrograms NNS B-noun.quantity	/ : 0	mL LS 0	) ) 0	reduced VBD B-verb.change	the DT 0	CNS NNP B-noun.group	toxicity NN B-noun.attribute	of IN 0	caffeine NN B-noun.person	. . 0	. . 0
a2008831.s3	In IN 0	all DT 0	patients NNS B-noun.person	with IN 0	variant_angina NNP B-noun.person	, , 0	coronary_spasm NN B-noun.artifact	was VBD 0	provoked VBN B-verb.competition	at IN 0	a DT 0	mean JJ B-adj.all	dose NN 0	of IN 0	28 CD B-adj.all	+ SYM 0	/- $ 0	13 CD B-adj.all	micrograms NNS B-noun.quantity	( ( 0	mean VB B-verb.stative	+ : 0	/- '' 0	SD NNP 0	) ) 0	. . 0	. . 0
a19581773.s3	A DT 0	brain NN B-noun.substance	imaging NN B-verb.creation	study NN B-noun.artifact	and CC 0	repetitive JJ B-adj.all	nerve NN B-noun.attribute	stimulation NN I-noun.attribute	test NN B-noun.communication	indicated VBD B-verb.communication	no DT 0	abnormality NN B-noun.phenomenon	. . 0	. . 0
a11256525.s3	Due JJ 0	to TO 0	severe JJ B-adj.all	systolic_dysfunction NN B-noun.act	losartan NN B-noun.event	was VBD 0	prescribed VBN B-verb.communication	. . 0	. . 0
a15632880.s8	Patients NNS B-noun.person	who WP 0	developed VBD B-verb.body	hyperkalemia NN B-noun.person	were VBD B-verb.stative	older JJR B-adj.all	and CC 0	more RBR B-adv.all	likely JJ B-adj.all	to TO 0	have VB B-verb.social	diabetes NNS B-noun.person	, , 0	had VBD 0	higher JJR B-adj.all	baseline NN B-noun.person	serum NN B-noun.person	potassium NN B-noun.phenomenon	levels NNS B-noun.attribute	and CC 0	lower JJR B-adj.all	baseline NN B-noun.person	potassium NN B-noun.person	supplement NN B-noun.artifact	doses NNS B-noun.artifact	, , 0	and CC 0	were VBD B-verb.stative	more RBR B-adv.all	likely JJ B-adj.all	to TO 0	be VB 0	treated VBN B-verb.change	with IN 0	beta JJ B-noun.body	- : 0	blockers NNS B-noun.person	than IN 0	controls NNS B-noun.cognition	( ( 0	n UH 0	= $ 0	134 CD 0	) ) 0	. . 0	. . 0
a11569530.s4	2 LS 0	. . 0	. . 0
a9249847.s1	In IN 0	a DT 0	patient NN B-noun.person	with IN 0	WPW_syndrome JJ 0	and CC 0	idiopathic_dilated_cardiomyopathy JJ B-adj.all	, , 0	intractable JJ B-adj.all	atrioventricular_reentrant_tachycardia NNS B-noun.location	( ( 0	AVRT NNP 0	) ) 0	was VBD B-verb.stative	iatrogenically RB B-adv.all	induced VBN B-verb.creation	. . 0	. . 0
a17491223.s0	Assessment NNP B-noun.person	of IN 0	a DT 0	new JJ B-adj.all	non NN B-noun.person	- : 0	invasive JJ B-adj.all	index NN B-noun.act	of IN 0	cardiac JJ B-adj.all	performance NN B-noun.act	for IN 0	detection NN B-noun.act	of IN 0	dobutamine NN B-noun.act	- : 0	induced VBN B-verb.creation	myocardial_ischemia NNP B-noun.person	. . 0	. . 0
a3676049.s7	There EX 0	was VBD B-verb.stative	a DT 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	CBF NNP 0	, , 0	although IN 0	CMRO2 NNP B-noun.person	was VBD B-verb.stative	unchanged JJ B-adj.all	, , 0	compared VBN B-verb.cognition	with IN 0	pre SYM 0	- : 0	hypotensive JJ B-adj.all	values NNS B-noun.attribute	. . 0	. . 0
a9653867.s4	In IN 0	particular JJ 0	it PRP 0	illustrates VBZ B-verb.change	the DT 0	derangements NNS B-noun.person	of IN 0	thyroid JJ B-noun.body	function NN B-noun.attribute	seen VBN B-verb.perception	in IN 0	pregnant JJ B-adj.all	women NNS B-noun.person	with IN 0	eating_disorders NNS B-noun.person	and CC 0	reminds VBZ B-verb.stative	us PRP 0	that IN 0	when WRB 0	a DT 0	cause NN B-noun.act	for IN 0	thyrotoxicosis NN B-noun.event	remains VBZ B-verb.change	obscure JJ I-verb.change	, , 0	thyroxine JJ B-adj.all	abuse NN B-noun.attribute	should MD 0	be VB 0	considered VBN B-verb.cognition	and CC 0	explored VBD B-verb.communication	. . 0	. . 0
a11256525.s7	Ultimately RB B-adv.all	, , 0	an DT 0	arteriography NN B-noun.person	showed VBD B-verb.communication	a DT 0	70 CD B-adj.all	- : 0	80 CD B-adj.all	% NN 0	renal_artery_stenosis NN B-noun.act	. . 0	. . 0
a3358181.s5	Careful JJ B-adj.all	fluid JJ B-adj.all	administration NN B-noun.person	and CC 0	cautious JJ B-adj.all	use NN 0	of IN 0	titrated VBN B-adj.all	doses NNS B-noun.quantity	of IN 0	ephedrine NN B-noun.person	are VBP 0	advised VBN B-verb.communication	. . 0	. . 0
a18503483.s1	TAC NNP B-noun.group	has VBZ 0	been VBN 0	shown VBN B-verb.perception	to TO 0	be VB B-verb.stative	a DT 0	potent JJ B-adj.all	immunosuppressive JJ B-adj.all	agent NN B-noun.person	for IN 0	solid JJ B-adj.all	organ NN B-noun.artifact	transplantation NN I-noun.artifact	in IN 0	pediatrics NNS B-noun.person	. . 0	. . 0
a11897407.s2	The DT 0	animal NN B-adj.all	model NN B-noun.person	used VBN B-verb.consumption	to TO 0	produce VB B-verb.cognition	infarction NN B-noun.cognition	implies VBZ B-verb.cognition	artery NN I-verb.cognition	ligation NN B-noun.person	but CC 0	chemical NN B-noun.body	induction NN B-noun.act	can MD 0	be VB 0	easily RB B-adv.all	obtained VBN B-verb.change	with IN 0	isoproterenol NN B-noun.feeling	. . 0	. . 0
a18081909.s6	OUTCOME NN 0	, , 0	Following JJ 0	discontinuation NN B-noun.act	of IN 0	LEV NNP B-noun.person	, , 0	EEG NNP 0	and CC 0	neuropsychological JJ B-adj.all	findings NNS B-noun.act	improved VBN B-verb.change	and CC 0	seizure NN B-noun.act	frequency NN B-noun.person	decreased VBD B-verb.change	. . 0	. . 0
a18081909.s2	FINDINGS NNS B-noun.act	, , 0	A DT 0	28-year JJ 0	- : 0	old JJ B-adj.all	man NN 0	suffering VBG B-verb.body	from IN 0	idiopathic_epilepsy JJ B-adj.all	with IN 0	generalized JJ B-adj.all	seizures NNS B-noun.person	was VBD 0	treated VBN B-verb.change	with IN 0	LEV NNP B-noun.person	( ( 0	3000 CD 0	mg NN B-noun.quantity	) ) 0	added VBD B-verb.communication	to TO 0	valproate VB B-verb.social	( ( 0	VPA NNP 0	) ) 0	( ( 0	2000 CD 0	mg NN B-noun.quantity	) ) 0	. . 0	. . 0
a19581773.s5	The DT 0	patient NN B-noun.person	's POS 0	ophthalmological JJ B-adj.all	symptoms NNS B-noun.body	improved VBD B-verb.change	rapidly RB B-adv.all	3 CD B-adj.all	weeks NNS B-noun.time	after IN 0	discontinuation NN B-noun.act	of IN 0	pegylated_IFN_alpha-2b NNP B-noun.person	and CC 0	ribavirin NN B-noun.body	. . 0	. . 0
a2071257.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	carried VBN B-verb.change	out IN 0	to TO 0	test VB B-verb.social	the DT 0	effects NNS B-noun.phenomenon	of IN 0	L NNP 0	- : 0	alpha NN B-noun.person	- : 0	glycerylphosphorylcholine NN B-noun.person	( ( 0	L SYM 0	- : 0	alpha NN B-noun.person	- : 0	GFC NNP B-noun.group	) ) 0	on IN 0	memory_impairment NN B-noun.person	induced VBN B-verb.creation	by IN 0	scopolamine NN B-noun.person	in IN 0	man NN 0	. . 0	. . 0
a15458908.s9	CONCLUSION NN B-noun.group	, , 0	Raloxifene NNP B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	an DT 0	increased VBN B-verb.social	risk NN I-verb.social	for IN 0	venous_thromboembolism NN B-noun.artifact	, , 0	but CC 0	there EX 0	was VBD B-verb.stative	no DT 0	increased VBN B-verb.social	risk NN I-verb.social	for IN 0	cataracts NNS B-noun.location	, , 0	gallbladder_disease NNP B-noun.person	, , 0	endometrial_hyperplasia NNP B-noun.location	, , 0	or CC 0	endometrial_cancer JJR B-adj.all	. . 0	. . 0
a3192036.s1	Multiple JJ B-adj.all	cytotoxic JJ B-adj.all	drug NN B-noun.person	administration NN B-noun.person	is VBZ B-verb.stative	the DT 0	generally RB B-adv.all	accepted VBN B-verb.communication	treatment NN B-noun.person	of IN 0	patients NNS B-noun.person	with IN 0	a DT 0	high JJ B-noun.group	- : 0	risk NN 0	stage NN 0	of IN 0	choriocarcinoma NN B-noun.food	. . 0	. . 0
a15632880.s10	CONCLUSIONS NNS B-noun.artifact	, , 0	Spironolactone NNP B-noun.person	- : 0	induced VBN B-verb.creation	hyperkalemia NN I-noun.animal	and CC 0	renal_insufficiency NN B-noun.person	are VBP B-verb.stative	more RBR B-adv.all	common JJ B-adj.all	in IN 0	our PRP$ 0	clinical JJ B-adj.all	experience NN B-noun.cognition	than IN 0	reported VBN B-verb.communication	previously RB B-adv.all	. . 0	. . 0
a6634932.s1	UM-272 NN 0	( ( 0	N NNP 0	, , 0	N NNP 0	- : 0	dimethylpropranolol NN B-noun.act	) ) 0	, , 0	a DT 0	quaternary JJ B-adj.all	antiarrhythmic JJ B-adj.all	agent NN B-noun.person	, , 0	was VBD 0	administered VBN B-verb.possession	sublingually RB B-adv.all	to TO 0	dogs NNS B-noun.person	with IN 0	ouabain JJ B-adj.all	- : 0	induced VBN B-verb.creation	ventricular_tachycardias NNS B-noun.artifact	. . 0	. . 0
a16680561.s1	OBJECTIVE NNP B-noun.group	, , 0	In IN 0	vitro NN 0	work NN B-noun.cognition	has VBZ 0	demonstrated VBN B-verb.cognition	that DT 0	cinacalcet NN B-noun.person	is VBZ B-verb.stative	a DT 0	strong JJ B-adj.all	inhibitor NN B-noun.person	of IN 0	cytochrome NN 0	P450 NN 0	isoenzyme NN B-noun.attribute	( ( 0	CYP NNP 0	) ) 0	2D6 NN 0	. . 0	. . 0
a11391224.s10	PTCR NNP B-noun.group	also RB B-adv.all	occurs VBZ B-verb.stative	in IN 0	certain JJ B-adj.all	native JJ B-adj.all	kidney_diseases NNS B-noun.person	, , 0	though IN 0	the DT 0	association NN B-noun.communication	is VBZ B-verb.stative	not RB I-verb.stative	as RB 0	strong JJ 0	as IN 0	that DT 0	for IN 0	TG NNP 0	. . 0	. . 0
a7516729.s4	It PRP 0	decreased VBD B-verb.change	by IN 0	16 CD B-adj.all	+ CD 0	/- $ 0	3 CD B-adj.all	% NN 0	by IN 0	lowering VBG B-verb.motion	[ : 0	Na]o JJ 0	to TO 0	78 CD 0	mM . 0	( ( 0	LNa NNP 0	) ) 0	, , 0	23 CD B-adj.all	+ CD 0	/- # 0	2 CD B-adj.all	% NN 0	by IN 0	lowering VBG B-verb.motion	simultaneously RB B-adv.all	[ RB 0	Na]o JJ 0	to TO 0	78 CD B-adj.all	mM CD B-noun.quantity	and CC 0	[ : 0	Ca]o NN 0	to TO 0	0.675 CD 0	mM . 0	( ( 0	LNa+LCa NNP 0	) ) 0	and CC 0	31 CD 0	+ SYM 0	/- $ 0	5 CD B-adj.all	% NN 0	by IN 0	lowering VBG B-verb.motion	[ : 0	Na]o JJ 0	to TO 0	78 CD 0	mM : 0	plus CC 0	increasing VBG B-verb.change	[ : 0	Ca]o NN 0	to TO 0	3.6 CD 0	mM . 0	( ( 0	LNa+HCa NNP 0	) ) 0	. . 0	. . 0
a3192036.s7	In IN 0	view NN 0	of IN 0	the DT 0	close JJ B-adj.all	time NN B-noun.time	association NN B-noun.state	between IN 0	the DT 0	start NN B-noun.attribute	of IN 0	chemotherapy NN B-noun.communication	and CC 0	the DT 0	acute JJ B-adj.all	onset NN B-noun.event	of IN 0	massive JJ B-adj.all	embolism NN B-noun.artifact	other JJ 0	explanations NNS B-noun.person	, , 0	such JJ 0	as IN 0	spontaneous JJ B-adj.all	necrosis NN B-noun.communication	, , 0	must MD 0	be VB 0	considered VBN B-verb.cognition	less RBR B-adv.all	likely JJ B-adj.all	. . 0	. . 0
a18182964.s7	Moderate JJ B-adj.all	or CC 0	severe JJ B-adj.all	adverse JJ B-adj.all	events NNS B-noun.person	were VBD B-verb.stative	more JJR B-adv.all	common JJ B-noun.person	in IN 0	subjects NNS B-noun.artifact	on IN 0	clonidine NN 0	( ( 0	79.4 CD 0	% NN 0	versus CC 0	49.2 CD 0	% NN 0	, , 0	p UH 0	= : 0	.0006 LS 0	) ) 0	but CC 0	not RB B-adv.all	associated VBN B-verb.cognition	with IN 0	higher JJR B-adj.all	rates NNS B-noun.time	of IN 0	early JJ B-adj.all	study NN B-noun.artifact	withdrawal NN B-noun.artifact	. . 0	. . 0
a2673163.s5	Cerebral_infarction NN 0	occurred VBD B-verb.stative	in IN 0	10 CD B-adj.all	patients NNS B-noun.person	( ( 0	22 CD B-adj.all	% NN 0	) ) 0	, , 0	intracerebral_hemorrhage NN 0	in IN 0	22 CD 0	( ( 0	49 CD 0	% NN 0	) ) 0	, , 0	and CC 0	subarachnoid_hemorrhage NN B-noun.artifact	in IN 0	13 CD 0	( ( 0	29 CD B-noun.quantity	% NN 0	) ) 0	. . 0	. . 0
a16680561.s4	Blood NN B-noun.act	samples NNS B-noun.cognition	were VBD 0	obtained VBN B-verb.possession	predose NN B-noun.person	and CC 0	up RB 0	to TO 0	72 CD 0	h NN 0	postdose NN B-noun.state	. . 0	. . 0
a435349.s4	Six CD 0	additional JJ B-adj.all	patients NNS B-noun.person	received VBD B-verb.possession	a DT 0	30-mg JJ B-noun.person	i.v NNP I-noun.person	. . 0	. . 0
a17175308.s10	In IN 0	40 CD B-adj.all	% NN 0	it PRP 0	increased VBN B-verb.change	by IN 0	more JJR B-noun.quantity	than IN 0	100 CD 0	% NN 0	. . 0	. . 0
a12202650.s0	Capsaicin NNP B-noun.person	- : 0	induced VBD B-verb.creation	muscle_pain JJ B-adj.all	alters NNS B-noun.substance	the DT 0	excitability NN B-noun.act	of IN 0	the DT 0	human JJ B-adj.all	jaw NN B-noun.person	- : 0	stretch NN B-noun.act	reflex NN I-noun.act	. . 0	. . 0
a11166519.s0	Acute NNP B-noun.person	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.artifact	, , 0	differential JJ B-adj.all	sensitivity NN B-noun.feeling	of IN 0	six CD 0	inbred JJ B-adj.all	mouse NN B-noun.body	strains NNS I-noun.body	. . 0	. . 0
a3750012.s2	Although IN 0	acetylcholine NN B-noun.act	receptor NN I-noun.act	antibodies NNS I-noun.act	were VBD B-verb.stative	not RB B-adv.all	detectable JJ B-adj.all	, , 0	the DT 0	time NN B-noun.time	course NN B-noun.location	was VBD B-verb.stative	consistent JJ B-adj.all	with IN 0	an DT 0	autoimmune JJ B-adj.all	process NN B-noun.attribute	. . 0	. . 0
a17042910.s3	Atorvastatin NNP B-noun.person	( ( 0	Ato NNP 0	) ) 0	possesses VBZ B-verb.stative	pleiotropic JJ B-adj.all	properties NNS B-noun.attribute	that WDT 0	have VBP 0	been VBN 0	reported VBN B-verb.communication	to TO 0	improve VB B-verb.change	endothelial JJ B-adj.all	function NN B-noun.act	through IN 0	increased VBN B-verb.change	availability NN B-noun.attribute	of IN 0	NO NNP B-noun.communication	and CC 0	reduced VBD B-verb.change	O2- JJ 0	production NN B-noun.artifact	in IN 0	various JJ B-adj.all	forms NNS B-noun.attribute	of IN 0	hypertension NN B-noun.act	. . 0	. . 0
a17466854.s3	METHODS NNS B-noun.attribute	, , 0	A DT 0	double JJ B-adj.all	- : 0	blind JJ B-adj.all	double JJ B-noun.group	- : 0	armed JJ B-adj.all	prospective JJ B-adj.all	study NN B-noun.artifact	comprised VBD B-verb.stative	40 CD B-adj.all	patients NNS B-noun.person	who WP 0	had VBD 0	uneventful JJ B-adj.all	sutureless NN 0	phacoemulsification NN 0	under IN 0	sub SYM 0	- : 0	Tenon NNP B-noun.person	's POS 0	local JJ B-adj.all	infiltration NN B-noun.cognition	of IN 0	3 CD B-adj.all	mL CD B-noun.quantity	of IN 0	plain JJ B-adj.all	lignocaine NN B-noun.attribute	. . 0	. . 0
a18343374.s7	RESULT(S LS 0	) ) 0	, , 0	A DT 0	36-year JJ 0	- : 0	old JJ 0	Chinese JJ B-adj.all	woman NN B-noun.person	developed VBD B-verb.body	central JJ B-adj.pert	retinal_vein_occlusion NN B-noun.act	after IN 0	eight CD B-adj.all	courses NNS B-noun.act	of IN 0	CC NNP 0	. . 0	. . 0
a6387529.s3	Delayed_free_recall_was_also_impaired JJ B-adj.all	but CC 0	the DT 0	two CD 0	drugs NNS B-noun.artifact	did VBD 0	not RB B-adv.all	differ VB B-verb.cognition	. . 0	. . 0
a3782049.s0	A DT 0	case NN B-noun.state	of IN 0	massive JJ B-adj.all	rhabdomyolysis NN B-noun.event	following VBG 0	molindone JJ 0	administration NN B-noun.person	. . 0	. . 0
a16160878.s2	Intracerebroventricular NNP B-noun.person	( ( 0	i.c.v NNP B-noun.person	. . 0	) ) 0	. . 0
a20621845.s0	Elevation NN B-noun.person	of IN 0	ADAM10 NN B-noun.person	, , 0	ADAM17 NN B-noun.person	, , 0	MMP-2 NN B-noun.person	and CC 0	MMP-9 JJ B-adj.all	expression NN B-noun.communication	with IN 0	media NNS B-noun.person	degeneration NN B-noun.person	features NNS B-noun.person	CaCl2-induced VBD B-verb.social	thoracic_aortic_aneurysm CD I-verb.social	in IN 0	a DT 0	rat NN B-noun.artifact	model NN B-noun.person	. . 0	. . 0
a10342929.s2	This DT 0	potentially RB B-adv.all	serious JJ B-adj.all	adverse JJ B-adj.all	effect NN B-noun.phenomenon	is VBZ B-verb.stative	often RB B-adv.all	preceded VBN B-verb.creation	by IN 0	minor JJ B-adj.all	manifestations NNS B-noun.communication	that WDT 0	may MD 0	serve VB B-verb.social	as IN 0	a DT 0	warning NN B-noun.act	. . 0	. . 0
a17242861.s6	Highest JJS 0	stage NN 0	reached VBN B-verb.contact	and CC 0	latency NN B-noun.person	to TO 0	each DT 0	stage NN B-noun.artifact	were VBD 0	recorded VBN B-verb.communication	for IN 0	all DT 0	mice NNS B-noun.animal	. . 0	. . 0
a10807237.s2	However RB 0	, , 0	no DT 0	study NN B-noun.artifact	in IN 0	the DT 0	literature NN B-noun.act	has VBZ 0	reported VBN B-verb.communication	the DT 0	use NN 0	of IN 0	a DT 0	statistical JJ B-adj.all	model NN B-noun.person	to TO 0	analyze VB B-verb.cognition	the DT 0	variables NNS B-noun.communication	that WDT 0	influence VBP B-verb.emotion	outcome NN I-verb.emotion	. . 0	. . 0
a7516729.s1	The DT 0	effects NNS B-noun.phenomenon	of IN 0	varying VBG B-verb.change	the DT 0	extracellular JJ B-adj.all	concentrations NNS B-noun.attribute	of IN 0	Na NNP B-noun.person	and CC 0	Ca NNP 0	( ( 0	[ PRP$ 0	Na]o JJ B-noun.group	and CC 0	[ : 0	Ca]o NN 0	) ) 0	on IN 0	both DT 0	, , 0	the DT 0	spontaneous JJ B-adj.all	beating NN B-noun.food	and CC 0	the DT 0	negative JJ B-adj.all	chronotropic NN B-noun.phenomenon	action NN B-noun.process	of IN 0	verapamil NN B-noun.food	, , 0	were VBD 0	studied VBN B-verb.cognition	in IN 0	the DT 0	isolated JJ B-adj.all	rat NN 0	atria NN 0	. . 0	. . 0
a17042910.s5	Ato NNP B-noun.person	could MD 0	prevent VB B-verb.possession	endothelial JJ B-adj.all	NO NNP 0	synthase NN 0	( ( 0	eNOS NNS B-noun.attribute	) ) 0	downregulation NN B-noun.quantity	and CC 0	the DT 0	increase NN B-noun.event	in IN 0	O2- CD 0	in IN 0	Sprague NNP B-noun.location	- : 0	Dawley NNP B-noun.person	( ( 0	SD NNP 0	) ) 0	rats NNS B-noun.animal	, , 0	thereby RB 0	reducing VBG B-verb.creation	blood NN B-noun.phenomenon	pressure NN I-noun.phenomenon	. . 0	. . 0
a17175308.s12	Biopsies NNS B-noun.person	performed VBN B-verb.social	in IN 0	five CD 0	patients NNS B-noun.person	revealed VBD B-verb.communication	new JJ B-adj.all	pathological JJ B-noun.event	changes NNS I-noun.event	, , 0	One CD 0	membranoproliferative_glomerulopathy NN B-noun.person	and CC 0	interstitial_nephritis NNP B-noun.location	. . 0	. . 0
a7453952.s4	At IN 0	12 CD B-adj.all	h NN B-noun.quantity	, , 0	all PDT 0	the DT 0	tissues NNS B-noun.body	showed VBD B-verb.communication	a DT 0	slight JJ B-adj.all	increase NN B-noun.event	in IN 0	lithium NN B-noun.animal	levels NNS B-noun.attribute	. . 0	. . 0
a869641.s4	In IN 0	addition NN 0	, , 0	reflex JJ B-adj.all	bradycardia NNS B-noun.person	caused VBN B-verb.communication	by IN 0	injected JJ B-adj.all	norepinephrine NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	enhanced VBN B-verb.change	by IN 0	L NNP 0	- : 0	dopa NN B-noun.person	, , 0	DL NNP 0	- : 0	Threo SYM 0	- : 0	dihydroxyphenylserine NN B-noun.person	had VBD 0	no DT 0	effect NN B-noun.cognition	on IN 0	blood NN B-noun.act	pressure NN B-noun.act	, , 0	heart NN B-noun.body	rate NN B-noun.time	or CC 0	reflex JJ B-adj.all	responses NNS B-noun.act	to TO 0	norepinephrine VB B-verb.communication	. . 0	. . 0
a10739826.s5	The DT 0	adjusted JJ B-adj.all	rate NN B-noun.person	ratio NN B-noun.person	of IN 0	VTE NNP 0	for IN 0	repeat NN B-noun.artifact	users NNS B-noun.person	of IN 0	third JJ B-adj.all	generation NN B-noun.group	OC NNP 0	was VBD B-verb.stative	0.6 CD 0	( ( 0	95 CD 0	% NN 0	CI,0.3 SYM 0	- : 0	1.2 CD 0	) ) 0	relative JJ 0	to TO 0	repeat VB B-verb.social	users NNS B-noun.person	of IN 0	second JJ B-adj.all	generation NN B-noun.artifact	pills NNS B-noun.artifact	, , 0	whereas IN 0	it PRP 0	was VBD B-verb.stative	1.3 CD 0	( ( 0	95 CD 0	% NN 0	CI,0.7 SYM 0	- : 0	2.4 CD 0	) ) 0	for IN 0	switchers NNS B-noun.person	from IN 0	second JJ B-adj.all	to TO 0	third JJ B-adj.all	generation NN B-noun.group	pills NNS B-noun.artifact	relative VBP B-verb.stative	to TO 0	switchers NNS B-noun.person	from IN 0	third JJ 0	to TO 0	second JJ B-adj.all	generation NN B-noun.artifact	pills NNS B-noun.artifact	. . 0	. . 0
a11027905.s6	This DT 0	effect NN B-noun.cognition	was VBD B-verb.stative	more RBR B-adv.all	relevant JJ B-adj.all	in IN 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	higher JJR B-adj.all	doses NNS B-noun.person	. . 0	. . 0
a1786266.s3	Repeated VBN B-verb.communication	cerebral JJ B-adj.all	perfusion NN B-noun.person	SPECT NNP I-noun.person	scans NNS B-noun.person	revealed VBD B-verb.communication	decreased_basal_ganglia_perfusion NN B-noun.communication	while IN 0	the DT 0	movement_disorder NN B-noun.person	was VBD B-verb.stative	present JJ B-adj.all	, , 0	and CC 0	a DT 0	return NN 0	to TO 0	normal JJ B-adj.all	perfusion NN B-noun.time	when WRB 0	the DT 0	rabbit_syndrome JJ 0	resolved VBN B-verb.communication	. . 0	. . 0
a10704919.s15	Additionally RB B-adv.all	, , 0	since IN 0	membrane NN B-noun.state	leakage NN I-noun.state	is VBZ B-verb.stative	a DT 0	final JJ B-adj.all	stage NN B-noun.artifact	of IN 0	cytotoxicity NN B-noun.state	, , 0	the DT 0	disruption NN B-noun.act	of IN 0	the DT 0	structural JJ B-adj.all	characteristics NNS B-noun.act	of IN 0	biomembranes NNS B-noun.food	by IN 0	TAM NNP 0	may MD 0	contribute VB B-verb.cognition	to TO 0	the DT 0	multiple JJ B-adj.all	mechanisms NNS B-noun.person	of IN 0	its PRP$ 0	anticancer NN B-noun.event	action NN B-noun.process	. . 0	. . 0
a8669433.s1	Six CD 0	epidemiologic JJ B-adj.all	studies NNS B-noun.group	in IN 0	the DT 0	United NNP B-noun.group	States NNPS I-noun.group	and CC 0	Europe NNP B-noun.person	indicate VBP B-verb.communication	that IN 0	habitual JJ B-adj.all	use NN 0	of IN 0	phenacetin NN B-noun.food	is VBZ 0	associated VBN B-verb.cognition	with IN 0	the DT 0	development NN B-noun.process	of IN 0	chronic_renal_failure NN B-noun.food	and CC 0	end NN B-noun.person	- : 0	stage_renal_disease NN 0	( ( 0	ESRD NNP 0	) ) 0	, , 0	with IN 0	a DT 0	relative JJ B-adj.all	risk NN B-noun.person	in IN 0	the DT 0	range NN B-noun.location	of IN 0	4 CD B-adj.all	to TO 0	19 CD 0	. . 0	. . 0
a6634932.s3	Sublingual JJ B-noun.person	UM-272 NN I-noun.person	converted VBD B-verb.stative	ventricular_tachycardia NNS I-verb.stative	to TO 0	sinus VB 0	rhythm NN B-noun.act	in IN 0	all DT 0	5 CD B-adj.all	dogs NNS B-noun.act	. . 0	. . 0
a18208574.s2	PATIENTS NNPS B-noun.group	AND CC 0	METHODS NNS B-noun.attribute	, , 0	Patients NNPS B-noun.person	with IN 0	more JJR B-noun.quantity	than IN 0	50 CD B-adj.all	% NN 0	decrease NN B-noun.act	in IN 0	platelet NN 0	count NN B-noun.act	or CC 0	thrombocytopenia NN B-noun.communication	( ( 0	< $ 0	150 CD 0	x IN 0	10(9)/L NNP 0	) ) 0	after IN 0	exposure NN B-noun.person	to TO 0	heparin VB B-verb.social	, , 0	who WP 0	had VBD 0	a DT 0	positive JJ B-adj.all	two CD 0	- : 0	step NN B-noun.quantity	antigen NN 0	assay NN B-noun.cognition	[ : 0	optical JJ B-adj.all	density NN B-noun.process	( ( 0	OD NNP 0	) ) 0	> $ 0	0.4 CD 0	and CC 0	> $ 0	50 CD B-adj.all	inhibition NN B-noun.quantity	with IN 0	high JJ B-adj.all	concentration NN B-noun.attribute	of IN 0	heparin NN B-noun.person	] '' 0	were VBD 0	included VBN B-verb.stative	in IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a2670794.s6	The DT 0	amount NN B-noun.possession	of IN 0	fibrin NN B-noun.food	in IN 0	the DT 0	kidneys NNS B-noun.person	was VBD B-verb.stative	also RB B-adv.all	considerably RB B-adv.all	lower JJR B-adj.all	than IN 0	in IN 0	animals NNS B-noun.animal	which WDT 0	received VBD B-verb.possession	thrombin NN B-noun.communication	and CC 0	AMCA NNP B-noun.group	alone RB 0	. . 0	. . 0
a10739826.s2	Data NNS B-noun.cognition	from IN 0	a DT 0	Transnational NNP B-noun.person	case NN B-noun.feeling	- : 0	control NN B-noun.act	study NN B-noun.artifact	were VBD 0	used VBN B-verb.consumption	to TO 0	assess VB B-verb.cognition	the DT 0	risk NN 0	of IN 0	VTE NNP 0	for IN 0	the DT 0	latter JJ B-adj.all	patterns NNS B-noun.person	of IN 0	use NN 0	, , 0	while IN 0	accounting VBG B-verb.communication	for IN 0	duration NN B-noun.act	of IN 0	use NN 0	. . 0	. . 0
a11897407.s8	ROIs NNP B-noun.person	drawn NN B-verb.motion	over IN 0	the DT 0	gamma NN B-noun.act	camera NN I-noun.act	images NNS B-noun.person	showed VBD B-verb.communication	a DT 0	ratio NN B-noun.time	of IN 0	4.4 CD 0	. . 0	. . 0
a7053303.s6	There EX 0	was VBD 0	only RB 0	one CD 0	case NN 0	of IN 0	dementia NN B-noun.communication	possibly RB 0	due JJ 0	to TO 0	cimetidine VB B-verb.social	( ( 0	with IN 0	a DT 0	drug NN B-noun.phenomenon	level NN B-noun.attribute	of IN 0	1.9 CD 0	microgram NN B-noun.quantity	/ : 0	ml CC 0	6 CD B-adj.all	hr NN B-noun.time	after IN 0	a DT 0	dose NN B-noun.event	) ) 0	in IN 0	a DT 0	group NN 0	of IN 0	13 CD B-adj.all	patients NNS B-noun.person	without IN 0	liver_or_kidney_disease NN B-noun.time	who WP 0	had VBD B-verb.perception	cimetidine JJ B-adj.all	levels NNS B-noun.state	above IN 0	1.25 CD 0	microgram NN B-noun.quantity	/ : 0	ml PRP 0	. . 0	. . 0
a10704919.s14	These DT 0	defects NNS B-noun.phenomenon	explain VBP B-verb.communication	the DT 0	abnormal JJ B-adj.all	erythrocyte NN B-noun.act	shape NN I-noun.act	and CC 0	decreased VBD B-verb.change	mechanical JJ B-adj.all	stability NN B-noun.attribute	promoted VBN B-verb.cognition	by IN 0	TAM NNP B-noun.other	, , 0	resulting VBG B-verb.stative	in IN 0	hemolytic_anemia NNP B-noun.location	. . 0	. . 0
a1420741.s8	There EX 0	were VBD B-verb.stative	no DT 0	serious JJ B-adj.all	clinical JJ B-adj.all	side NN B-noun.body	effects NNS B-noun.phenomenon	, , 0	but CC 0	dose DT 0	reduction NN B-noun.act	was VBD 0	required VBN B-verb.stative	in IN 0	two CD 0	patients NNS B-noun.person	because IN 0	of IN 0	nausea NN B-noun.state	. . 0	. . 0
a11027905.s3	A DT 0	slow JJ B-adj.all	bolus NN B-noun.person	of IN 0	subhypnotic JJ B-adj.all	doses NNS B-noun.event	of IN 0	ketamine NN B-noun.phenomenon	( ( 0	0.25 CD 0	mg PRP B-noun.quantity	/ : 0	kg PRP 0	or CC 0	0.50 CD 0	mg PRP B-noun.quantity	/ : 0	kg LS 0	) ) 0	was VBD 0	given VBN B-verb.possession	to TO 0	10 CD B-adj.all	cancer NN B-noun.state	patients NNS B-noun.person	whose WP$ 0	pain NN B-noun.person	was VBD 0	unrelieved VBN B-verb.social	by IN 0	morphine NN B-noun.person	in IN 0	a DT 0	randomized VBN B-verb.cognition	, , 0	double RB 0	- : 0	blind NN B-noun.person	, , 0	crossover NN B-noun.person	, , 0	double RB 0	- : 0	dose NN B-noun.quantity	study NN B-noun.artifact	. . 0	. . 0
a230316.s2	In IN 0	80 CD B-adj.all	cases NNS B-noun.person	insufficient VBP B-verb.emotion	information NN B-noun.cognition	was VBD B-verb.stative	available JJ B-adj.all	for IN 0	adequate JJ B-adj.all	comment NN B-noun.person	and CC 0	in IN 0	29 CD 0	a DT 0	relationship NN B-noun.state	to TO 0	the DT 0	administration NN B-noun.time	of IN 0	clioquinol NN B-noun.person	could MD 0	be VB 0	excluded VBN B-verb.social	. . 0	. . 0
a17491223.s8	RESULTS NNS B-noun.artifact	, , 0	The DT 0	sensitivity NN B-noun.feeling	improved VBD B-verb.change	dramatically RB B-adv.all	from IN 0	16 CD B-adj.all	% NN 0	to TO 0	79 CD 0	% NN 0	, , 0	positive JJ B-adj.all	predictive JJ B-adj.all	value NN B-noun.attribute	increased VBN B-verb.change	from IN 0	60 CD B-adj.all	% NN 0	to TO 0	68 CD 0	% NN 0	and CC 0	negative JJ B-adj.all	predictive JJ B-adj.all	value NN B-noun.possession	from IN 0	54 CD B-adj.all	% NN 0	to TO 0	78 CD 0	% NN 0	, , 0	and CC 0	specificity NN B-noun.body	decreased VBD B-verb.change	from IN 0	90 CD B-adj.all	% NN 0	to TO 0	67 CD 0	% NN 0	. . 0	. . 0
a3693336.s3	Manic JJ B-adj.all	excitement NN B-noun.act	was VBD B-verb.stative	coincident JJ B-adj.all	with IN 0	the DT 0	duration NN 0	of IN 0	action NN B-noun.process	of IN 0	triazolam NN B-noun.act	. . 0	. . 0
a1732369.s6	Dobutamine NNP 0	infusion NN 0	at IN 0	10 CD B-adj.all	micrograms NNS B-noun.quantity	/ : 0	kg PRP 0	per IN 0	min NN B-noun.animal	was VBD 0	discontinued VBN B-verb.contact	after IN 0	six CD B-noun.animal	studies NNS I-noun.animal	secondary JJ B-adj.all	to TO 0	a DT 0	50 CD B-adj.all	% NN 0	incidence NN B-adj.all	rate NN B-noun.time	of IN 0	adverse JJ B-adj.all	symptoms NNS B-noun.body	. . 0	. . 0
a7862923.s4	The DT 0	results NNS B-noun.communication	of IN 0	this DT 0	case NN B-noun.state	report NN B-noun.state	support NN I-noun.state	the DT 0	idea NN B-noun.cognition	that IN 0	in IN 0	contrast NN 0	with IN 0	carbamazepine NN 0	oxcarbazepine NN 0	does VBZ 0	not RB B-adv.all	induce VB B-verb.cognition	the DT 0	hepatic JJ B-adj.all	microsomal JJ B-adj.all	enzyme NN B-noun.act	systems NNS B-noun.substance	regulating VBG B-verb.stative	the DT 0	inactivation NN B-noun.act	of IN 0	antipsychotic JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a15632880.s0	Spironolactone NN B-noun.person	- : 0	induced VBN B-verb.creation	renal_insufficiency NN I-noun.act	and CC 0	hyperkalemia NN B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	heart_failure NN B-noun.food	. . 0	. . 0
a20470218.s4	Exclusion NN 0	criteria NNS 0	included VBD B-verb.stative	CNS NNP 0	leukemic_infiltration NN 0	at IN 0	diagnosis NN B-noun.food	, , 0	therapy NN B-noun.person	- : 0	related VBN B-verb.cognition	peripheral_neuropathy JJ 0	, , 0	late RB B-adv.all	- : 0	onset RB B-adv.all	encephalopathy JJ B-adj.all	, , 0	or CC 0	long RB B-noun.body	- : 0	term NN B-noun.time	neurocognitive_defects NNS B-noun.act	. . 0	. . 0
a1987816.s5	The DT 0	dosing NN B-noun.communication	schedule NN B-noun.communication	, , 0	duration NN 0	of IN 0	lithium NN B-noun.substance	treatment NN I-noun.substance	, , 0	and CC 0	daily JJ B-adj.pert	dose NN B-noun.act	of IN 0	lithium NN B-noun.artifact	did VBD 0	not RB B-adv.all	affect VB B-verb.change	maximum JJ B-adj.all	osmolality NN B-noun.cognition	or CC 0	creatinine JJ B-adj.all	clearance NN B-noun.attribute	. . 0	. . 0
a1420741.s6	The DT 0	disease NN B-noun.state	activity NN B-noun.state	was VBD B-verb.stative	primarily RB B-adv.all	measured VBN B-verb.cognition	by IN 0	a DT 0	modified VBN B-verb.change	individual JJ B-adj.all	grading NN B-noun.act	score NN B-noun.group	. . 0	. . 0
a11679859.s10	Seventy NNP B-noun.person	- : 0	three CD 0	percent NN B-noun.person	( ( 0	73/99 CD 0	) ) 0	of IN 0	the DT 0	study NN B-noun.artifact	participants NNS B-noun.artifact	were VBD 0	treated VBN B-verb.social	for IN 0	headache NN B-noun.state	and CC 0	70 CD B-adj.all	% NN 0	( ( 0	70/99 CD 0	) ) 0	for IN 0	nausea NN B-noun.state	. . 0	. . 0
a10520387.s4	The DT 0	addition NN 0	of IN 0	ephedrine NN 0	to TO 0	propofol NN B-noun.person	appears VBZ B-verb.social	to TO 0	be VB B-verb.stative	an DT 0	effective JJ B-adj.all	method NN B-noun.attribute	of IN 0	obtunding VBG B-verb.possession	the DT 0	hypotensive JJ B-adj.all	response NN B-noun.communication	to TO 0	propofol VB B-verb.communication	at IN 0	all DT 0	doses NNS B-noun.person	used VBN B-verb.consumption	in IN 0	this DT 0	study NN B-noun.artifact	. . 0	. . 0
a84204.s3	These DT 0	6 CD B-adj.all	patients NNS B-noun.person	had VBD 0	both DT 0	renal_and_liver_dysfunction NNP B-noun.person	( ( 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	) ) 0	, , 0	as RB 0	well RB 0	as IN 0	cimetidine JJ B-adj.all	trough NN B-noun.person	- : 0	concentrations NNS B-noun.attribute	of IN 0	more JJR B-noun.quantity	than IN 0	1.25 CD 0	microgram NN B-noun.quantity	/ : 0	ml PRP 0	( ( 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	) ) 0	. . 0	. . 0
a6133211.s1	Three CD 0	infants NNS B-noun.person	, , 0	born VBN B-verb.body	of IN 0	two CD 0	mothers NNS B-noun.person	with IN 0	inflammatory_bowel_disease NN 0	who WP 0	received VBD B-verb.possession	treatment NN B-noun.communication	with IN 0	sulphasalazine NN 0	throughout IN 0	pregnancy NN B-noun.person	, , 0	were VBD 0	found VBN B-verb.perception	to TO 0	have VB B-verb.social	major JJ B-adj.all	congenital_anomalies NNS B-noun.group	. . 0	. . 0
a12090760.s6	Endothelial JJ B-adj.all	cell NN B-noun.body	culture NN I-noun.body	supernatants NNS B-noun.person	separated VBN B-verb.social	by IN 0	ultrafiltration NN B-noun.person	and CC 0	ultracentrifugation NN B-noun.person	from IN 0	cells NNS B-noun.body	treated VBN B-verb.change	with IN 0	EPO NNP B-noun.group	and CC 0	IL-3 NNP B-noun.other	significantly RB B-adv.all	reduced VBN B-verb.change	thymidine JJ 0	incorporation NN 0	into IN 0	erythroid JJ B-noun.body	cells NNS B-noun.body	as IN 0	compared VBN 0	to TO 0	identical JJ B-adj.all	fractions NNS B-noun.communication	obtained VBN B-verb.possession	from IN 0	the DT 0	media NNS B-noun.location	of IN 0	cells NNS B-noun.body	cultured VBN B-verb.change	with IN 0	EPO NNP 0	alone RB 0	. . 0	. . 0
a1468485.s6	In IN 0	future NN 0	, , 0	this DT 0	form NN B-noun.attribute	of IN 0	therapy NN B-noun.person	can MD 0	offer VB B-verb.possession	a DT 0	safe JJ B-adj.all	alternative NN B-noun.act	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	cyclophosphamide NN B-noun.person	- : 0	induced VBN B-verb.creation	hemorrhagic_cystitis NNP B-noun.location	. . 0	. . 0
a16298782.s4	In IN 0	this DT 0	experimental JJ B-adj.all	study NN B-noun.communication	we PRP 0	used VBD B-verb.consumption	30 CD B-adj.all	Sprague NNP B-noun.person	- : 0	Dawley NN B-noun.person	rats NNS I-noun.person	, , 0	27 CD 0	of IN 0	which WDT 0	had_gentamicin VBP 0	instilled VBN B-verb.contact	into IN 0	the DT 0	middle JJ B-adj.all	ear NN B-noun.state	. . 0	. . 0
a11166519.s5	DBA/2J NN B-noun.artifact	, , 0	BALB NNP B-noun.group	/ POS I-noun.group	cByJ NNP I-noun.group	and CC 0	NZW NNP 0	/ : 0	LacJ JJ B-adj.all	strains NNS B-noun.artifact	exhibited VBD B-verb.stative	intermediate JJ B-adj.all	sensitivity NN B-noun.feeling	. . 0	. . 0
a3750012.s0	Myasthenia_gravis NN 0	caused VBN B-verb.communication	by IN 0	penicillamine NN B-noun.person	and CC 0	chloroquine NN B-noun.act	therapy NN B-noun.act	for IN 0	rheumatoid_arthritis NN B-noun.food	. . 0	. . 0
a1992636.s2	It PRP 0	has VBZ 0	been VBN 0	shown VBN B-verb.perception	to TO 0	be VB B-verb.stative	extremely RB B-adv.all	effective JJ B-adj.all	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	peptic_ulcer_disease NN B-noun.food	, , 0	reflux_esophagitis NNP B-noun.location	, , 0	and CC 0	the DT 0	Zollinger NNP B-noun.person	- : 0	Ellison_syndrome NN 0	. . 0	. . 0
a1436384.s0	Protection NN 0	against IN 0	amphetamine JJ B-noun.person	- : 0	induced VBN B-verb.creation	neurotoxicity NN 0	toward IN 0	striatal JJ B-adj.all	dopamine NN B-noun.act	neurons NNS B-noun.artifact	in IN 0	rodents NNS B-noun.animal	by IN 0	LY274614 NNP B-noun.person	, , 0	an DT 0	excitatory JJ B-adj.all	amino_acid JJ B-adj.all	antagonist NN B-noun.person	. . 0	. . 0
a15957009.s11	In IN 0	conclusion NN 0	, , 0	although IN 0	Ro4368554 NNP B-noun.person	did VBD 0	not RB B-adv.all	improve VB B-verb.creation	a DT 0	time NN B-noun.time	- : 0	related JJ B-adj.all	retention NN B-noun.act	deficit NN B-noun.act	, , 0	it PRP 0	reversed VBD B-verb.change	a DT 0	cholinergic NN B-noun.person	and CC 0	a DT 0	serotonergic JJ B-adj.all	memory_deficit NN B-noun.relation	, , 0	suggesting VBG B-verb.communication	that IN 0	both DT 0	mechanisms NNS B-noun.person	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	the DT 0	facilitation NN B-noun.act	of IN 0	object JJ B-adj.all	memory NN B-noun.person	by IN 0	Ro4368554 NNP B-noun.person	and CC 0	, , 0	possibly RB 0	, , 0	other JJ 0	5-HT(6 NN 0	) ) 0	receptor NN B-noun.person	antagonists NNS B-noun.person	. . 0	. . 0
a3358181.s3	Preoperative JJ B-adj.all	assessment NN B-noun.object	should MD 0	focus VB B-verb.stative	on IN 0	cardiovascular JJ B-adj.all	status NN B-noun.state	and CC 0	serum NN B-noun.body	potassium NN B-noun.attribute	level NN I-noun.attribute	. . 0	. . 0
a17042910.s0	Anti NNP B-noun.person	- : 0	oxidant JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	atorvastatin NN B-noun.food	in IN 0	dexamethasone NN 0	- : 0	induced VBN B-verb.creation	hypertension NN 0	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a18343374.s5	INTERVENTION(S LS 0	) ) 0	, , 0	Ophthalmic JJ B-adj.all	examination NN B-noun.act	after IN 0	CC NNP 0	therapy NN 0	. . 0	. . 0
a567256.s2	Angiosarcoma NNP B-noun.person	was VBD B-verb.stative	also RB B-adv.all	present JJ B-verb.stative	within IN 0	pulmonary NN B-noun.person	and CC 0	renal JJ B-noun.body	arteries NNS I-noun.body	. . 0	. . 0
a2887062.s3	Electron NNP B-noun.person	microscopy NN B-noun.person	disclosed VBD B-verb.communication	many JJ 0	secretory JJ B-adj.all	granules NNS B-noun.artifact	, , 0	slightly RB B-adv.all	distorted VBN B-verb.perception	rough JJ B-adj.all	endoplasmic JJ B-adj.all	reticulum NN B-noun.person	, , 0	and CC 0	partially RB B-adv.all	dilated VBD B-verb.change	Golgi NNP B-noun.person	cisternae NN I-noun.person	in IN 0	the DT 0	prolactinoma NN B-noun.body	cells NNS B-noun.body	. . 0	. . 0
a20470218.s7	In IN 0	conclusion NN 0	, , 0	CNS NNP 0	complications NNS B-noun.animal	are VBP B-verb.stative	frequent JJ B-adj.all	events NNS B-noun.artifact	during IN 0	ALL DT 0	therapy NN B-noun.animal	, , 0	and CC 0	require VB B-verb.consumption	rapid JJ B-noun.phenomenon	detection NN I-noun.phenomenon	and CC 0	prompt JJ B-adj.all	treatment NN B-noun.attribute	to TO 0	limit VB B-verb.change	permanent JJ B-adj.all	damage NN B-noun.event	. . 0	. . 0
a9293063.s1	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	bile_duct_hamartoma CD B-noun.group	which WDT 0	developed VBD B-verb.creation	in IN 0	a DT 0	patient NN B-noun.person	who WP 0	had VBD 0	been VBN B-verb.stative	on RB 0	long JJ 0	- : 0	term NN B-noun.time	danazol NN 0	treatment NN B-noun.communication	. . 0	. . 0
a17466854.s7	RESULTS NNS B-noun.artifact	, , 0	Sixty CD 0	percent NN B-noun.person	in IN 0	Group NNP 0	A NNP 0	developed JJ B-adj.all	postoperative_emetic_symptoms NNS B-noun.location	, , 0	headache NN 0	, , 0	or CC 0	both DT 0	, , 0	1 CD B-adj.all	patient NN B-noun.person	in IN 0	Group NNP B-noun.group	B NNP B-noun.group	developed VBD B-verb.creation	symptoms NNS B-noun.communication	. . 0	. . 0
a17854040.s10	It PRP 0	remains VBZ B-verb.change	to TO 0	be VB 0	seen VBN B-verb.perception	whether IN 0	such JJ B-adj.all	pre NN B-noun.person	- : 0	existing VBG B-verb.stative	antiviral JJ B-adj.all	mutations NNS B-noun.person	could MD 0	result VB B-verb.perception	in IN 0	widespread JJ B-adj.all	emergence NN B-noun.state	of IN 0	HBV NNP 0	resistant JJ B-adj.all	strains NNS B-noun.communication	when WRB 0	lamivudine NN B-noun.act	- : 0	containing VBG B-verb.communication	highly RB B-adv.all	active JJ B-adj.all	antiretroviral JJ B-adj.all	( ( 0	ARV NNP 0	) ) 0	treatment NN B-noun.communication	( ( 0	HAART NNP 0	) ) 0	regimens VBZ 0	become VBN 0	widely RB B-adv.all	applied VBN B-verb.consumption	in IN 0	South NNP B-noun.other	Africa NNP I-noun.other	, , 0	as IN 0	this DT 0	is VBZ B-verb.stative	likely JJ B-adj.all	to TO 0	have VB B-verb.change	potential JJ B-adj.all	implications NNS B-noun.motive	in IN 0	the DT 0	management NN B-noun.group	of IN 0	HBV NNP B-noun.group	- : 0	HIV_co SYM 0	- : 0	infected JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a20698227.s4	Serum NNP B-noun.person	hemoglobin NN I-noun.person	, , 0	haptoglobin NN B-noun.person	and CC 0	angiogenesis NN B-noun.plant	markers NNS B-noun.person	of IN 0	vascular JJ B-adj.all	endothelial JJ B-adj.all	growth NN B-noun.process	factor NN B-noun.location	and CC 0	angiopoetin-2 NN 0	were VBD 0	investigated VBN B-verb.communication	before IN 0	and CC 0	after IN 0	therapy NN B-noun.person	. . 0	. . 0
a15278670.s11	Apamin NNP B-noun.person	( ( 0	10 CD B-adj.all	ng NN B-noun.quantity	) ) 0	had VBD B-verb.stative	a DT 0	tendency NN B-noun.attribute	to TO 0	decrease VB B-verb.communication	the DT 0	convulsive JJ B-adj.all	threshold NN B-noun.artifact	( ( 0	21.6 CD 0	+ : 0	/- # 0	2.2 CD 0	to TO 0	19.9 CD 0	+ : 0	/- $ 0	2.5 CD 0	mg NN B-noun.quantity	. . 0	. . 0
a1786266.s0	Rabbit_syndrome JJ 0	, , 0	antidepressant JJ B-adj.all	use NN B-noun.person	, , 0	and CC 0	cerebral JJ B-adj.all	perfusion NN B-noun.group	SPECT NNP B-noun.group	scan JJ B-adj.all	findings NNS B-noun.act	. . 0	. . 0
a1130930.s4	Patients NNS B-noun.person	with IN 0	renal_insufficiency NN B-noun.group	should MD 0	not RB 0	be VB 0	given VBN B-verb.possession	this DT 0	regimen NNS B-noun.person	. . 0	. . 0
a15957009.s3	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	sought VBD B-verb.contact	to TO 0	characterize VB B-verb.change	the DT 0	cognitive JJ B-adj.all	- : 0	enhancing VBG B-verb.communication	effects NNS B-noun.phenomenon	of IN 0	the DT 0	5-HT(6 NN B-noun.location	) ) 0	antagonist VBP B-verb.stative	Ro4368554 NNP I-verb.stative	( ( 0	3-benzenesulfonyl-7-(4-methyl UH 0	- : 0	piperazin-1-yl)1H SYM 0	- : 0	indole NN B-noun.attribute	) ) 0	in IN 0	a DT 0	rat NN B-noun.artifact	object NN I-noun.artifact	recognition NN B-noun.artifact	task NN 0	employing VBG B-verb.change	a DT 0	cholinergic NN B-noun.cognition	( ( 0	scopolamine NN B-noun.person	pretreatment NN B-noun.artifact	) ) 0	and CC 0	a DT 0	serotonergic- NN B-noun.person	( ( 0	tryptophan FW 0	( ( 0	TRP NNP 0	) ) 0	depletion NN B-noun.act	) ) 0	deficient NN B-adj.pert	model NN B-noun.person	, , 0	and CC 0	compared VBN B-verb.change	its PRP$ 0	pattern NN B-noun.act	of IN 0	action NN B-noun.process	with IN 0	that DT 0	of IN 0	the DT 0	acetylcholinesterase NN 0	inhibitor NN 0	metrifonate NN B-noun.attribute	. . 0	. . 0
a8669433.s8	The DT 0	possibility NN B-noun.state	that IN 0	habitual JJ B-adj.all	use NN 0	of IN 0	acetaminophen NN 0	alone RB 0	increases VBZ B-verb.change	the DT 0	risk NN 0	of IN 0	ESRD NNP B-noun.group	has VBZ 0	not RB 0	been VBN 0	clearly RB B-adv.all	demonstrated VBN B-verb.cognition	, , 0	but CC 0	can MD 0	not RB B-adv.all	be VB 0	dismissed VBN B-verb.communication	. . 0	. . 0
a9523805.s10	Times NNS B-noun.event	to TO 0	ambulate VB B-verb.communication	and CC 0	to TO 0	void VB B-verb.social	were VBD B-verb.stative	similar JJ B-adj.all	after IN 0	lidocaine NN B-noun.person	and CC 0	prilocaine NN B-noun.person	( ( 0	150 CD 0	vs. IN 0	165 CD 0	min NN 0	and CC 0	238 CD B-noun.other	vs. IN I-noun.other	253 CD I-noun.other	min NN B-noun.quantity	, , 0	respectively RB B-adv.all	) ) 0	but CC 0	prolonged VBN B-verb.creation	after IN 0	bupivacaine NN B-noun.person	( ( 0	200 CD 0	and CC 0	299 CD 0	min NN 0	, , 0	respectively RB B-adv.all	, , 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a19356307.s4	Simultaneously RB B-adv.all	, , 0	we PRP 0	found VBD B-verb.cognition	that IN 0	these DT 0	two CD 0	lemon JJ B-adj.all	essential JJ B-adj.all	oil NN B-noun.person	components NNS B-noun.person	could MD 0	inhibit VB B-verb.emotion	acetylcholinesterase NN I-verb.emotion	activity NN B-noun.process	in IN 0	vitro NN B-noun.animal	using VBG B-verb.consumption	the DT 0	Ellman NNP B-noun.person	method NN I-noun.person	. . 0	. . 0
a6692345.s5	The DT 0	present JJ B-adj.all	results NNS B-noun.communication	are VBP B-verb.stative	consistent JJ B-adj.all	with IN 0	the DT 0	carcinogenicity NN B-noun.group	experiment NN B-noun.person	suggesting VBG B-verb.communication	that IN 0	different JJ B-noun.person	mechanisms NNS I-noun.person	are VBP 0	involved VBN B-verb.stative	in IN 0	FANFT NNP B-noun.group	carcinogenesis NN B-noun.food	in IN 0	the DT 0	bladder NN B-noun.person	and CC 0	forestomach NN B-noun.act	, , 0	and CC 0	that DT 0	aspirin NN B-noun.person	's POS 0	effect NN B-noun.cognition	on IN 0	FANFT NNP B-noun.group	in IN 0	the DT 0	forestomach NN B-noun.act	is VBZ B-verb.stative	not RB 0	due JJ 0	to TO 0	an DT 0	irritant JJ B-adj.all	effect NN B-noun.cognition	associated VBN B-verb.cognition	with IN 0	increased VBN B-adj.all	cell NN B-noun.body	proliferation NN I-noun.body	. . 0	. . 0
a9401499.s0	Ticlopidine SYM 0	- : 0	induced VBN B-verb.creation	aplastic_anemia NNP I-verb.creation	, , 0	report NN B-noun.person	of IN 0	three CD 0	Chinese JJ B-adj.all	patients NNS B-noun.person	and CC 0	review NN B-noun.act	of IN 0	the DT 0	literature NN B-noun.act	. . 0	. . 0
a2549018.s4	Akathisia NNP B-noun.person	appeared VBD B-verb.social	to TO 0	be VB B-verb.stative	a DT 0	common JJ B-noun.person	side NN 0	effect NN 0	of IN 0	fluoxetine NN B-noun.substance	and CC 0	generally RB B-adv.all	responded VBD B-verb.stative	well RB 0	to TO 0	treatment NN B-noun.person	with IN 0	the DT 0	beta NN B-noun.body	- : 0	adrenergic JJ B-adj.all	antagonist JJ B-adj.all	propranolol NN B-noun.person	, , 0	dose DT 0	reduction NN B-noun.act	, , 0	or CC 0	both DT 0	. . 0	. . 0
a7199841.s2	The DT 0	possible JJ B-adj.all	role NN B-noun.attribute	of IN 0	low JJ B-adj.all	pH CC 0	as RB 0	well RB 0	as IN 0	total JJ B-adj.all	volume NN B-noun.artifact	as IN 0	potential JJ B-adj.all	factors NNS B-noun.person	in IN 0	causing VBG B-verb.communication	neurotoxicity NN B-noun.person	was VBD 0	evaluated VBN B-verb.change	. . 0	. . 0
a12627929.s8	CONCLUSION NN B-noun.group	, , 0	The DT 0	addition NN 0	of IN 0	thalidomide IN 0	to TO 0	docetaxel VB B-verb.social	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	prostate_cancer NN B-noun.person	significantly RB B-adv.all	increases VBZ B-verb.change	the DT 0	frequency NN B-noun.person	of IN 0	VTE NNP B-noun.group	. . 0	. . 0
a9034419.s6	Based VBN B-verb.cognition	on IN 0	nonoverdose JJ B-adj.all	pharmacokinetics NNS B-noun.person	and CC 0	pharmacodynamics NNS B-noun.person	of IN 0	venlafaxine NN B-noun.location	and CC 0	the DT 0	potential JJ B-adj.all	risks NNS B-noun.act	of IN 0	available JJ B-adj.all	interventions NNS B-noun.artifact	, , 0	no DT 0	emergent NN B-noun.person	therapy NN B-noun.person	was VBD 0	instituted VBN B-verb.communication	. . 0	. . 0
a3676049.s5	This DT 0	resulted VBD B-verb.stative	in IN 0	a DT 0	significant JJ B-adj.all	decrease NN B-noun.state	in IN 0	CMRO2 NNP B-noun.other	( ( 0	to TO 0	1.73 CD 0	+ : 0	/- $ 0	0.16 CD 0	ml/100 CD 0	g IN 0	min-1 JJ 0	) ) 0	, , 0	while IN 0	CBF NNP B-noun.person	was VBD B-verb.stative	unchanged JJ B-adj.all	. . 0	. . 0
a12615818.s6	Using VBG B-verb.consumption	as IN 0	the DT 0	reference NN B-noun.location	group NN B-noun.person	women NNS B-noun.person	who WP 0	were VBD B-verb.stative	not RB B-adv.all	using VBG B-verb.consumption	oral JJ B-adj.all	contraception NN B-noun.cognition	, , 0	had VBD 0	no DT 0	recent JJ B-adj.all	pregnancy NN B-noun.state	or CC 0	menopausal NN B-noun.substance	symptoms NNS I-noun.substance	, , 0	the DT 0	case NN B-noun.communication	- : 0	control NN B-noun.act	analysis NN I-noun.act	gave VBD B-verb.possession	an DT 0	adjusted JJ B-adj.all	odds NNS B-noun.person	ratio NN B-noun.person	( ( 0	OR(adj NNP 0	) ) 0	) ) 0	of IN 0	7.44 CD 0	( ( 0	95 CD 0	% NN 0	CI $ 0	3.67 CD 0	- : 0	15.08 CD 0	) ) 0	for IN 0	CPA NNP 0	/ ( 0	EE NNP 0	use NN 0	compared VBN B-verb.stative	with IN 0	an DT 0	OR(adj NNP B-noun.group	) ) 0	of IN 0	2.58 CD 0	( ( 0	95 CD 0	% NN 0	CI $ 0	1.60 CD 0	- : 0	4.18 NN 0	) ) 0	for IN 0	use NN 0	of IN 0	conventional JJ B-adj.all	COCs NNP B-noun.person	. . 0	. . 0
a2070391.s5	The DT 0	pH JJ B-adj.all	adjustment NN B-noun.communication	of IN 0	standard JJ B-adj.all	lidocaine NN B-noun.person	can MD 0	be VB 0	accomplished VBN B-verb.creation	easily RB B-adv.all	in IN 0	the DT 0	catheterization NN B-noun.artifact	laboratory NN B-noun.artifact	before IN 0	injection NN B-noun.act	and CC 0	results NNS B-noun.communication	in IN 0	a DT 0	reduction NN B-noun.act	of IN 0	the DT 0	pain NN B-noun.person	occurring VBG B-verb.motion	during IN 0	the DT 0	infiltration NN B-noun.cognition	of IN 0	tissues NNS B-noun.animal	. . 0	. . 0
a6133211.s0	Possible JJ B-adj.all	teratogenicity NN B-noun.attribute	of IN 0	sulphasalazine NN B-noun.person	. . 0	. . 0
a9653867.s3	This DT 0	case NN B-noun.state	illustrates VBZ B-verb.change	a DT 0	number NN B-noun.quantity	of IN 0	problems NNS B-noun.communication	that WDT 0	may MD 0	be VB 0	encountered VBN B-verb.social	in IN 0	women NNS B-noun.person	with IN 0	eating_disorders NNS B-noun.person	in IN 0	pregnancy NN B-noun.animal	, , 0	including VBG B-verb.change	prolonged VBN B-verb.creation	and CC 0	recurrent JJ B-adj.all	metabolic JJ B-adj.all	disturbances NNS B-noun.artifact	and CC 0	diuretic JJ B-adj.all	abuse NN B-noun.act	. . 0	. . 0
a6308277.s4	The DT 0	frequency NN B-noun.quantity	of IN 0	sound NN B-noun.communication	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.body	after IN 0	12.5 CD 0	or CC 0	25 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	caffeine NN 0	was VBD 0	reduced VBN B-verb.change	from IN 0	50 CD B-adj.all	to TO 0	5 CD B-adj.all	% NN 0	by IN 0	acetaminophen NN B-noun.person	. . 0	. . 0
a12820454.s4	Hb NNP 0	, , 0	PSA NNP B-noun.person	and CC 0	Testosterone NNP B-noun.person	measurements NNS I-noun.person	were VBD 0	recorded VBN B-verb.communication	. . 0	. . 0
a6103707.s11	The DT 0	drug NN B-noun.person	was VBD 0	still RB B-adv.all	present JJ B-adj.all	in IN 0	measurable JJ B-adj.all	quantities NNS B-noun.person	after IN 0	24 CD B-adj.all	h NNS 0	even RB B-adv.all	with IN 0	the DT 0	smallest JJS B-adj.all	dose NN B-noun.event	. . 0	. . 0
a2670794.s3	The DT 0	lung NN B-noun.artifact	weights NNS B-noun.artifact	were VBD B-verb.stative	lower JJR B-adj.all	and CC 0	PaO2 NN B-noun.person	was VBD 0	improved VBN B-verb.change	in IN 0	rats NNS B-noun.animal	given VBN B-verb.possession	this DT 0	enzyme NN B-noun.cognition	- : 0	blocking VBG B-verb.communication	agent NN B-noun.person	. . 0	. . 0
a3070035.s0	Reversibility NN B-noun.person	of IN 0	captopril NN B-noun.act	- : 0	induced VBN B-verb.creation	renal_insufficiency NN B-noun.act	after IN 0	prolonged VBN B-verb.social	use NN B-verb.consumption	in IN 0	an DT 0	unusual JJ B-adj.all	case NN B-noun.state	of IN 0	renovascular_hypertension NN B-noun.act	. . 0	. . 0
a9034419.s4	She PRP 0	was VBD 0	admitted VBN B-verb.social	to TO 0	the DT 0	medical JJ B-adj.all	intensive JJ B-adj.all	care NN B-noun.group	unit NN B-noun.artifact	, , 0	venlafaxine NN B-noun.person	was VBD 0	discontinued VBN B-verb.stative	, , 0	and CC 0	no DT 0	further JJ B-adj.all	sequelae NNS B-noun.person	were VBD 0	seen VBN B-verb.perception	. . 0	. . 0
a11256525.s0	Repeated VBN B-verb.communication	transient NN B-verb.motion	anuria NN 0	following VBG 0	losartan JJ B-adj.all	administration NN B-noun.person	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	a DT 0	solitary JJ B-adj.all	kidney NN B-noun.person	. . 0	. . 0
a7199841.s3	The DT 0	65 CD 0	dogs NNS B-noun.quantity	in IN 0	the DT 0	study NN B-noun.artifact	received VBD B-verb.possession	injections NNS B-noun.communication	in IN 0	the DT 0	subarachnoid JJ B-adj.all	space NN B-noun.location	as IN 0	follows VBZ B-verb.stative	, , 0	6 CD 0	to TO 0	8 CD B-adj.all	ml NN B-noun.quantity	of IN 0	bupivacaine NN B-noun.substance	( ( 0	N NNP 0	= SYM 0	15 CD B-adj.all	) ) 0	, , 0	2-chloroprocaine JJ 0	- : 0	CE NNP 0	( ( 0	N NNP 0	= $ 0	20 CD B-adj.all	) ) 0	, , 0	low JJ B-adj.all	pH IN 0	normal JJ B-adj.all	saline NN B-noun.act	( ( 0	pH $ 0	3.0 CD 0	) ) 0	( ( 0	N NNP 0	= $ 0	20 CD B-adj.all	) ) 0	, , 0	or CC 0	normal JJ B-adj.all	saline NN B-noun.act	( ( 0	N NNP 0	= $ 0	10 CD B-adj.all	) ) 0	. . 0	. . 0
a18182964.s0	Clonidine NN B-noun.person	for IN 0	attention NN B-noun.act	- : 0	deficit NN B-noun.communication	/ : 0	hyperactivity_disorder NN B-noun.person	, , 0	II NNP 0	. . 0	ECG NNP 0	changes NNS B-noun.artifact	and CC 0	adverse JJ B-adj.all	events NNS 0	analysis NN 0	. . 0	. . 0
a15632880.s4	METHODS NNS B-noun.attribute	, , 0	We PRP 0	performed VBD B-verb.social	a DT 0	case NN 0	control NN B-noun.act	study NN B-noun.artifact	of IN 0	heart_failure NN B-noun.location	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	spironolactone NN 0	in IN 0	our PRP$ 0	clinical JJ B-adj.all	practice NN B-noun.communication	. . 0	. . 0
a15957009.s10	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a8669433.s7	Thus RB 0	, , 0	acetaminophen NN B-noun.person	has VBZ 0	been VBN 0	used VBN B-verb.consumption	both DT 0	as IN 0	a DT 0	single JJ B-adj.all	agent NN B-noun.person	and CC 0	in IN 0	combination NN 0	with IN 0	other JJ 0	analgesics NNS B-noun.person	, , 0	whereas IN 0	phenacetin NN B-noun.person	was VBD B-verb.stative	available JJ B-adj.all	only RB B-adv.all	in IN 0	combinations NNS B-noun.animal	. . 0	. . 0
a1420741.s10	All DT 0	reversed VBD B-verb.change	to TO 0	pre VB B-verb.social	- : 0	treatment NN B-noun.plant	levels NNS B-noun.state	after IN 0	cessation NN B-noun.time	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a8073369.s7	All DT 0	concentrations NNS B-noun.cognition	of IN 0	nicotine JJ B-adj.all	sulfate NN B-noun.person	caused VBD B-verb.communication	some DT 0	lethality NN B-noun.attribute	but CC 0	a DT 0	no DT 0	effect NN B-noun.phenomenon	level NN B-noun.attribute	for IN 0	coniine JJ B-adj.all	lethality NN B-noun.attribute	was VBD B-verb.stative	0.75 CD 0	% NN 0	. . 0	. . 0
a6503301.s5	Eosinophilic JJ B-adj.all	infiltrations NNS B-noun.motive	were VBD 0	found VBN B-verb.possession	around IN 0	the DT 0	vessels NNS B-noun.body	. . 0	. . 0
a3714122.s3	These DT 0	data NNS B-noun.cognition	were VBD 0	correlated VBN B-verb.stative	with IN 0	histologically RB B-adv.all	scored VBN B-verb.communication	cervical JJ B-adj.all	cord_damage NN B-noun.food	in IN 0	a DT 0	separate JJ B-adj.all	group NN 0	of IN 0	similarly RB B-adj.all	dosed VBN I-adj.all	rats NNS B-noun.animal	sampled VBN B-verb.consumption	14 CD B-adj.all	- : 0	21 CD B-adj.all	days NNS B-noun.act	post VBN B-verb.possession	- : 0	exposure NN B-noun.person	. . 0	. . 0
a18081909.s5	The DT 0	interictal JJ B-adj.all	electroencephalogram NN B-noun.cognition	( ( 0	EEG NNP 0	) ) 0	showed VBD B-verb.communication	a DT 0	generalized JJ B-adj.all	slowing NN B-noun.person	to TO 0	5 CD B-adj.all	per IN 0	second JJ B-adj.all	theta NN B-noun.act	rhythms NNS I-noun.act	with IN 0	bilateral NN B-noun.group	generalized VBD B-verb.communication	high JJ B-noun.group	- : 0	amplitude JJ B-adj.all	discharges NNS B-noun.person	. . 0	. . 0
a6503301.s0	Veno NNP B-noun.person	- : 0	occlusive_liver_disease NN B-noun.time	after IN 0	dacarbazine NN B-noun.person	therapy NN B-noun.person	( ( 0	DTIC NNP 0	) ) 0	for IN 0	melanoma NN B-noun.person	. . 0	. . 0
a12627929.s3	SETTING NN B-noun.artifact	, , 0	National NNP B-noun.group	Institutes NNPS I-noun.group	of IN I-noun.group	Health NNP I-noun.group	clinical JJ B-adj.all	research NN B-noun.artifact	center NN B-noun.artifact	. . 0	. . 0
a2440413.s4	One CD 0	hour NN 0	after IN 0	the DT 0	administration NN B-noun.time	of IN 0	gamma NN B-noun.act	- : 0	HCH NN 0	, , 0	the DT 0	activity NN B-noun.process	of IN 0	seizure NN B-noun.act	- : 0	inducing VBG B-verb.communication	agents NNS B-noun.person	was VBD 0	increased VBN B-verb.change	, , 0	regardless RB 0	of IN 0	their PRP$ 0	mechanism NN B-noun.attribute	, , 0	while IN 0	24 CD B-adj.all	h NN 0	after IN 0	gamma NN B-noun.act	- : 0	HCH VB 0	a DT 0	differential JJ B-adj.all	response NN B-noun.communication	was VBD 0	observed VBN B-verb.perception	. . 0	. . 0
a8421099.s8	It PRP 0	is VBZ B-verb.stative	therefore RB B-adv.all	very RB B-adv.all	important JJ B-adj.all	to TO 0	follow VB B-verb.possession	the DT 0	changes NNS B-noun.relation	of IN 0	gallbladder NN B-noun.person	function NN B-noun.act	during IN 0	long JJ B-noun.body	- : 0	term NN B-noun.time	octreotide NN 0	therapy NN 0	of IN 0	acromegalic JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a6861444.s1	Sodium_chloride JJ B-adj.all	solution NN B-noun.cognition	( ( 0	0.9 CD 0	% NN 0	) ) 0	or CC 0	noradrenaline NN B-noun.person	in IN 0	doses NNS B-noun.quantity	of IN 0	4 CD B-adj.all	, , 0	12 CD B-adj.all	and CC 0	36 CD 0	micrograms NNS B-noun.quantity	h-1 JJ B-noun.person	kg-1 NN I-noun.person	was VBD 0	infused VBN B-verb.communication	for IN 0	five CD B-adj.all	consecutive JJ B-adj.all	days NNS B-noun.person	, , 0	either CC 0	intrarenally RB B-adv.all	( ( 0	by IN 0	a DT 0	new JJ B-adj.all	technique NN B-noun.artifact	) ) 0	or CC 0	intravenously RB B-adv.all	into IN 0	rats NNS B-noun.time	with IN 0	one CD 0	kidney NN B-noun.person	removed VBN B-verb.change	. . 0	. . 0
a6308277.s6	Acetaminophen NNP B-noun.person	( ( 0	up IN 0	to TO 0	150 CD 0	micrograms NNS B-noun.quantity	/ : 0	mL LS 0	) ) 0	did VBD 0	not RB B-adv.all	retard VB B-verb.perception	the DT 0	incorporation NN B-noun.act	of IN 0	radioactive JJ B-noun.phenomenon	adenosine NN I-noun.phenomenon	into IN 0	ATP NNP 0	in IN 0	slices NNS B-noun.act	of IN 0	rat JJ B-adj.all	cerebral JJ B-noun.body	cortex NN I-noun.body	. . 0	. . 0
a9523805.s1	BACKGROUND NN 0	, , 0	Recent JJ B-adj.all	evidence NN B-noun.communication	suggests VBZ B-verb.communication	that IN 0	transient_neurologic_symptoms NNS B-noun.location	( ( 0	TNSs NNP B-noun.person	) ) 0	frequently RB B-adv.all	follow VBP B-verb.stative	lidocaine JJ B-adj.all	spinal JJ B-adj.all	anesthesia NN B-noun.person	but CC 0	are VBP B-verb.stative	infrequent JJ B-adj.all	with IN 0	bupivacaine NN B-noun.person	. . 0	. . 0
a7516729.s9	The DT 0	[ ( 0	verapamil]o NNP B-noun.person	that WDT 0	arrested VBD B-verb.contact	atrial JJ B-adj.all	beating NN B-noun.cognition	( ( 0	AC NNP 0	) ) 0	was VBD B-verb.stative	also RB B-adv.all	potentiated VBN B-verb.possession	with IN 0	the DT 0	order NN 0	LNa NNP B-noun.other	= SYM I-noun.other	LNa+LCa FW I-noun.other	= FW I-noun.other	LNa+HCa FW I-noun.other	= . 0	LCa NNP B-noun.person	> NNP I-noun.person	HCa NNP I-noun.person	= NNP I-noun.person	N. NNP I-noun.person	The NNP I-noun.person	results NNS I-noun.person	indicate VBP B-verb.cognition	that WDT 0	rat VBD B-verb.stative	atrial JJ B-adj.all	spontaneous JJ B-adj.all	beating NN B-noun.attribute	is VBZ B-verb.stative	more RBR B-adv.all	dependent JJ B-adj.all	on IN 0	[ : 0	Na]o JJ 0	than IN 0	on IN 0	[ : 0	Ca]o NN B-noun.artifact	in IN 0	a DT 0	range NN B-noun.person	of IN 0	+ : 0	/- $ 0	50 CD B-adj.all	% NN 0	of IN 0	their PRP$ 0	normal JJ B-adj.all	concentration NN B-noun.cognition	. . 0	. . 0
a11679859.s1	STUDY NNP B-noun.group	OBJECTIVE NNP I-noun.group	, , 0	We PRP 0	sought VBD B-verb.social	to TO 0	compare VB B-verb.stative	the DT 0	rate NN B-noun.time	of IN 0	akathisia NN B-noun.location	after IN 0	administration NN B-noun.time	of IN 0	intravenous JJ B-adj.all	prochlorperazine NN B-noun.communication	as IN 0	a DT 0	2-minute JJ B-adj.all	bolus NN B-noun.artifact	or CC 0	15-minute JJ 0	infusion NN B-noun.cognition	. . 0	. . 0
a8690168.s0	Reduction NN B-noun.process	of IN 0	heparan_sulphate NNP B-noun.person	- : 0	associated VBN B-verb.cognition	anionic JJ B-adj.all	sites NNS B-noun.location	in IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	of IN 0	rats NNS B-noun.plant	with IN 0	streptozotocin NN B-noun.person	- : 0	induced VBN B-verb.creation	diabetic_nephropathy NNP B-noun.person	. . 0	. . 0
a2348231.s5	or CC 0	theophylline PRP 0	( ( 0	3 CD 0	mg FW 0	/ FW 0	kg FW 0	i.v FW 0	. . 0	) ) 0	. . 0	. . 0
a11198499.s5	The DT 0	possible JJ B-adj.all	interaction NN B-noun.act	of IN 0	tizanidine NN B-noun.location	and CC 0	other JJ 0	antihypertensive JJ B-adj.all	agents NNS B-noun.person	should MD 0	be VB 0	kept VBN B-verb.stative	in IN 0	mind NN 0	when WRB 0	prescribing VBG B-verb.creation	therapy NN 0	to TO 0	treat VB B-verb.body	either DT 0	hypertension NN B-noun.state	or CC 0	spasticity NN B-noun.attribute	in IN 0	such JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a2008831.s5	The DT 0	basal NN B-noun.shape	tone NN B-noun.attribute	of IN 0	the DT 0	right JJ B-noun.body	coronary JJ I-noun.body	artery NN I-noun.body	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	than IN 0	that DT 0	of IN 0	the DT 0	left VBN B-verb.possession	coronary JJ B-noun.body	artery NN I-noun.body	. . 0	. . 0
a1639466.s8	Renal JJ B-adj.all	plasma NN B-noun.attribute	flow NN B-noun.event	increased VBD B-verb.change	, , 0	but CC 0	albumin IN 0	excretion NN B-noun.act	and CC 0	glomerulosclerosis NN B-noun.person	did VBD 0	not RB B-adv.all	change VB B-verb.change	after IN 0	enalapril NN B-noun.relation	treatment NN I-noun.relation	. . 0	. . 0
a20882060.s6	Electrophysiological JJ B-adj.all	recordings NNS B-noun.person	showed VBD B-verb.communication	that IN 0	microinjection NN B-noun.act	of IN 0	neurotensin NN B-noun.communication	induced VBN B-verb.creation	excitation NN B-noun.act	of IN 0	pallidal JJ B-adj.all	neurons NNS B-noun.person	in IN 0	the DT 0	presence NN B-noun.person	of IN 0	systemic JJ B-adj.all	haloperidol NN B-noun.person	administration NN B-noun.person	. . 0	. . 0
a15278670.s0	The DT 0	effects NNS B-noun.phenomenon	of IN 0	sevoflurane NN 0	on IN 0	lidocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	convulsions NNS B-noun.artifact	. . 0	. . 0
a18208574.s10	Similarly RB B-adv.all	, , 0	thrombotic JJ B-adj.all	risk NN 0	increased VBN B-verb.change	with IN 0	age NN B-noun.person	and CC 0	OD NNP 0	values NNS B-noun.attribute	. . 0	. . 0
a10520387.s2	We PRP 0	investigated VBD B-verb.communication	the DT 0	safety NN B-noun.artifact	and CC 0	efficacy NN B-noun.person	of IN 0	adding VBG B-verb.change	different JJ B-adj.all	doses NNS B-noun.act	of IN 0	ephedrine NN 0	to TO 0	propofol VB B-verb.communication	in IN 0	order NN 0	to TO 0	obtund VB B-verb.possession	the DT 0	hypotensive JJ B-adj.all	response NN B-noun.communication	. . 0	. . 0
a9034419.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	report VB B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	venlafaxine NN B-noun.artifact	overdose NN I-noun.artifact	. . 0	. . 0
a16680561.s7	The DT 0	t NN 0	( ( 0	1/2,z JJ 0	) ) 0	of IN 0	desipramine NN B-noun.location	was VBD B-verb.stative	longer RB B-adv.all	when WRB 0	desipramine NN B-noun.person	was VBD 0	coadministered VBN B-verb.contact	with IN 0	cinacalcet NN B-noun.person	( ( 0	21.0 CD 0	versus CC 0	43.3 CD 0	hs NN B-noun.quantity	) ) 0	. . 0	. . 0
a6387529.s7	Accumulation NNP B-noun.person	of IN 0	drugs NNS B-noun.artifact	was VBD B-verb.stative	not RB B-adv.all	reflected VBN B-verb.perception	in IN 0	prolonged VBN B-verb.creation	behavioral_impairment NN B-noun.attribute	. . 0	. . 0
a17491223.s6	The DT 0	increase NN B-noun.event	in IN 0	dP : 0	/ PRP$ 0	dtejc NN B-noun.artifact	during IN 0	infusion NN B-noun.cognition	of IN 0	dobutamine NN B-noun.act	in IN 0	this DT 0	group NN B-noun.location	was VBD B-verb.stative	severely RB B-adv.all	impaired VBN B-verb.change	as IN 0	compared VBN 0	to TO 0	the DT 0	non NN B-noun.person	- : 0	ischemic JJ B-adj.all	group NN B-noun.group	. . 0	. . 0
a9293063.s2	Such JJ B-adj.all	patients NNS B-noun.person	should MD 0	be VB B-verb.stative	under IN 0	close RB 0	follow VB B-verb.stative	- : 0	up RB B-adv.all	, , 0	preferably RB B-adv.all	with IN 0	periodic JJ B-adj.all	ultrasound NN B-noun.phenomenon	examination NN I-noun.phenomenon	of IN 0	the DT 0	liver NN B-noun.person	. . 0	. . 0
a2348231.s3	Whether IN 0	pentoxifylline NN 0	inhibits VBZ B-verb.stative	dipyridamole NN I-verb.stative	- : 0	induced VBN B-verb.creation	coronary JJ B-adj.all	hyperemia NN B-noun.location	like IN 0	other JJ 0	methylxanthines NNS B-noun.object	such JJ 0	as IN 0	theophylline PRP 0	and CC 0	should MD 0	be VB 0	stopped VBN B-verb.stative	prior RB 0	to TO 0	dipyridamole VB B-verb.communication	- : 0	thallium-201 JJ 0	imaging NN B-noun.attribute	is VBZ B-verb.stative	unknown JJ B-adj.all	. . 0	. . 0
a3125768.s0	Intracranial JJ B-adj.all	pressure NN B-noun.act	increases NNS B-noun.event	during IN 0	alfentanil SYM 0	- : 0	induced VBN B-verb.creation	rigidity NN B-noun.attribute	. . 0	. . 0
a10520387.s5	However RB 0	, , 0	marked VBD B-verb.contact	tachycardia NN B-noun.person	associated VBN B-verb.cognition	with IN 0	the DT 0	use NN 0	of IN 0	ephedrine NN B-noun.person	in IN 0	combination NN 0	with IN 0	propofol NN B-noun.person	occurred VBD B-verb.stative	in IN 0	the DT 0	majority NN B-noun.time	of IN 0	patients NNS B-noun.person	, , 0	occasionally RB B-adv.all	reaching VBG B-verb.contact	high JJ B-adj.all	levels NNS B-noun.attribute	in IN 0	individual JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a18343374.s4	PATIENT(S NN B-noun.artifact	) ) 0	, , 0	A DT 0	36-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	referred VBD B-verb.cognition	from IN 0	the DT 0	infertility NN B-noun.phenomenon	clinic NN B-noun.person	for IN 0	blurred_vision NN B-noun.act	. . 0	. . 0
a2673163.s3	Stroke NNP B-noun.person	followed VBD B-verb.stative	cocaine NN 0	use NN 0	by IN 0	inhalation NN B-noun.person	, , 0	intranasal NN B-noun.person	, , 0	intravenous JJ B-adj.all	, , 0	and CC 0	intramuscular JJ B-adj.all	routes NNS B-noun.location	. . 0	. . 0
a1992636.s1	Omeprazole NNP B-noun.person	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	drug NN B-noun.communication	designed VBN B-verb.creation	to TO 0	block VB B-verb.change	the DT 0	final JJ B-adj.all	step NN B-noun.quantity	in IN 0	the DT 0	acid NN B-noun.person	secretory JJ B-adj.all	process NN B-noun.person	within IN 0	the DT 0	parietal JJ B-adj.all	cell NN B-noun.body	. . 0	. . 0
a8302922.s5	Heart NN B-noun.body	rate NN B-noun.time	( ( 0	HR NNP 0	) ) 0	did VBD 0	not RB B-adv.all	change VB B-verb.change	in IN 0	either DT 0	group NN B-noun.location	. . 0	. . 0
a11679859.s12	The DT 0	difference NN B-noun.cognition	between IN 0	the DT 0	bolus NN B-noun.artifact	and CC 0	infusion NN B-noun.person	groups NNS B-noun.group	in IN 0	the DT 0	percentage NN B-noun.possession	of IN 0	participants NNS B-noun.person	who WP 0	saw VBD B-verb.perception	a DT 0	50 CD B-adj.all	% NN 0	reduction NN B-noun.act	in IN 0	their PRP$ 0	headache NN 0	intensity NN 0	within IN 0	30 CD B-adj.all	minutes NNS B-noun.time	was VBD B-verb.stative	11.8 CD 0	% NN 0	( ( 0	95 CD 0	% NN 0	CI NNP 0	-9.6 CD 0	% NN 0	to TO 0	33.3 CD 0	% NN 0	) ) 0	. . 0	. . 0
a6634932.s4	The DT 0	area NN B-noun.body	under IN 0	the DT 0	plasma NN B-noun.substance	concentration NN 0	time NN 0	curve NN B-noun.communication	at IN 0	90 CD B-adj.all	min NN B-noun.person	was VBD B-verb.stative	4 CD B-adj.all	- : 0	12 CD B-adj.all	times NNS B-noun.event	greater JJR B-adj.all	than IN 0	for IN 0	oral JJ B-adj.all	drug NN B-noun.person	, , 0	suggesting VBG B-verb.communication	the DT 0	existence NN B-noun.state	of IN 0	an DT 0	absorption NN B-noun.act	- : 0	limiting VBG B-verb.social	process NN B-noun.person	in IN 0	the DT 0	intestine NN B-noun.location	, , 0	and CC 0	providing VBG B-verb.stative	an DT 0	alternate JJ B-adj.all	form NN B-noun.cognition	of IN 0	administration NN B-noun.person	for IN 0	quaternary JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a8669433.s5	This DT 0	apparent JJ B-adj.all	difference NN B-noun.cognition	in IN 0	risk NN 0	may MD 0	not RB 0	be VB B-verb.stative	due JJ 0	to TO 0	differences NNS B-noun.person	in IN 0	nephrotoxic JJ B-adj.all	potential NN B-noun.state	of IN 0	the DT 0	drugs NNS B-noun.artifact	themselves PRP 0	. . 0	. . 0
a8421099.s7	Our PRP$ 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	the DT 0	suppression NN B-noun.artifact	of IN 0	gallbladder NN B-noun.person	contractility NN B-noun.person	is VBZ B-verb.stative	the DT 0	cause NN B-noun.act	of IN 0	the DT 0	successive JJ B-adj.all	formation NN B-noun.act	of IN 0	bile CD B-adj.all	sludge NN B-noun.attribute	, , 0	gallstones NNS B-noun.artifact	, , 0	and CC 0	cholecystitis NN B-noun.act	during IN 0	octreotide NN 0	therapy NN 0	in IN 0	Chinese JJ 0	acromegalic JJ 0	patients NNS B-noun.person	. . 0	. . 0
a1420741.s5	and CC 0	the DT 0	treatment NN B-noun.plant	was VBD 0	planned VBN B-verb.cognition	to TO 0	last VB B-verb.contact	8 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a6386793.s3	The DT 0	overall JJ B-adj.all	incidence NN B-noun.event	of IN 0	side JJ B-adj.all	effects NNS B-noun.phenomenon	and CC 0	the DT 0	frequency NN B-noun.person	and CC 0	severity NN B-noun.attribute	of IN 0	blurred_vision NN B-noun.act	, , 0	dry_mouth NNP 0	, , 0	and CC 0	drowsiness NN B-noun.person	were VBD 0	significantly RB B-adv.all	less RBR B-adv.all	with IN 0	dothiepin NN 0	than IN 0	with IN 0	amitriptyline NN B-noun.person	. . 0	. . 0
a3782049.s1	Rhabdomyolysis NNP B-noun.person	is VBZ B-verb.stative	a DT 0	potentially RB B-adv.all	lethal JJ B-adj.all	syndrome NN B-noun.cognition	that IN 0	psychiatric JJ B-adj.pert	patients NNS B-noun.person	seem VBP 0	predisposed VBN B-verb.communication	to TO 0	develop VB B-verb.communication	. . 0	. . 0
a3412544.s1	The DT 0	risk NN 0	of IN 0	developing VBG B-verb.creation	renal_papillary_necrosis NN B-noun.act	or CC 0	cancer_of_the_renal_pelvis,_ureter_or_bladder NN B-noun.other	associated VBN B-verb.cognition	with IN 0	consumption NN B-noun.act	of IN 0	either DT 0	phenacetin NN B-noun.state	or CC 0	paracetamol NN B-noun.possession	was VBD 0	calculated VBN B-verb.cognition	from IN 0	data NNS B-noun.cognition	acquired VBN B-verb.possession	by IN 0	questionnaire NN B-noun.communication	from IN 0	381 CD 0	cases NNS B-noun.quantity	and CC 0	808 CD 0	controls NNS B-noun.artifact	. . 0	. . 0
a3358181.s1	This DT 0	case NN B-noun.communication	illustrates VBZ B-verb.communication	that IN 0	patients NNS B-noun.person	receiving VBG B-verb.communication	ritodrine NN B-noun.person	for IN 0	preterm_labor NNP B-noun.person	may MD 0	risk VB B-verb.social	interactions NNS B-noun.act	between IN 0	the DT 0	residual JJ B-adj.all	betamimetic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	ritodrine NN B-noun.act	and CC 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	anesthetics NNS B-noun.artifact	during IN 0	cesarean JJ B-adj.all	section NN B-noun.location	. . 0	. . 0
a12483326.s10	Although IN 0	the DT 0	intraocular JJ B-adj.all	pressure NN B-noun.act	elevation NN B-noun.act	caused VBN B-verb.creation	by IN 0	secondary JJ B-adj.all	acute JJ B-noun.person	angle NN B-noun.person	- : 0	closure NN B-noun.person	glaucoma NN B-noun.person	decreased VBD B-verb.change	and CC 0	ocular_pain NNP B-noun.person	diminished VBD B-verb.motion	, , 0	inexorable JJ B-adj.all	papilledema NN B-noun.person	and CC 0	exudative JJ B-adj.all	retinal_detachment NN B-noun.person	continued VBD B-verb.stative	for IN 0	3 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a3192036.s5	Within IN 0	8 CD B-adj.all	hours NNS B-noun.time	after IN 0	initiation NN B-noun.time	of IN 0	therapy NN 0	the DT 0	patient NN B-noun.person	died VBD B-verb.change	with IN 0	a DT 0	clinical JJ B-adj.all	picture NN B-noun.state	resembling VBG B-verb.stative	massive JJ B-adj.all	pulmonary_obstruction NN 0	due JJ 0	to TO 0	choriocarcinomic JJ B-adj.all	tissue NN B-noun.body	plugs NNS I-noun.body	, , 0	probably RB B-adv.all	originating VBG B-verb.stative	from IN 0	the DT 0	uterus NN B-noun.communication	. . 0	. . 0
a2008831.s2	Methylergonovine NN B-noun.person	was VBD 0	administered VBN B-verb.possession	continuously RB B-adv.all	at IN 0	a DT 0	rate NN B-noun.time	of IN 0	10 CD B-adj.all	micrograms NNS B-noun.quantity	/ CC 0	min VB B-verb.social	up RP I-verb.social	to TO 0	50 CD B-adj.all	micrograms NNS B-noun.quantity	. . 0	. . 0
a230316.s1	An DT 0	analysis NN B-noun.communication	is VBZ 0	presented VBN B-verb.possession	of IN 0	220 CD 0	cases NNS B-noun.quantity	of IN 0	possible JJ B-adj.all	neurotoxic JJ B-adj.all	reactions NNS B-noun.motive	to TO 0	halogenated_hydroxyquinolines NNS B-noun.person	reported VBD B-verb.communication	from IN 0	outside IN 0	Japan NNP B-noun.person	. . 0	. . 0
a2670794.s0	Effects NNS B-noun.phenomenon	of IN 0	an DT 0	inhibitor NN B-noun.person	of IN 0	angiotensin NN 0	converting VBG B-verb.possession	enzyme NN B-noun.person	( ( 0	Captopril NNP B-noun.location	) ) 0	on IN 0	pulmonary_and_renal_insufficiency NN 0	due JJ 0	to TO 0	intravascular_coagulation NN B-noun.act	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a567256.s0	Angiosarcoma_of_the_liver RB 0	associated VBN B-verb.cognition	with IN 0	diethylstilbestrol NN B-noun.person	. . 0	. . 0
a19300402.s6	Moreover RB B-adv.all	, , 0	L NNP 0	- : 0	NOArg NN B-noun.person	and CC 0	7-NI NNP B-noun.person	but CC 0	not RB B-adv.all	L SYM 0	- : 0	NIL NNP 0	intensify VB B-verb.change	antihyperalgesic JJ B-adj.all	activity NN B-noun.state	of IN 0	HOE_140 JJ 0	or CC 0	des NNS B-noun.person	- : 0	Arg10HOE_140 NN B-noun.person	in IN 0	toxic_neuropathy JJ 0	. . 0	. . 0
a9334596.s21	Testosterone NN B-noun.person	was VBD B-verb.stative	low JJ B-adj.all	in IN 0	less JJR 0	than IN 0	50 CD B-adj.all	% NN 0	of IN 0	cases NNS B-noun.person	with IN 0	prolactin NN B-noun.person	greater JJR B-adj.all	than IN 0	35 CD 0	ng./ml NNP B-noun.person	. . 0	. . 0
a19581773.s4	The DT 0	acetylcholine NN 0	receptor NN 0	antibody NN 0	titer NN B-noun.attribute	and CC 0	response NN B-noun.communication	to TO 0	acetylcholinesterase VB B-verb.body	inhibitors NNS B-noun.person	were VBD B-verb.stative	negative JJ B-adj.all	, , 0	and CC 0	the DT 0	results NNS B-noun.communication	of IN 0	thyroid JJ B-noun.body	function NN I-noun.body	tests NNS B-noun.person	were VBD B-verb.stative	normal JJ B-adj.all	. . 0	. . 0
a6287825.s6	Diabetes_mellitus NN B-noun.person	was VBD B-verb.stative	the DT 0	major JJ B-adj.all	cause NN B-noun.act	of IN 0	autonomic_neuropathy JJ 0	. . 0	. . 0
a26094.s2	The DT 0	results NNS B-noun.communication	showed VBD B-verb.communication	a DT 0	high JJ B-adj.all	prevalence NN B-noun.attribute	of IN 0	depression NN B-noun.act	in IN 0	both DT 0	groups NNS B-noun.group	of IN 0	patients NNS B-noun.person	, , 0	with IN 0	no DT 0	preponderance NN B-noun.person	in IN 0	the DT 0	hypertensive JJ B-adj.all	group NN B-noun.group	. . 0	. . 0
a9401499.s8	The DT 0	fact NN B-noun.state	that IN 0	5 CD 0	of IN 0	the DT 0	6 CD B-adj.all	patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	concurrent JJ B-adj.all	calcium NN 0	channel NN 0	blockers NNS B-noun.person	died VBD B-verb.change	, , 0	should MD 0	alert VB B-verb.possession	clinicians NNS B-noun.person	to TO 0	be VB B-verb.stative	more RBR B-adv.all	cautious JJ B-adj.all	when WRB 0	using VBG B-verb.consumption	these DT 0	two CD 0	drugs NNS B-noun.person	simultaneously RB B-adv.all	. . 0	. . 0
a1732369.s8	End SYM 0	- : 0	systolic NN B-noun.person	left VBD B-verb.motion	ventricular JJ B-adv.all	posterior JJ B-adj.all	wall NN 0	dimension NN 0	at IN 0	baseline NN B-noun.act	for IN 0	the DT 0	doxorubicin NN B-noun.person	- : 0	treated VBN B-verb.communication	group NN B-noun.person	was VBD B-verb.stative	11 CD B-adj.all	+ . 0	/- $ 0	1.9 CD 0	mm DT 0	versus NN B-noun.cognition	13.1 CD 0	+ : 0	/- $ 0	1.5 CD 0	mm NN B-noun.quantity	for IN 0	control NN B-noun.act	subjects NNS B-noun.person	( ( 0	p IN 0	less JJR B-noun.quantity	than IN 0	0.01 CD 0	) ) 0	. . 0	. . 0
a6888657.s5	Intracellular JJ 0	PRL NNP 0	content NN B-noun.communication	ranged VBD B-verb.stative	from IN 0	1.9 CD 0	to TO 0	9.4 CD 0	times NNS B-noun.event	control NN B-noun.state	levels NNS B-noun.state	, , 0	and CC 0	PRL NNP B-noun.other	release NN B-noun.process	in IN 0	vitro NN B-noun.artifact	was VBD 0	significantly RB B-adv.all	and CC 0	consistently RB B-adv.all	higher JJR B-adj.all	than IN 0	controls NNS B-noun.cognition	, , 0	after IN 0	at IN 0	least JJS 0	8 CD B-adj.all	days NNS B-noun.time	of IN 0	DES NNP B-noun.group	exposure NN B-noun.communication	. . 0	. . 0
a12596116.s0	Octreotide SYM 0	- : 0	induced VBN B-verb.creation	hypoxemia NN I-noun.animal	and CC 0	pulmonary_hypertension NN B-noun.act	in IN 0	premature JJ B-adj.all	neonates NNS B-noun.artifact	. . 0	. . 0
a16330766.s3	Abnormal JJ B-adj.all	brain NN B-noun.group	responses NNS B-noun.act	to TO 0	somatosensory JJ B-adj.all	stimuli NNS B-noun.artifact	have VBP 0	been VBN 0	found VBN B-verb.possession	in IN 0	patients NNS B-noun.person	with IN 0	hyperalgesia NN 0	as RB 0	well RB 0	as IN 0	in IN 0	normal JJ B-adj.all	subjects NNS B-noun.artifact	during IN 0	experimental JJ B-adj.all	central JJ B-noun.body	sensitization NN I-noun.body	. . 0	. . 0
a3187073.s1	Survival NN B-noun.person	for IN 0	patients NNS B-noun.person	with IN 0	advanced JJ B-adj.all	head_and_neck_carcinoma NN B-noun.body	and CC 0	esophageal_carcinoma NNP B-noun.other	is VBZ B-verb.stative	poor JJ B-adj.all	with IN 0	radiotherapy NN B-noun.artifact	and/or NN I-noun.artifact	surgery NN B-noun.artifact	. . 0	. . 0
a17042910.s4	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	we PRP 0	investigated VBD B-verb.communication	whether IN 0	50 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	per FW 0	day NN 0	, , 0	p.o RB 0	. . 0	, , 0	. . 0
a15278670.s8	The DT 0	rise NN B-noun.attribute	in IN 0	blood NN B-adj.all	pressure NN B-noun.act	became VBD B-verb.change	less RBR B-adv.all	marked VBN B-verb.cognition	when WRB 0	higher JJR B-adj.all	concentrations NNS B-noun.attribute	of IN 0	sevoflurane CD 0	or CC 0	enflurane NN B-noun.person	were VBD 0	administered VBN B-verb.possession	and CC 0	the DT 0	blood NN B-noun.group	pressure NN B-noun.person	at IN 0	convulsions NNS B-noun.person	decreased VBD B-verb.change	significantly RB B-adv.all	in IN 0	1.6 CD 0	% NN 0	sevoflurane NN 0	, , 0	and CC 0	in IN 0	0.8 CD 0	% NN 0	and CC 0	1.6 CD 0	% NN 0	enflurane NN B-noun.person	. . 0	. . 0
a6287825.s1	The DT 0	anatomical JJ B-adj.all	and CC 0	aetiological JJ B-adj.all	diagnoses NNS B-noun.attribute	of IN 0	peripheral_nerve_disease NN 0	excluding VBG B-verb.stative	its PRP$ 0	primary JJ B-adj.all	benign NN B-noun.person	and CC 0	malignant JJ B-adj.all	disorders NNS B-noun.person	, , 0	as RB 0	seen VBN B-verb.perception	in IN 0	358 CD 0	Nigerians NNPS B-noun.person	are VBP 0	presented VBN B-verb.perception	. . 0	. . 0
a11027905.s7	Hallucinations NNS B-noun.person	occurred VBD B-verb.competition	in IN 0	4 CD B-adj.all	patients NNS B-noun.person	, , 0	and CC 0	an DT 0	unpleasant JJ B-adj.all	sensation NN B-noun.person	( ( 0	" PRP$ 0	empty JJ B-adj.all	head NN B-noun.cognition	" : 0	) ) 0	was VBD B-verb.stative	also RB B-adv.all	reported VBN B-verb.communication	by IN 0	2 CD B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a17242861.s0	Use NNP B-noun.person	of IN 0	chromosome NN 0	substitution NN B-noun.person	strains VBZ B-verb.emotion	to TO 0	identify VB B-verb.cognition	seizure NN B-noun.phenomenon	susceptibility NN B-noun.phenomenon	loci NN B-noun.artifact	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a3070035.s1	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	severe JJ 0	hypertension NN 0	with IN 0	an DT 0	occluded JJ B-adj.all	renal JJ B-noun.body	artery NN I-noun.body	to TO 0	a DT 0	solitary JJ B-adj.all	kidney NN B-noun.person	, , 0	who WP 0	developed VBD B-verb.creation	sudden_deterioration_of_renal_function NN 0	following VBG 0	treatment NN B-noun.communication	with IN 0	captopril NN B-noun.artifact	. . 0	. . 0
a6103707.s0	Comparison NNP B-noun.person	of IN 0	the DT 0	subjective JJ B-adj.all	effects NNS B-noun.phenomenon	and CC 0	plasma NN B-noun.plant	concentrations NNS B-noun.artifact	following VBG B-verb.stative	oral JJ B-adj.all	and CC 0	i.m RB 0	. . 0	administration NN B-noun.time	of IN 0	flunitrazepam NN B-noun.food	in IN 0	volunteers NNS B-noun.artifact	. . 0	. . 0
a16680561.s5	RESULTS NNS B-noun.artifact	, , 0	Fourteen JJ B-noun.person	subjects NNS B-noun.person	completed VBD B-verb.change	both DT 0	treatment NN B-noun.plant	arms NNS B-noun.body	. . 0	. . 0
a2887062.s2	One CD 0	h NN 0	after IN 0	treatment NN B-noun.plant	, , 0	serum NN B-noun.body	prolactin NN B-adj.all	levels NNS B-noun.attribute	decreased VBD B-verb.change	markedly RB B-adv.all	. . 0	. . 0
a9034419.s2	CASE NN B-noun.state	SUMMARY NNP B-noun.communication	, , 0	A DT 0	40-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	with IN 0	major_depression NN B-noun.person	took VBD B-verb.motion	an DT 0	overdose NN B-noun.act	of IN 0	venlafaxine NN B-noun.food	in IN 0	an DT 0	apparent JJ B-adj.all	suicide NN B-noun.artifact	attempt NN B-noun.act	. . 0	. . 0
a6666578.s5	TEM NNP 0	revealed VBD B-verb.perception	extensive JJ B-adj.all	elastolysis NN B-noun.food	in IN 0	the DT 0	arterial JJ B-adj.all	wall NN 0	of IN 0	D NNP 0	- : 0	pen SYM 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	, , 0	consistent JJ B-adj.all	with IN 0	an DT 0	inhibitory JJ B-adj.all	effect NN B-noun.cognition	on IN 0	crosslink NN B-noun.artifact	formation NN B-noun.act	. . 0	. . 0
a891050.s2	She PRP 0	was VBD 0	treated VBN B-verb.change	with IN 0	heparin NN B-noun.person	, , 0	dipyridamole NN B-noun.person	and CC 0	hemodialysis NN B-noun.location	, , 0	and CC 0	after IN 0	more RBR B-noun.quantity	than IN 0	three CD 0	months NNS B-noun.person	, , 0	her PRP$ 0	urinary JJ B-adj.all	output NN B-noun.person	rose VBD B-verb.motion	above IN 0	500 CD B-adj.all	ml NN B-noun.quantity	, , 0	and CC 0	six CD B-adj.all	months NNS B-noun.person	after IN 0	the DT 0	onset NN B-noun.event	of IN 0	anuria NN B-noun.animal	, , 0	dialysis NN B-noun.relation	treatment NN I-noun.relation	was VBD 0	stopped VBN B-verb.stative	. . 0	. . 0
a19581773.s1	A DT 0	63-year JJ 0	- : 0	old JJ B-adj.all	male NN B-noun.person	experienced VBD B-verb.perception	sudden JJ B-adj.all	diplopia NN B-noun.communication	after IN 0	9 CD B-adj.all	weeks NNS B-noun.time	of IN 0	administration NN B-noun.time	of IN 0	pegylated_interferon_(IFN)_alpha-2b NNP B-noun.person	and CC 0	ribavirin NN B-noun.person	for IN 0	chronic_hepatitis NNP B-noun.group	C NNP 0	( ( 0	CHC NNP 0	) ) 0	. . 0	. . 0
a6387529.s4	Patients NNS B-noun.person	tapped VBD B-verb.contact	faster RBR B-adj.all	after IN 0	propranolol NN B-noun.person	than IN 0	diazepam NN B-noun.person	and CC 0	they PRP 0	were VBD B-verb.stative	more RBR B-adv.all	sedated VBN B-verb.emotion	after IN 0	diazepam NN B-noun.person	than IN 0	propranolol NN B-noun.person	. . 0	. . 0
a17175308.s4	The DT 0	patient JJ B-adj.all	cohort NN B-noun.person	( ( 0	14 CD B-adj.all	men NNS B-noun.person	, , 0	11 CD B-adj.all	women NNS B-noun.person	) ) 0	was VBD 0	treated VBN B-verb.change	with IN 0	SRL NNP 0	as IN 0	conversion NN 0	therapy NN 0	, , 0	due JJ 0	to TO 0	chronic_allograft_nephropathy NNP 0	( ( 0	CAN MD 0	) ) 0	( ( 0	n UH 0	= $ 0	15 CD B-adj.all	) ) 0	neoplasia NN B-noun.quantity	( ( 0	n FW 0	= FW 0	8) FW 0	, , 0	Kaposi's_sarcoma NNP B-noun.person	, , 0	Four CD B-noun.group	skin_cancers NNS I-noun.group	, , 0	One CD 0	intestinal_tumors NNS B-noun.person	, , 0	One CD 0	renal_cell_carsinom NN B-noun.act	) ) 0	or CC 0	BK NNP 0	virus NN 0	nephropathy JJ 0	( ( 0	n UH 0	= : 0	2 LS 0	) ) 0	. . 0	. . 0
a17175308.s6	Mean VB B-verb.stative	follow VB 0	- : 0	up RB 0	on IN 0	SRL NNP 0	therapy NN 0	was VBD B-verb.stative	20 CD B-adj.all	+ SYM 0	/- $ 0	12 CD B-adj.all	( ( 0	6 CD 0	to TO 0	43 CD 0	) ) 0	months NNS B-noun.person	. . 0	. . 0
a12483326.s0	Severe JJ B-adj.all	ocular_and_orbital_toxicity NN B-noun.state	after IN 0	intracarotid JJ B-adj.all	injection NN B-noun.event	of IN 0	carboplatin NN B-noun.food	for IN 0	recurrent NN B-noun.act	glioblastomas NNS B-noun.communication	. . 0	. . 0
a6888657.s3	The DT 0	cell NN B-noun.body	populations NNS B-noun.person	were VBD 0	examined VBN B-verb.perception	regarding VBG B-verb.stative	total JJ B-adj.all	cell NN B-noun.body	recovery NN I-noun.body	correlated VBD B-verb.stative	with IN 0	gland NN B-noun.artifact	weight NN B-noun.artifact	, , 0	intracellular JJ B-adj.all	prolactin NN B-noun.substance	( ( 0	PRL NNP 0	) ) 0	content NN B-noun.quantity	and CC 0	subsequent JJ B-adj.all	release NN B-noun.act	in IN 0	primary JJ B-adj.all	culture NN B-noun.cognition	, , 0	immunocytochemical JJ B-adj.all	PRL NNP 0	staining VBG B-verb.change	, , 0	density NN B-noun.quantity	and/or NN 0	size NN B-noun.attribute	alterations NNS B-noun.artifact	via IN 0	separation NN B-noun.state	on IN 0	Ficoll NNP B-noun.person	- : 0	Hypaque NN B-noun.person	and CC 0	by IN 0	unit NN B-noun.artifact	gravity NN B-noun.possession	sedimentation NN B-noun.act	, , 0	and CC 0	cell NN B-noun.body	cycle NN 0	analysis NN 0	, , 0	after IN 0	acriflavine JJ 0	DNA NN 0	staining VBG B-verb.change	, , 0	by IN 0	laser NN B-adj.all	flow NN B-noun.plant	cytometry NN B-noun.state	. . 0	. . 0
a12820454.s8	Severe NNP B-noun.person	and CC 0	clinically RB B-adv.all	evident JJ B-adj.all	anemia NN B-noun.state	of IN 0	Hb NNP 0	< $ 0	11 CD B-adj.all	g FW 0	/ FW 0	dl FW 0	with IN 0	clinical JJ B-adj.all	symptoms NNS B-noun.body	was VBD 0	detected VBN B-verb.perception	in IN 0	6 CD B-adj.all	patients NNS B-noun.person	( ( 0	14.3 CD 0	% NN 0	) ) 0	. . 0	. . 0
a18081909.s3	Frequency NN B-noun.person	of IN 0	generalized JJ B-adj.all	tonic JJ B-adj.pert	- : 0	clonic_seizures NNS B-noun.object	increased VBN B-verb.change	from IN 0	one CD 0	per IN 0	6 CD B-adj.all	months NNS B-noun.person	to TO 0	two CD 0	per IN 0	month NN B-noun.animal	. . 0	. . 0
a2348231.s4	Therefore RB 0	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	hyperemic JJ B-adj.all	response NN B-noun.communication	to TO 0	dipyridamole VB B-verb.change	in IN 0	seven CD 0	open JJ B-noun.person	- : 0	chest NN B-noun.group	anesthetized JJ B-adj.all	dogs NNS B-noun.communication	after IN 0	pretreatment NN B-noun.person	with IN 0	either DT 0	pentoxifylline NN B-noun.location	( ( 0	0 CD B-noun.quantity	, , 0	7.5 CD 0	, , 0	or CC 0	15 CD 0	mg FW 0	/ FW 0	kg FW 0	i.v FW 0	. . 0	) ) 0	. . 0
a2549018.s2	The DT 0	typical JJ B-adj.all	fluoxetine NN B-noun.person	- : 0	induced VBN B-verb.creation	symptoms NNS B-noun.cognition	of IN 0	restlessness NN B-noun.act	, , 0	constant JJ B-adj.all	pacing NN B-noun.artifact	, , 0	purposeless JJ B-adj.all	movements NNS B-noun.person	of IN 0	the DT 0	feet NNS B-noun.body	and CC 0	legs NNS B-noun.body	, , 0	and CC 0	marked VBD B-verb.communication	anxiety NN B-noun.person	were VBD B-verb.stative	indistinguishable JJ B-adj.all	from IN 0	those DT 0	of IN 0	neuroleptic JJ B-adj.all	- : 0	induced VBN B-verb.creation	akathisia NN B-noun.artifact	. . 0	. . 0
a11166519.s8	Additional JJ B-adj.all	studies NNS B-noun.act	of IN 0	these DT 0	murine NN B-noun.act	strains NNS B-noun.artifact	may MD 0	be VB B-verb.stative	useful JJ B-adj.all	for IN 0	investigating VBG B-verb.creation	genetic JJ B-adj.all	influences NNS B-noun.cognition	on IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.feeling	. . 0	. . 0
a2008831.s1	The DT 0	effects NNS B-noun.phenomenon	of IN 0	intracoronary JJ B-adj.all	administration NN B-noun.time	of IN 0	methylergonovine NN B-noun.food	were VBD 0	studied VBN B-verb.cognition	in IN 0	21 CD B-adj.all	patients NNS B-noun.person	with IN 0	variant_angina NNP B-noun.person	and CC 0	22 CD B-adj.all	patients NNS B-noun.person	with IN 0	atypical JJ B-adj.all	chest_pain NN B-noun.communication	and CC 0	in IN 0	others NNS 0	without IN 0	angina_pectoris NNP 0	( ( 0	control NN 0	group NN 0	) ) 0	. . 0	. . 0
a11569530.s9	3 LS 0	. . 0	. . 0
a3676049.s3	Anaesthesia NNP B-noun.person	was VBD 0	maintained VBN B-verb.stative	with IN 0	an DT 0	inspired VBN B-verb.creation	isoflurane NN 0	concentration NN B-noun.event	of IN 0	0.75 CD 0	% NN 0	( ( 0	plus CC 0	67 CD 0	% NN 0	nitrous_oxide CD 0	in IN 0	oxygen NN 0	) ) 0	, , 0	during IN 0	which WDT 0	CBF NNP B-noun.group	and CC 0	CMRO2 NNP B-noun.person	were VBD B-verb.stative	34.3 CD 0	+ : 0	/- $ 0	2.1 CD 0	ml/100 CD B-noun.quantity	g IN 0	min-1 JJ 0	and CC 0	2.32 CD 0	+ : 0	/- $ 0	0.16 CD 0	ml/100 CD 0	g IN 0	min-1 NN B-noun.time	at IN B-adj.all	PaCO2 JJ I-adj.all	4.1 CD 0	+ : 0	/- $ 0	0.1 CD 0	kPa CD 0	( ( 0	mean VB B-verb.stative	+ RP 0	/- DT 0	SEM NNP B-noun.group	) ) 0	. . 0	. . 0
a2312209.s1	A DT 0	78-year JJ 0	- : 0	old JJ 0	with IN 0	healed VBN B-verb.social	septal JJ B-adj.all	necrosis NN B-noun.person	suffered VBD B-verb.cognition	a DT 0	recurrent NN B-noun.artifact	myocardial_infarction NN 0	of IN 0	the DT 0	anterior JJ B-adj.all	wall NN 0	following VBG 0	the DT 0	administration NN B-noun.time	of IN 0	isosorbide_dinitrate JJ B-noun.communication	5 CD B-adj.all	mg NN B-noun.quantity	sublingually RB B-adv.all	. . 0	. . 0
a11897407.s1	Infarct SYM 0	- : 0	avid JJ B-adj.all	radiopharmaceuticals NNS B-noun.artifact	are VBP B-verb.stative	necessary JJ B-adj.all	for IN 0	rapid JJ B-adj.all	and CC 0	timely JJ B-adj.all	diagnosis NN B-noun.person	of IN 0	acute JJ B-adj.all	myocardial_infarction NN B-noun.person	. . 0	. . 0
a6229975.s5	The DT 0	timolol NN B-noun.group	- : 0	related JJ B-adj.all	increase NN B-noun.act	in IN 0	heart NN 0	size NN B-noun.attribute	was VBD 0	observed VBN B-verb.perception	only RB B-adv.all	in IN 0	patients NNS B-noun.person	with IN 0	normal JJ B-adj.all	and CC 0	borderline NN B-noun.body	heart NN B-noun.body	size NN B-noun.attribute	. . 0	. . 0
a16330766.s5	Using VBG B-verb.consumption	functional JJ B-adj.all	magnetic JJ B-adj.all	resonance NN B-noun.phenomenon	imaging NN B-noun.attribute	( ( 0	fMRI NNP B-noun.person	) ) 0	in IN 0	normal JJ B-adj.all	volunteers NNS B-noun.person	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	gabapentin NN B-noun.communication	- : 0	induced VBN B-verb.creation	modulation NN B-noun.process	of IN 0	brain NN B-noun.phenomenon	activity NN B-noun.process	in IN 0	response NN B-noun.communication	to TO 0	nociceptive JJ B-adj.all	mechanical JJ B-adj.all	stimulation NN B-noun.process	of IN 0	normal JJ B-adj.all	skin NN B-noun.person	and CC 0	capsaicin NN B-noun.person	- : 0	induced VBN B-verb.creation	secondary_hyperalgesia NNP B-noun.location	. . 0	. . 0
a2348231.s1	Dipyridamole SYM 0	- : 0	thallium-201 JJ 0	imaging NN B-noun.attribute	is VBZ B-verb.stative	often RB B-adv.all	performed VBN B-verb.social	in IN 0	patients NNS B-noun.location	unable JJ B-adj.all	to TO 0	exercise VB B-verb.body	because IN 0	of IN 0	peripheral_vascular_disease NN B-noun.person	. . 0	. . 0
a15632880.s1	BACKGROUND NN 0	, , 0	A DT 0	previous JJ B-adj.all	randomized VBN I-adj.all	controlled VBN B-verb.social	trial NN B-noun.act	evaluating VBG B-verb.change	the DT 0	use NN 0	of IN 0	spironolactone NN 0	in IN 0	heart_failure NN B-noun.location	patients NNS B-noun.person	reported VBD B-verb.communication	a DT 0	low JJ B-adj.all	risk NN 0	of IN 0	hyperkalemia NN 0	( ( 0	2 CD B-adj.all	% NN 0	) ) 0	and CC 0	renal_insufficiency NN B-noun.person	( ( 0	0 CD B-noun.quantity	% NN 0	) ) 0	. . 0	. . 0
a8302922.s0	Epidural JJ B-adj.pert	blood NN B-noun.attribute	flow NN B-noun.process	during IN 0	prostaglandin_E1 JJ B-noun.other	or CC 0	trimethaphan RBR B-adj.all	induced JJ 0	hypotension NN 0	. . 0	. . 0
a1732369.s7	The DT 0	most RBS 0	important JJ B-adj.all	findings NNS B-noun.act	were VBD B-verb.stative	that IN 0	compared VBN B-verb.stative	with IN 0	values NNS B-noun.attribute	in IN 0	control NN B-noun.act	subjects NNS B-noun.artifact	, , 0	end NN B-noun.person	- : 0	systolic NN B-noun.person	left VBD B-verb.motion	ventricular JJ B-adv.all	posterior JJ B-adj.all	wall NN 0	dimension NN 0	and CC 0	percent NN B-noun.person	of IN 0	left JJ B-adj.all	ventricular JJ B-adj.all	posterior JJ B-adj.all	wall NN 0	thickening NN 0	in IN 0	doxorubicin NN B-noun.act	- : 0	treated VBN B-verb.communication	patients NNS B-noun.person	were VBD 0	decreased VBN B-verb.change	at IN 0	baseline NN B-noun.act	study NN B-noun.artifact	and CC 0	these DT 0	findings NNS B-noun.act	were VBD B-verb.stative	more RBR B-adv.all	clearly RB B-adv.all	delineated VBN B-verb.contact	with IN 0	dobutamine NN 0	stimulation NN B-noun.artifact	. . 0	. . 0
a11642480.s1	Current JJ B-adj.all	estimates NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	between IN 0	0.4 CD 0	% NN 0	and CC 0	8.3 CD 0	% NN 0	of IN 0	children NNS B-noun.person	and CC 0	adolescents NNS B-noun.person	are VBP 0	affected VBN B-verb.change	by IN 0	major_depression NN B-noun.time	. . 0	. . 0
a10704919.s1	Tamoxifen NNP B-noun.person	( ( 0	TAM NNP 0	) ) 0	, , 0	the DT 0	antiestrogenic JJ B-noun.artifact	drug NN I-noun.artifact	most RBS 0	widely RB B-adv.all	prescribed VBN B-verb.communication	in IN 0	the DT 0	chemotherapy NN B-noun.communication	of IN 0	breast_cancer NN B-noun.person	, , 0	induces VBZ B-verb.creation	changes NNS B-noun.phenomenon	in IN 0	normal JJ B-adj.all	discoid JJ B-adj.all	shape NN 0	of IN 0	erythrocytes NNS B-noun.time	and CC 0	hemolytic_anemia NNP B-noun.location	. . 0	. . 0
a11027905.s8	These DT 0	episodes NNS B-noun.communication	reversed VBD B-verb.change	after IN 0	the DT 0	administration NN B-noun.time	of IN 0	diazepam NN B-noun.communication	1 CD B-adj.all	mg NN B-noun.quantity	intravenously RB B-adv.all	. . 0	. . 0
a4071154.s3	Our PRP$ 0	case NN B-noun.state	supports VBZ B-verb.stative	the DT 0	hypothesis NN B-noun.communication	that WDT 0	endogenous JJ B-adj.all	renal JJ B-adj.all	prostaglandins NNS B-noun.person	play VBP B-verb.creation	a DT 0	role NN B-noun.attribute	in IN 0	the DT 0	maintenance NN B-noun.act	of IN 0	renal JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.time	when WRB 0	circulating VBG B-verb.communication	plasma NN B-noun.substance	volume NN B-noun.artifact	is VBZ 0	diminished VBN B-verb.change	. . 0	. . 0
a9334596.s25	Prolactin NNP B-noun.person	should MD 0	be VB 0	determined VBN B-verb.communication	only RB B-adv.all	in IN 0	cases NNS B-noun.person	of_low_sexual_desire,_gynecomastia NNP I-noun.person	and CC 0	/ $ 0	or_testosterone CD 0	less JJR B-noun.quantity	than IN 0	4 CD B-adj.all	ng./ml NNP B-noun.person	. . 0	. . 0
a2024540.s4	Subjects NNS B-noun.person	were VBD B-verb.stative	1210 CD 0	inpatients NNS B-noun.quantity	with IN 0	New NNP B-noun.group	York NNP I-noun.group	Heart NNP I-noun.group	Association NNP I-noun.group	( ( 0	NYHA NNP 0	) ) 0	functional JJ B-adj.all	class NN B-noun.group	II NNP 0	and CC 0	III NNP 0	. . 0	. . 0
a10520387.s6	Due JJ 0	to TO 0	the DT 0	risk NN 0	of IN 0	this DT 0	tachycardia NN B-noun.communication	inducing VBG B-verb.creation	myocardial_ischemia NN I-verb.creation	, , 0	we PRP 0	would MD 0	not RB B-adv.all	recommend VB B-verb.communication	the DT 0	use NN B-noun.person	in IN 0	elderly JJ B-adj.all	patients NNS B-noun.person	of IN 0	any DT 0	of IN 0	the DT 0	ephedrine NN B-noun.communication	/ : 0	propofol NN B-noun.time	/ : 0	mixtures NNS B-noun.person	studied VBN B-verb.cognition	. . 0	. . 0
a15458908.s5	RESULTS NNS B-noun.artifact	, , 0	During IN 0	a DT 0	mean JJ B-adj.all	follow NN B-noun.person	- : 0	up IN 0	of IN 0	3.3 CD 0	years NNS B-noun.attribute	, , 0	raloxifene NN B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	an DT 0	increased VBN B-verb.social	risk NN I-verb.social	for IN 0	venous_thromboembolism NN B-noun.artifact	( ( 0	relative JJ B-adj.all	risk NN B-noun.attribute	[ IN 0	RR NNP 0	] $ 0	2.1 CD 0	, , 0	95 CD 0	% NN 0	confidence NN B-noun.act	interval NN I-noun.act	[ '' 0	CI NNP 0	] $ 0	1.2 CD 0	- : 0	3.8 CD 0	) ) 0	. . 0	. . 0
a20621845.s6	MMP-2 NN B-noun.artifact	, , 0	MMP-9 NNP B-noun.person	, , 0	ADAM-10 NNP B-noun.person	and CC 0	ADAM-17 JJ B-noun.other	mRNA JJ B-adj.all	levels NNS B-noun.state	were VBD 0	increased VBN B-verb.change	in IN 0	CaCl(2)-treated JJ B-adj.all	segments NNS B-noun.person	( ( 0	all DT 0	p<0.01 NNP B-noun.location	) ) 0	, , 0	with IN 0	trends NNS B-noun.person	of IN 0	elevation NN B-noun.act	in IN 0	CaCl(2)-untreated JJ B-adj.all	segments NNS B-noun.person	, , 0	as IN 0	compared VBN B-verb.creation	with IN 0	NaCl NNP B-noun.person	- : 0	treated VBN B-verb.communication	segments NNS B-noun.person	. . 0	. . 0
a12820454.s1	BACKGROUND NN 0	, , 0	To TO 0	determine VB B-verb.communication	the DT 0	onset NN B-noun.event	and CC 0	extent NN B-noun.act	of IN 0	combined VBN B-verb.change	androgen NN B-adj.all	blockade NN B-noun.attribute	( ( 0	CAB)-induced VBN B-verb.contact	anemia NN B-noun.state	in IN 0	prostate_cancer NN B-noun.location	patients NNS B-noun.person	without IN 0	bone NN 0	involvement NN B-noun.artifact	. . 0	. . 0
a2071257.s0	Effect NN 0	of IN 0	L NNP 0	- : 0	alpha NN B-noun.person	- : 0	glyceryl NN B-noun.person	- : 0	phosphorylcholine NN B-noun.person	on IN 0	amnesia NN 0	caused VBN B-verb.communication	by IN 0	scopolamine NN B-noun.person	. . 0	. . 0
a6229975.s4	These DT 0	differences NNS B-noun.communication	may MD 0	be VB 0	caused VBN B-verb.communication	by IN 0	timolol NN B-noun.person	- : 0	induced VBN B-verb.creation	bradycardia NNS B-noun.person	and CC 0	a DT 0	compensatory JJ B-adj.all	increase NN B-noun.event	in IN 0	end NN 0	- : 0	diastolic JJ B-adj.all	volume NN B-noun.artifact	. . 0	. . 0
a18343374.s9	CONCLUSION(S LS 0	) ) 0	, , 0	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	reported VBN B-verb.communication	case NN B-noun.state	of IN 0	central JJ B-adj.pert	retinal_vein_occlusion NN B-noun.act	after IN 0	treatment NN B-noun.plant	with IN 0	CC NNP 0	. . 0	. . 0
a6287825.s0	Diseases_of_peripheral_nerves NNS B-noun.artifact	as IN 0	seen VBN B-verb.perception	in IN 0	the DT 0	Nigerian JJ B-noun.other	African NNP I-noun.other	. . 0	. . 0
a9195768.s0	The DT 0	site NN 0	of IN 0	common JJ B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	of IN 0	sumatriptan NN B-noun.time	. . 0	. . 0
a6666578.s4	In IN 0	addition NN 0	, , 0	the DT 0	endothelial JJ B-adj.all	permeability NN B-noun.person	and CC 0	the DT 0	penetration NN B-noun.artifact	through IN 0	the DT 0	aortic JJ B-adj.all	wall NN 0	of IN 0	albumin NN B-noun.person	were VBD 0	studied VBN B-verb.cognition	10 CD B-adj.all	minutes NNS B-noun.time	, , 0	24 CD B-adj.all	and CC 0	48 CD 0	hours NNS 0	after IN 0	i. : 0	v. CC 0	injection NN B-noun.quantity	of IN 0	human JJ B-adj.all	serum NN B-noun.body	131I SYM 0	- : 0	albumin NN B-noun.person	( ( 0	131I UH 0	- : 0	HSA NNP B-noun.group	) ) 0	. . 0	. . 0
a17854040.s1	This DT 0	was VBD B-verb.stative	an DT 0	exploratory JJ B-adj.all	study NN B-noun.artifact	to TO 0	investigate VB B-verb.communication	lamivudine NN B-noun.person	- : 0	resistant JJ B-adj.all	hepatitis NN 0	B NNP 0	virus NN B-noun.animal	( ( 0	HBV NNP 0	) ) 0	strains VBZ B-verb.stative	in IN 0	selected VBN B-verb.cognition	lamivudine NN B-noun.act	- : 0	na PRP 0	_ ( 0	ve IN 0	HBV NNP 0	carriers NNS 0	with IN 0	and CC 0	without IN 0	human_immunodeficiency_virus_(HIV)_co NNP B-noun.person	- : 0	infection NN B-noun.cognition	in IN 0	South JJ B-adj.all	African JJ B-adj.pert	patients NNS B-noun.person	. . 0	. . 0
a17042910.s17	Aortic JJ B-adj.all	superoxide NN B-noun.artifact	production NN B-noun.artifact	was VBD B-verb.stative	lower JJR B-adj.all	in IN 0	the DT 0	Dex NNP B-noun.person	+ NNP I-noun.person	Ato NNP I-noun.person	group NN 0	compared VBN B-verb.change	with IN 0	the DT 0	group NN 0	treated VBN B-verb.change	with IN 0	Dex NNP B-noun.person	alone RB B-adv.all	( ( 0	P NNP 0	< $ 0	0.0001 CD 0	) ) 0	. . 0	. . 0
a16160878.s7	Administration NN B-noun.person	of IN 0	graded JJ B-adj.all	doses NNS B-noun.person	of IN 0	U NNP 0	- : 0	II NNP 0	( ( 0	1 CD 0	- : 0	10,000 CD 0	ng PRP 0	/ `` 0	mouse NN B-noun.animal	) ) 0	provoked VBD B-verb.communication	, , 0	( ( 0	1 CD 0	) ) 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	reduction NN B-noun.act	in IN 0	the DT 0	number NN B-noun.quantity	of IN 0	head NN B-noun.location	dips NNS B-noun.person	in IN 0	the DT 0	hole NN B-noun.shape	- : 0	board NN B-noun.substance	test NN I-noun.substance	, , 0	( ( 0	2 CD 0	) ) 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	reduction NN B-noun.act	in IN 0	the DT 0	number NN B-noun.quantity	of IN 0	entries NNS B-noun.Tops	in IN 0	the DT 0	white JJ B-adj.all	chamber NN B-noun.body	in IN 0	the DT 0	black JJ B-noun.person	- : 0	and CC 0	- : 0	white JJ 0	compartment NN 0	test NN 0	, , 0	and CC 0	in IN 0	the DT 0	number NN B-noun.quantity	of IN 0	entries NNS B-noun.Tops	in IN 0	the DT 0	central JJ B-adj.all	platform NN B-noun.cognition	and CC 0	open JJ B-adj.all	arms NNS B-noun.body	in IN 0	the DT 0	plus NN 0	- : 0	maze NN 0	test NN 0	, , 0	and CC 0	( ( 0	3 CD 0	) ) 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	increase NN B-noun.event	in IN 0	the DT 0	duration NN 0	of IN 0	immobility NN B-noun.state	in IN 0	the DT 0	forced VBN B-verb.creation	- : 0	swimming NN B-verb.motion	test NN 0	and CC 0	tail JJ B-noun.body	suspension NN 0	test NN 0	. . 0	. . 0
a7516729.s5	At IN 0	normal JJ B-adj.all	[ RB 0	Na]o JJ 0	, , 0	decrease VB B-verb.communication	( ( 0	0.675 CD 0	mM CD B-noun.quantity	) ) 0	or CC 0	increase VB B-verb.social	( ( 0	3.6 CD 0	mM CD B-noun.quantity	) ) 0	of IN 0	[ : 0	Ca]o NN B-noun.artifact	did VBD 0	not RB B-adv.all	modify VB B-verb.change	BF NNP 0	, , 0	a DT 0	reduction NN B-noun.act	of IN 0	ten CD B-adj.all	times NNS B-noun.event	( ( 0	0.135 CD 0	mM CD B-noun.quantity	of IN 0	normal JJ B-adj.all	[ : 0	Ca]o NN B-noun.person	was VBD B-verb.stative	effective JJ B-adj.all	to TO 0	reduce VB B-verb.change	BF NNP 0	by IN 0	40 CD B-adj.all	+ SYM 0	/- $ 0	13 CD B-adj.all	% NN 0	. . 0	. . 0
a15120741.s1	Similar JJ B-adj.all	to TO 0	rats NNS B-noun.animal	, , 0	systemic JJ B-adj.all	pilocarpine NN B-noun.person	injection NN B-noun.person	causes VBZ B-verb.communication	status_epilepticus NNP B-noun.other	( ( 0	SE NNP 0	) ) 0	and CC 0	the DT 0	eventual JJ B-adj.all	development NN B-noun.process	of IN 0	spontaneous JJ B-adj.all	seizures NNS B-noun.act	and CC 0	mossy JJS 0	fiber NN 0	sprouting NN B-verb.contact	in IN 0	C57BL/6 NNP B-noun.other	and CC 0	CD1 JJ B-noun.body	mice NNS I-noun.body	, , 0	but CC 0	the DT 0	physiological JJ B-noun.body	correlates NNS I-noun.body	of IN 0	these DT 0	events NNS B-noun.artifact	have VBP 0	not RB 0	been VBN 0	identified VBN B-verb.cognition	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a20882060.s8	CONCLUSION NN B-noun.group	, , 0	Activation NNP B-noun.person	of IN 0	pallidal JJ B-adj.all	neurotensin NN B-noun.person	receptors NNS B-noun.person	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	neurotensin NN B-noun.act	- : 0	induced VBN B-verb.creation	antiparkinsonian JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a12820454.s2	PATIENTS NNPS B-noun.group	AND CC 0	METHODS NNS B-noun.attribute	, , 0	Forty NNP B-noun.person	- : 0	two CD 0	patients NNS B-noun.person	with IN 0	biopsy NN B-noun.food	- : 0	proven VBN B-verb.cognition	prostatic_adenocarcinoma NNP I-verb.cognition	[ $ 0	26 CD 0	with IN 0	stage NN B-noun.artifact	C NNP 0	( ( 0	T3N0M0 NNP 0	) ) 0	and CC 0	16 CD B-adj.all	with IN 0	stage NN B-noun.artifact	D1 : 0	( ( 0	T3N1M0 NNP 0	) ) 0	] PRP 0	were VBD 0	included VBN B-verb.stative	in IN 0	this DT 0	study NN B-noun.artifact	. . 0	. . 0
a230316.s5	The DT 0	most RBS 0	common JJ B-noun.person	manifestation NN B-noun.person	, , 0	observed VBN B-verb.perception	in IN 0	15 CD B-adj.all	further JJ B-adj.all	cases NNS B-noun.person	, , 0	was VBD 0	isolated VBN B-verb.change	optic_atrophy NN I-verb.change	. . 0	. . 0
a3676049.s2	Flow NN B-noun.plant	and CC 0	metabolism NN B-noun.artifact	were VBD 0	measured VBN B-verb.stative	5 CD B-adj.all	- : 0	13 CD B-adj.all	days NNS B-noun.phenomenon	after IN 0	the DT 0	subarachnoid_haemorrhage NN B-noun.artifact	by IN 0	a DT 0	modification NN B-noun.time	of IN 0	the DT 0	classical JJ B-noun.person	Kety NNP I-noun.person	- : 0	Schmidt NNP B-noun.person	technique NN I-noun.person	using VBG B-verb.consumption	xenon-133 JJ B-noun.person	i.v NNP I-noun.person	. . 0	. . 0
a15036754.s1	Such JJ B-adj.all	organophosphorus NN B-noun.cognition	( ( 0	OP NNP 0	) ) 0	compounds VBZ B-verb.stative	as IN 0	diisopropylfluorophosphate NN B-noun.person	( ( 0	DFP NNP 0	) ) 0	, , 0	sarin NN B-noun.person	and CC 0	soman NN B-noun.communication	are VBP B-verb.stative	potent JJ B-adj.all	inhibitors NNS B-noun.person	of IN 0	acetylcholinesterases NNS B-noun.quantity	( ( 0	AChEs NNP B-noun.person	) ) 0	and CC 0	butyrylcholinesterases NNS B-noun.person	( ( 0	BChEs NNP B-noun.person	) ) 0	. . 0	. . 0
a15957009.s7	and CC 0	metrifonate NN B-noun.attribute	( ( 0	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	p.o RB 0	. . 0	, , 0	. . 0
a10520387.s0	The DT 0	haemodynamic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	propofol NN B-noun.person	in IN 0	combination NN 0	with IN 0	ephedrine NN B-noun.person	in IN 0	elderly JJ B-adj.all	patients NNS B-noun.person	( ( 0	ASA NNP 0	groups NNS B-noun.group	3 CD 0	and CC 0	4 CD B-adj.all	) ) 0	. . 0	. . 0
a10807237.s7	In IN 0	patients NNS B-noun.person	in IN 0	the DT 0	study NN B-noun.artifact	group NN I-noun.artifact	, , 0	all DT 0	aneurysms NNS B-noun.object	were VBD 0	located VBN B-verb.change	in IN 0	the DT 0	anterior JJ B-adj.all	circulation NN B-noun.act	. . 0	. . 0
a12596116.s1	The DT 0	authors NNS B-noun.person	report VBP B-verb.stative	2 CD B-adj.all	cases NNS B-noun.quantity	of IN 0	premature JJ B-adj.all	neonates NNS B-noun.person	who WP 0	had VBD B-verb.body	enterocutaneous JJ B-adj.all	fistula NN 0	complicating VBG B-verb.stative	necrotizing_enterocolitis NN 0	. . 0	. . 0
a17175308.s2	More RBR B-adv.all	recently RB B-adv.all	, , 0	proteinuria NN B-noun.person	has VBZ 0	been VBN 0	reported VBN B-verb.communication	as IN 0	a DT 0	consequence NN B-noun.attribute	of IN 0	sirolimus NN 0	therapy NN 0	, , 0	although IN 0	the DT 0	mechanism NN B-noun.object	has VBZ 0	remained VBN B-verb.change	unclear JJ B-adj.all	. . 0	. . 0
a8302922.s1	To TO 0	evaluate VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	prostaglandin_E1 NNP B-noun.person	( ( 0	PGE1 NN 0	) ) 0	or CC 0	trimethaphan NN B-noun.communication	( ( 0	TMP NNP 0	) ) 0	induced VBN B-verb.creation	hypotension NN 0	on IN 0	epidural JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	( ( 0	EBF NNP 0	) ) 0	during IN 0	spinal JJ B-adj.all	surgery NN B-noun.location	, , 0	EBF NNP 0	was VBD 0	measured VBN B-verb.cognition	using VBG B-verb.consumption	the DT 0	heat NN B-noun.cognition	clearance NN B-noun.act	method NN B-noun.attribute	in IN 0	30 CD B-adj.all	patients NNS B-noun.person	who WP 0	underwent VBD B-verb.social	postero NNS B-noun.person	- : 0	lateral JJ B-adj.all	interbody NN 0	fusion NN B-noun.act	under IN 0	isoflurane NN 0	anaesthesia NN 0	. . 0	. . 0
a18343374.s10	Extra JJ B-adj.all	caution NN B-noun.communication	is VBZ 0	warranted VBN B-verb.communication	in IN 0	treating VBG B-verb.change	infertility NN B-noun.phenomenon	patients NNS B-noun.person	with IN 0	CC NNP 0	, , 0	and CC 0	patients NNS B-noun.person	should MD 0	be VB B-verb.stative	well RB 0	informed VBN B-verb.communication	of IN 0	this DT 0	side NN 0	effect NN 0	before IN 0	commencement NN B-noun.relation	of IN 0	therapy NN B-noun.act	. . 0	. . 0
a12443032.s2	The DT 0	emergency NN B-noun.state	nurse NN I-noun.state	ought MD 0	to TO 0	be VB B-verb.stative	familiar JJ B-adj.all	with IN 0	some DT 0	of IN 0	the DT 0	cardiovascular JJ B-adj.all	consequences NNS B-noun.phenomenon	of IN 0	cocaine NN 0	use NN 0	. . 0	. . 0
a11256525.s5	One CD 0	week NN 0	later RB B-adv.all	, , 0	by IN 0	mistake NN 0	, , 0	losartan NN B-noun.person	was VBD 0	prescribed VBN B-verb.communication	again RB B-adv.all	and CC 0	after IN 0	the DT 0	second JJ B-adj.all	dose NN B-noun.event	of IN 0	50 CD B-adj.all	mg NN B-noun.quantity	, , 0	the DT 0	patient NN B-noun.person	developed VBD B-verb.body	a DT 0	second JJ B-adj.all	episode NN B-noun.communication	of IN 0	transient NN B-verb.motion	anuria NN 0	lasting VBG B-verb.stative	10 CD B-adj.all	hours NNS B-noun.person	. . 0	. . 0
a9625142.s0	Acute NNP B-noun.person	hepatitis NNP I-noun.person	, , 0	autoimmune_hemolytic_anemia NN B-noun.person	, , 0	and CC 0	erythroblastocytopenia NN B-noun.person	induced VBN B-verb.creation	by IN 0	ceftriaxone NN 0	. . 0	. . 0
a3676049.s0	Cerebral JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	and CC 0	metabolism NN B-noun.artifact	during IN 0	isoflurane NN B-noun.person	- : 0	induced VBN B-verb.creation	hypotension NN 0	in IN 0	patients NNS B-noun.person	subjected VBD B-verb.social	to TO 0	surgery NN B-noun.location	for IN 0	cerebral_aneurysms NNS B-noun.location	. . 0	. . 0
a9401499.s1	In IN 0	this DT 0	study NN B-noun.artifact	, , 0	three CD 0	Chinese JJ B-adj.all	patients NNS B-noun.person	with IN 0	ticlopidine NN B-noun.person	- : 0	induced VBN B-verb.creation	aplastic_anemia NNP B-noun.person	were VBD 0	reported VBN B-verb.communication	and CC 0	another DT 0	13 CD B-adj.all	patients NNS B-noun.person	in IN 0	the DT 0	English JJ B-adj.all	literature NN B-noun.person	were VBD 0	reviewed VBN B-verb.change	. . 0	. . 0
a2673163.s2	Among IN 0	these DT 0	47 CD 0	patients NNS B-noun.quantity	the DT 0	mean NN B-noun.attribute	( ( 0	+ UH 0	/- : 0	SD NNP 0	) ) 0	age NN B-noun.quantity	was VBD B-verb.stative	32.5 CD 0	+ : 0	/- $ 0	12.1 CD 0	years NNS B-noun.quantity	, , 0	76 CD 0	% NN 0	( ( 0	34/45 CD 0	) ) 0	were VBD B-verb.stative	men NNS B-noun.person	. . 0	. . 0
a20882060.s5	RESULTS NNS B-noun.artifact	, , 0	Bilateral JJ B-adj.all	infusions NNS B-noun.cognition	of IN 0	neurotensin NN B-noun.food	into IN 0	the DT 0	globus JJ B-adj.all	pallidus NN B-noun.person	reversed VBD B-verb.change	haloperidol NN B-noun.person	- : 0	induced VBN B-verb.creation	parkinsonian_catalepsy NNP B-noun.person	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a18343374.s0	Central JJ B-adj.all	retinal_vein_occlusion NN B-noun.motive	associated VBN B-verb.cognition	with IN 0	clomiphene NN B-noun.person	- : 0	induced VBN B-verb.creation	ovulation NN B-noun.act	. . 0	. . 0
a10807237.s4	This DT 0	group NN B-noun.motive	was VBD 0	compared VBN B-verb.change	with IN 0	a DT 0	control NN B-noun.act	group NN B-noun.act	of IN 0	135 CD 0	patients NNS B-noun.person	with IN 0	ruptured_aneurysms NNS B-noun.person	and CC 0	no DT 0	history NN B-noun.cognition	of IN 0	cocaine_abuse NN 0	. . 0	. . 0
a14698717.s1	The DT 0	development NN B-noun.process	of IN 0	psychosis NN B-noun.person	related VBN B-verb.communication	to TO 0	antiepileptic JJ B-adj.all	drug NN B-noun.relation	treatment NN I-noun.relation	is VBZ B-verb.stative	usually RB B-adv.all	attributed VBN B-verb.social	to TO 0	the DT 0	interaction NN B-noun.act	between IN 0	the DT 0	epileptic JJ B-adj.all	brain NN B-noun.person	substratum NN B-noun.person	and CC 0	the DT 0	antiepileptic JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a20621845.s2	METHODS NNS B-noun.attribute	, , 0	Thoracic NNP B-noun.person	aorta NN I-noun.person	of IN 0	male NN B-noun.person	Sprague NNP B-noun.person	- : 0	Dawley NN B-noun.person	rats NNS I-noun.person	was VBD 0	exposed VBN B-verb.perception	to TO 0	0.5 CD 0	M NNP B-noun.group	CaCl(2 NNP I-noun.group	) ) 0	or CC 0	normal JJ B-adj.all	saline NN B-noun.act	( ( 0	NaCl NNP B-noun.person	) ) 0	. . 0	. . 0
a20621845.s7	Immunohistochemistry NNP B-noun.person	displayed VBD B-verb.communication	significantly RB B-adv.all	increased VBD B-verb.change	expressions NNS B-noun.communication	of IN 0	MMP-2 NN B-noun.other	, , 0	MMP-9 NNP B-noun.person	, , 0	ADAM-10 NNP B-noun.person	and CC 0	ADAM-17 NN B-noun.person	( ( 0	all DT 0	p<0.01 NNP B-noun.location	) ) 0	in IN 0	intima NN B-noun.animal	and CC 0	media NNS B-noun.person	for IN 0	CaCl(2)-treated JJ B-adj.all	segments NNS B-noun.person	. . 0	. . 0
a6386793.s5	There EX 0	were VBD B-verb.stative	no DT 0	clinically RB B-adv.all	important JJ B-adj.all	changes NNS B-noun.communication	in IN 0	laboratory NN B-noun.artifact	parameters NNS B-noun.person	. . 0	. . 0
a1436384.s2	Here RB 0	its PRP$ 0	ability NN B-noun.motive	to TO 0	antagonize VB B-verb.cognition	the DT 0	prolonged VBN B-adj.all	depletion NN B-noun.process	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.artifact	by IN 0	amphetamine NN B-noun.person	in IN 0	iprindole NN B-noun.attribute	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	is VBZ 0	reported VBN B-verb.communication	. . 0	. . 0
a869641.s2	decreased VBN B-verb.change	blood NN B-noun.act	pressure NN B-noun.act	and CC 0	heart NN B-noun.body	rate NN B-noun.time	after IN 0	extracerebral JJ B-adj.all	decarboxylase NN B-noun.event	inhibition NN 0	with IN 0	MK-486 NNP B-noun.other	( ( 0	25 CD 0	mg FW 0	/ FW 0	kg FW 0	i.v FW 0	. . 0	) ) 0	. . 0
a8421099.s2	During IN 0	treatment NN B-noun.plant	with IN 0	octreotide NN 0	, , 0	17 CD B-adj.all	patients NNS B-noun.person	developed VBD B-verb.creation	sludge NN B-noun.attribute	, , 0	10 CD B-adj.all	had VBD 0	gallstones NNS B-noun.artifact	, , 0	and CC 0	1 CD 0	developed VBD B-verb.communication	acute_cholecystitis RP 0	requiring VBG B-verb.stative	surgery NN B-adv.all	. . 0	. . 0
